Processing 00000000.tx.1: Rockefeller University Press, 0022-1007 $8.00 JEM, Volume 199, Number 9, 1213-1221 This Article Abstract PDF (Full Text) Alert me when this article is cited Citation Map Services Alert me to new content in the JEM Download to citation manager Cited by other online articles Google Scholar Articles by Metelitsa, L. 

Phrase: "Rockefeller University Press,"

Phrase: "0022-1007 $8.00 JEM,"

Phrase: "Volume 199,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "Number 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "1213-1221"

Phrase: "This Article Abstract PDF (Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: ")"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205314:New [Temporal Concept]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "in the JEM Download"

Phrase: "to citation manager"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0335141:manager [Professional or Occupational Group]
   861   C1546507:Manager [Idea or Concept]

Phrase: "Cited by other online articles Google Scholar Articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0684017:scholar [Professional or Occupational Group]
   711   C1706852:Article [Intellectual Product]

Phrase: "by Metelitsa,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.2: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: Articles by Seeger, R. 

Phrase: "Articles by Seeger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.4: C. 

Phrase: "C."
Processing 00000000.tx.5: Articles citing this Article PubMed PubMed Citation Articles by Metelitsa, L. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Metelitsa,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.6: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.7: Articles by Seeger, R. 

Phrase: "Articles by Seeger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.8: C. 

Phrase: "C."
Processing 00000000.tx.9: Natural Killer T Cells Infiltrate Neuroblastomas Expressing the Chemokine CCL2 Leonid S. 

Phrase: "Natural Killer T Cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C2350466:Natural Killer T-Cells [Cell]
   923   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   923   C0039195:killer t cells [Cell]
   923   C2363836:Natural Killer Cells [Laboratory Procedure]
   875   C0022686:Killer Cells [Cell]
   861   C0039194:T-Cells [Cell]
   861   C2709199:Natural killer [Cell]
   812   C0007634:Cells [Cell]
   812   C0205296:Natural [Functional Concept]
   812   C1336644:KILLER [Gene or Genome]
   812   C1705132:KILLER [Gene or Genome]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "Infiltrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332448:Infiltrate [Pathologic Function]
  1000   C1546677:Infiltrate [Intellectual Product]
  1000   C1549537:Infiltrate [Functional Concept]

Phrase: "Neuroblastomas"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027819:Neuroblastomas [Neoplastic Process]
   966 E C0700095:neuroblastoma [Neoplastic Process]
   966 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "Expressing"

Phrase: "the Chemokine CCL2 Leonid S."
Processing 00000000.tx.10: Metelitsa1, Hong-Wei Wu1, Hong Wang1, Yujun Yang1, Zamir Warsi1, Shahab Asgharzadeh1, Susan Groshen2, S. 

Phrase: "Metelitsa1,"

Phrase: "Hong-Wei Wu1,"

Phrase: "Hong Wang1,"

Phrase: "Yujun Yang1,"

Phrase: "Zamir Warsi1,"

Phrase: "Shahab Asgharzadeh1,"

Phrase: "Susan Groshen2,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.11: Brian Wilson3, and Robert C. 

Phrase: "Brian Wilson3,"

Phrase: "and"

Phrase: "Robert C."
Processing 00000000.tx.12: Seeger1,4 1 Department of Pediatrics, Division of Hematology-Oncology, Childrens Hospital Los Angeles and 2 Biostatistics Core Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90027 3 Cancer Immunology and AIDS Department, Dana Farber Cancer Institute, Boston, MA 02115 4 Children's Oncology Group, Arcadia, CA 91006 Address correspondence to Robert C. 

Phrase: "Seeger1,"

Phrase: "4 1 Department of Pediatrics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587482:department pediatrics [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Division of Hematology-Oncology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "Childrens Hospital Los Angeles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024015:Los Angeles [Geographic Area]

Phrase: "and"

Phrase: "2 Biostatistics Core Department of Preventive Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704729:Department [Organization]

Phrase: "Keck School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Southern California,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006754:California [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1710133:Southern [Spatial Concept]
   812   C3146274:California [Plant]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA 90027 3 Cancer Immunology"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C1521825:Cancer Immunology [Biomedical Occupation or Discipline]
   804   C0152036:Immunology [Biomedical Occupation or Discipline]
   804   C1522005:immunology [Qualitative Concept]
   733 E C0205470:Immunological [Functional Concept]
   708   C0006826:CA - Cancer [Neoplastic Process]

Phrase: "and"

Phrase: "AIDS Department,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704729:Department [Organization]

Phrase: "Dana Farber Cancer Institute,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1511716:Dana-Farber Cancer Institute [Health Care Related Organization]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115 4 Children's Oncology Group,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1516477:Children's Oncology Group [Health Care Related Organization]
   827   C1518578:Oncology Group [Professional or Occupational Group]
   799   C0441833:Group [Idea or Concept]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]

Phrase: "Arcadia,"

Phrase: "CA 91006 Address correspondence to Robert C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.13: Seeger, Dept. of Pediatrics, Div. of Hematology-Oncology, MS #57, Childrens Hospital Los Angeles, 4650 Sunset Blvd., Los Angeles, CA 90027. 

Phrase: "Seeger,"

Phrase: "Dept."

Phrase: "of Pediatrics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030755:Paediatrics [Biomedical Occupation or Discipline]

Phrase: "Div."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:div. [Functional Concept]

Phrase: "of Hematology-Oncology,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1441600:Hematology+Oncology [Biomedical Occupation or Discipline]
  1000   C1555762:Hematology & Oncology [Professional or Occupational Group]
   861   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   861   C0200627:HEMATOLOGY [Laboratory Procedure]
   861   C0278627:Oncology [Biomedical Occupation or Discipline]
   789 E C0205478:Oncologic [Biomedical Occupation or Discipline]
   789 E C0205488:Haematologic [Functional Concept]

Phrase: "MS #57,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Childrens Hospital Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024015:Los Angeles [Geographic Area]

Phrase: "4650 Sunset Blvd.,"

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA 90027."
Processing 00000000.tx.14: Phone: (323) 669-5618; 

Phrase: "Phone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1515258:Phone [Conceptual Entity]
  1000   C1705541:Phone [Manufactured Object]
   907 E C0042939:Voice [Organism Function]
   907 E C3244282:voice [Qualitative Concept]
   893 E C0205382:Vocal [Functional Concept]
   893 E C0871074:phonic [Intellectual Product]

Phrase: ":"

Phrase: "(323"

Phrase: ")"

Phrase: "669-5618"

Phrase: ";"
Processing 00000000.tx.15: Fax: (323) 664-9455; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "(323"

Phrase: ")"

Phrase: "664-9455"

Phrase: ";"
Processing 00000000.tx.16: email: rseeger{at}chla.usc.edu  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  CD1d-restricted V24-J18invariant natural killer T cells (iNKTs) are potentially important in tumor immunity. 

Phrase: "email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "rseeger{at}chla.usc.edu  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "CD1d-restricted V24-J18invariant natural killer T cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   861   C2350466:Natural Killer T-Cells [Cell]
   842   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   842   C2363836:Natural Killer Cells [Laboratory Procedure]
   835   C0039195:killer t cells [Cell]
   822   C0022686:Killer Cells [Cell]
   812   C0039194:T-Cells [Cell]
   812   C2709199:Natural killer [Cell]
   793   C0007634:Cells [Cell]
   793   C0205296:Natural [Functional Concept]
   793   C1336644:KILLER [Gene or Genome]
   793   C1705132:KILLER [Gene or Genome]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "(iNKTs"

Phrase: ")"

Phrase: "are"

Phrase: "potentially important in tumor immunity."
Processing 00000000.tx.17: However, little is known about their localization to tumors. 

Phrase: "However,"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about their localization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205309:Known [Qualitative Concept]
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "to tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]
Processing 00000000.tx.18: We analyzed 98 untreated primary neuroblastomas from patients with metastatic disease (stage 4) for tumor-infiltrating iNKTs using TaqMan reverse transcription polymerase chain reaction and immunofluorescent microscopy. 

Phrase: "We"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "98 untreated primary neuroblastomas from patients"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0027819:Neuroblastomas [Neoplastic Process]
   719 E C0700095:neuroblastoma [Neoplastic Process]
   719 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "with metastatic disease (stage 4"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   861   C0027627:metastatic disease [Neoplastic Process]
   861   C0441772:Stage 4 [Intellectual Product]
   861   C0699749:disease stage [Diagnostic Procedure]
   861   C2939420:metastatic disease [Neoplastic Process]
   847   C0622037:Mal.4 [Organic Chemical,Pharmacologic Substance]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0036525:Metastatic [Functional Concept]
   812   C0205390:Stage [Temporal Concept]
   812   C1300072:Stage [Clinical Attribute]
   812   C1306673:Stage [Qualitative Concept]
   812   C1522484:metastatic [Quantitative Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "for tumor-infiltrating iNKTs"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TaqMan reverse transcription polymerase chain reaction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   861   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0035380:Reverse Transcription [Genetic Function]
   799   C0040649:Transcription [Genetic Function]
   799   C0337112:Chain [Manufactured Object]
   799   C0443286:Reaction [Functional Concept]
   799   C1114821:Reaction [Clinical Attribute]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1524075:Chain [Idea or Concept]
   799   C1555029:Reverse [Idea or Concept]

Phrase: "and"

Phrase: "immunofluorescent microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.19: 52 tumors (53%) contained iNKTs, and oligonucleotide microarray analysis of the iNKT+ and iNKT tumors revealed that the former expressed higher levels of CCL2/MCP-1, CXCL12/SDF-1, CCL5/RANTES, and CCL21/SLC. 

Phrase: "52 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "(53%"

Phrase: ")"

Phrase: "contained iNKTs,"

Phrase: "and"

Phrase: "oligonucleotide microarray analysis of the iNKT+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1449575:Microarray Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "iNKT tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the former expressed higher levels of CCL2/MCP-1,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C0456947:Level 1 [Intellectual Product]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "CXCL12/SDF-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0218504:SDF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1704964:SDF-1 [Gene or Genome]

Phrase: "CCL5/RANTES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0072978:RANTES [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1522559:RANTES [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "CCL21/SLC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332684:SLC [Gene or Genome]
   861   C1705075:SLC [Gene or Genome]
Processing 00000000.tx.20: Eight tested neuroblastoma cell lines secreted a range of CCL2 (021.6 ng/ml), little CXCL12 (0.1 ng/ml), and no detectable CCL5 or CCL21. 

Phrase: "Eight tested neuroblastoma cell lines"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C0007600:Cell lines [Cell]
   840   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0027819:Neuroblastoma [Neoplastic Process]
   804   C0205132:lines [Spatial Concept]
   804   C0700095:neuroblastoma [Neoplastic Process]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C3540583:Neuroblastoma [Intellectual Product]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "a range of CCL2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "(021.6 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "little CXCL12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0218504:CXCL12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1332817:CXCL12 [Gene or Genome]

Phrase: "(0.1 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "no detectable CCL5"

Phrase: "or"

Phrase: "CCL21."
Processing 00000000.tx.21: CCR2, the receptor for CCL2, was more frequently expressed by iNKT compared with natural killer and T cells from blood (P < 0.001). 

Phrase: "CCR2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413188:CCR2 [Gene or Genome]
  1000   C3538748:CCR2 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "the receptor for CCL2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "more frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332183:Frequently [Temporal Concept]

Phrase: "expressed by iNKT"

Phrase: "compared with natural killer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2709199:Natural killer [Cell]
   770   C0205296:Natural [Functional Concept]
   770   C1336644:KILLER [Gene or Genome]
   770   C1705132:KILLER [Gene or Genome]
   770   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "T cells from blood"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0039194:T-Cells [Cell]
   819   C0005773:Blood Cells [Cell]
   775 E C2328697:Hemal cell [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.22: Supernatants of neuroblastoma cell lines that produced CCL2 induced in vitro migration of iNKTs from blood of patients and normal adults; 

Phrase: "Supernatants of neuroblastoma cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550101:Supernatant [Body Substance]

Phrase: "that produced CCL2"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "in vitro migration of iNKTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "from blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "normal adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001675:Adults [Age Group]
   827 E C1706450:Adult [Human]

Phrase: ";"
Processing 00000000.tx.23: this was abrogated by an anti-CCL2 monoclonal antibody. 

Phrase: "this"

Phrase: "was"

Phrase: "abrogated by an anti-CCL2 monoclonal antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0746619:monoclonal [Finding]
Processing 00000000.tx.24: CCL2 expression by tumors was found to inversely correlate with MYCN proto-oncogene amplification and expression (r = 0.5, P < 0.001), and MYCN-high/CCL2-low expression accurately predicted the absence of iNKTs (P < 0.001). 

Phrase: "CCL2 expression by tumors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to inversely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "correlate with MYCN proto-oncogene amplification"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0033713:Proto-Oncogene [Gene or Genome]
   783   C0812287:Oncogene MYCN [Gene or Genome]
           MYCN
   753   C0029016:Oncogene [Gene or Genome]
   753   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705027:MYCN [Gene or Genome]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(r = 0.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0444499:0/5 [Quantitative Concept]
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "MYCN-high/CCL2-low expression accurately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "the absence of iNKTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.25: In summary, iNKTs migrate toward neuroblastoma cells in a CCL2-dependent manner, preferentially infiltrating MYCN nonamplified tumors that express CCL2. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "iNKTs"

Phrase: "migrate toward neuroblastoma cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   816   C0815000:neuroblastoma cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0027819:Neuroblastoma [Neoplastic Process]
   770   C0232902:migrate [Functional Concept]
   770   C0700095:neuroblastoma [Neoplastic Process]
   770   C3282337:Cells [Cell]
   770   C3540583:Neuroblastoma [Intellectual Product]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in a CCL2-dependent manner,"

Phrase: "preferentially"

Phrase: "infiltrating"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332448:Infiltrating [Pathologic Function]
   966 E C1546677:Infiltrate [Intellectual Product]
   966 E C1549537:Infiltrate [Functional Concept]

Phrase: "MYCN nonamplified tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]

Phrase: "that"

Phrase: "express"

Phrase: "CCL2."
Processing 00000000.tx.26: Key Words: lymphocytes  tumor-infiltrating  T lymphocyte subsets  cell movement  immunologic surveillance Abbreviations used in this paper: GalCer, -galactosylceramide; 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "lymphocytes  tumor-infiltrating  T lymphocyte subsets  cell movement  immunologic surveillance Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1547566:Paper [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "GalCer, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016960:Galactosylceramide [Biologically Active Substance,Lipid]

Phrase: "galactosylceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016960:Galactosylceramide [Biologically Active Substance,Lipid]

Phrase: ";"
Processing 00000000.tx.27: DAPI, 4',6-diamidine-2'-phenylindole dihydrochloride; 

Phrase: "DAPI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "4',"

Phrase: "6-diamidine-2'-phenylindole dihydrochloride"

Phrase: ";"
Processing 00000000.tx.28: FU, fluorescence units; 

Phrase: "FU,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C2348686:Fluorescence Units [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "fluorescence units"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C2348686:Fluorescence Units [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.29: IHC, immunohistochemistry; 

Phrase: "IHC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.30: iNKT, V24-J18invariant natural killer T cell; 

Phrase: "iNKT,"

Phrase: "V24-J18invariant natural killer T cell"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   901   C2350466:Natural Killer T-Cell [Cell]
   867   C0022688:Natural killer cell [Cell]
           Killer cell
   861   C0039195:Killer T cell [Cell]
   839   C0022686:Killer cell [Cell]
   827   C0039194:T-cell [Cell]
   827   C2709199:Natural killer [Cell]
   799   C0007634:Cell [Cell]
   799   C0205296:Natural [Functional Concept]
   799   C1269647:Cell [Cell]
   799   C1336644:KILLER [Gene or Genome]
   799   C1704653:Cell [Medical Device]
   799   C1705132:KILLER [Gene or Genome]
   799   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.31: TEM, transendothelial migration.  

Phrase: "TEM,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2936223:Transendothelial Migration [Organ or Tissue Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "transendothelial migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2936223:Transendothelial Migration [Organ or Tissue Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.32: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  V24-J18invariant natural killer T cells (iNKTs) are an evolutionarily conserved subset of T cells that depend on CD1d for their development and that specifically recognize -galactosylceramide (GalCer) bound to CD1d. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "V24-J18invariant natural killer T cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   901   C2350466:Natural Killer T-Cells [Cell]
   867   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   867   C2363836:Natural Killer Cells [Laboratory Procedure]
   861   C0039195:killer t cells [Cell]
   839   C0022686:Killer Cells [Cell]
   827   C0039194:T-Cells [Cell]
   827   C2709199:Natural killer [Cell]
   799   C0007634:Cells [Cell]
   799   C0205296:Natural [Functional Concept]
   799   C1336644:KILLER [Gene or Genome]
   799   C1705132:KILLER [Gene or Genome]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "(iNKTs"

Phrase: ")"

Phrase: "are"

Phrase: "an evolutionarily conserved subset of T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C0080202:T-Cell Subset [Cell]
   748   C1515021:Subset [Classification]

Phrase: "that"

Phrase: "depend on CD1d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0725813:depend [Medical Device]
   790   C1413210:CD1D [Gene or Genome]

Phrase: "for their development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "that specifically"

Phrase: "recognize -"

Phrase: "galactosylceramide (GalCer)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016960:Galactosylceramide [Biologically Active Substance,Lipid]

Phrase: "bound to CD1d."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1413210:CD1D [Gene or Genome]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.33: iNKTs respond to specific stimulation by rapidly producing a spectrum of cytokines including IL-13 and IL-4 (type 2) and IFN- (type 1; references 1, 2). 

Phrase: "iNKTs"

Phrase: "respond to specific stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205369:Specific [Qualitative Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1552740:specific [Intellectual Product]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "producing"

Phrase: "a spectrum of cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883073:Spectrum [Quantitative Concept]
   770   C2827424:Spectrum [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "IL-13"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0214743:IL 13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "IL-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "(type 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441730:Type 2 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "IFN- (type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441729:Type 1 [Classification]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ";"

Phrase: "references"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.34: iNKTs may be a part of the innate immune reaction and promote initiation of acquired immune responses (3). 

Phrase: "iNKTs"

Phrase: "may"

Phrase: "be"

Phrase: "a part of the innate immune reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "initiation of acquired immune responses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0589507:Initiation [Mental Process]
   760   C1158830:Initiation [Genetic Function]
   760   C1704686:Initiation [Functional Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.35: iNKTs are potentially important in tumor immunity (4, 5). 

Phrase: "iNKTs"

Phrase: "are"

Phrase: "potentially important in tumor immunity"

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.36: They can naturally prevent formation of chemical carcinogeninduced tumors in mice (6, 7) and eradicate established tumors in mice after GalCer injection by inducing NK cells to produce IL-12 and IFN- (8). 

Phrase: "They"

Phrase: "can"

Phrase: "naturally"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "formation of chemical carcinogeninduced tumors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: "and"

Phrase: "eradicate"

Phrase: "established tumors in mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0027651:Tumors [Neoplastic Process]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "after GalCer injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "by inducing NK cells to"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   884   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   884   C2363836:Natural Killer Cells [Laboratory Procedure]
   840   C0022686:Killer Cells [Cell]
   840   C2709199:Natural killer [Cell]
   804   C0007634:Cells [Cell]
   804   C0205296:Natural [Functional Concept]
   804   C1336644:KILLER [Gene or Genome]
   804   C1705132:KILLER [Gene or Genome]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "produce"

Phrase: "IL-12"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0123759:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1149217:IL-12 [Molecular Function]
  1000   C1524115:IL-12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "IFN- (8"

Phrase: ")."
Processing 00000000.tx.37: However, a murine model of tumor growth-regression-recurrence suggested that, without exogenous stimulation, iNKTs may prevent CTL-mediated tumor eradication by producing IL-13 (9, 10). 

Phrase: "However,"

Phrase: "a murine model of tumor growth-regression-recurrence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1710493:Tumor Model [Intellectual Product]
   744   C3161035:Model [Intellectual Product]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "without exogenous stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "iNKTs"

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "CTL-mediated tumor eradication by producing IL-13"

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.38: Recent phase I clinical trials with GalCer-pulsed dendritic cells demonstrated that in vivo stimulation of iNKTs leads to modulation of NK, T, and B cell numbers and increased serum IFN- (11, 12). 

Phrase: "Recent phase I clinical trials with GalCer-pulsed dendritic cells"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0920321:Phase I Clinical Trials [Research Activity]
           i phase trials
   795 E C0282459:Clinical Trial, Phase I [Research Activity]
   760   C0008976:Clinical Trials [Research Activity]
           Trial
   760   C1096775:clinical trials [Intellectual Product]
   741   C1710475:Trial Phase [Classification]
   741   C1879951:Trial Phase [Intellectual Product]
   739   C0205210:Clinical [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that in vivo stimulation of iNKTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "leads to modulation of NK,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C2709199:Natural killer [Cell]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C0205296:Natural [Functional Concept]
   753   C0443264:Modulation [Spatial Concept]
   753   C1336644:KILLER [Gene or Genome]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1705132:KILLER [Gene or Genome]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "B cell numbers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007584:Numbers, Cell [Laboratory Procedure]
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]
   734   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "increased serum IFN- (11,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205217:Increased [Quantitative Concept]
   812   C0229671:Serum [Body Substance]
   812   C0442805:Increased [Functional Concept]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.39: Presumably, iNKT cell effector functions occur within the tumor microenvironment, but little is known about their infiltration into tumors. 

Phrase: "Presumably,"

Phrase: "iNKT cell effector functions"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   875   C0007613:cell functions [Cell Function]
   812   C0542341:Functions [Functional Concept]
   779 E C0031843:function [Physiologic Function]
   779 E C0700205:FUNCTION [Classification]
   779 E C1705273:Function [Intellectual Product]
   729 E C0205245:Functional [Functional Concept]
   729 E C2700217:Functional [Conceptual Entity]

Phrase: "occur within the tumor microenvironment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C2936626:Tumor Microenvironment [Natural Phenomenon or Process]
   760   C0027651:Tumor [Neoplastic Process]
   760   C1578706:Tumor [Intellectual Product]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C3273930:Tumor [Finding]

Phrase: "but"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about their infiltration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205309:Known [Qualitative Concept]
   770   C0332448:Infiltration [Pathologic Function]
   770   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   770   C1523986:Infiltration [Functional Concept]

Phrase: "into tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]
Processing 00000000.tx.40: Recent studies of human myeloma, lung adenocarcinomas, and lung squamous cell carcinomas demonstrated iNKTs in the tumor microenvironment (13, 14), but the mechanisms of their localization were not investigated. 

Phrase: "Recent studies of human myeloma,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0178693:human studies [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "lung adenocarcinomas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0152013:Lung adenocarcinoma [Neoplastic Process]
   861   C0001418:Adenocarcinomas [Neoplastic Process]

Phrase: "and"

Phrase: "lung squamous cell carcinomas"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   983   C0149782:lung squamous cell carcinoma [Neoplastic Process]
   923   C0007137:Squamous Cell Carcinomas [Neoplastic Process]
           Squamous Carcinomas
   886   C0684249:Lung Carcinoma [Neoplastic Process]
   861   C0221910:Squamous cell [Cell]
   812   C0007097:Carcinomas [Neoplastic Process]
   812   C0007634:Cell [Cell]
   812   C1182670:Squamous [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "demonstrated"

Phrase: "iNKTs in the tumor microenvironment"

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the mechanisms of their localization"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.41: Human iNKTs express chemokine receptors that may enable their migration into extra lymphoid tissues (15); 

Phrase: "Human iNKTs"

Phrase: "express"

Phrase: "chemokine receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524914:Receptors, Chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "may"

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "their migration into extra lymphoid tissues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C2755541:tissue migration [Organ or Tissue Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "(15"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.42: therefore, we hypothesized that they infiltrate tumors in response to one or more chemokines. 

Phrase: "therefore,"

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "they"

Phrase: "infiltrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332448:Infiltrate [Pathologic Function]
  1000   C1546677:Infiltrate [Intellectual Product]
  1000   C1549537:Infiltrate [Functional Concept]

Phrase: "tumors in response"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   841   C3539879:Tumor Response [Idea or Concept]
   790   C0027651:Tumors [Neoplastic Process]
   756 E C1578706:Tumor [Intellectual Product]
   756 E C3273930:Tumor [Finding]

Phrase: "to one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more chemokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.43: Similar to many types of cancer, lymphocytes have been detected in neuroblastomas from patients (16), and most are T cells with varying proportions of CD4+, CD8+, and double negative subsets (17). 

Phrase: "Similar to many types of cancer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "have"

Phrase: "been"

Phrase: "detected in neuroblastomas"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0027819:Neuroblastomas [Neoplastic Process]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C0700095:neuroblastoma [Neoplastic Process]
   756 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "are"

Phrase: "T cells with varying proportions of CD4+,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0039194:T-Cells [Cell]
   774   C0039215:cd4 cells [Cell]
   774   C3251824:Cells.CD4 [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "CD8+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538720:CD8 [Laboratory Procedure]
  1000   C3540595:CD8 [Gene or Genome]

Phrase: "and"

Phrase: "double negative subsets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1515021:Subset [Classification]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.44: We determined if some of these infiltrating T cells were iNKTs and if their localization was associated with intratumor expression of chemokines. 

Phrase: "We"

Phrase: "determined"

Phrase: "if"

Phrase: "some of these infiltrating T cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   790   C0039194:T-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0205392:Some [Quantitative Concept]
   753   C0332448:Infiltrating [Pathologic Function]
   753   C3282337:Cells [Cell]
   753   C3540770:Some [Intellectual Product]
   719 E C1269647:Cell [Cell]
   719 E C1546677:Infiltrate [Intellectual Product]
   719 E C1549537:Infiltrate [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "iNKTs"

Phrase: "and"

Phrase: "if"

Phrase: "their localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "associated with intratumor expression of chemokines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1517565:Intratumor [Functional Concept]
   753   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.45: 42% of neuroblastomas from patients with metastatic disease contain iNKTs, and their presence was highly correlated with expression of the chemokine CCL2. 

Phrase: "42% of neuroblastomas"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0027819:Neuroblastomas [Neoplastic Process]
   756 E C0700095:neuroblastoma [Neoplastic Process]
   756 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with metastatic disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0027627:metastatic disease [Neoplastic Process]
  1000   C2939420:metastatic disease [Neoplastic Process]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "iNKTs,"

Phrase: "and"

Phrase: "their presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "was"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "correlated with expression of the chemokine CCL2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0128897:Chemokine CCL2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1707520:Correlated [Qualitative Concept]
Processing 00000000.tx.46: Of note, tumors with genomic amplification and high expression of the MYCN oncogene had low expression of CCL2 and little or no iNKT infiltration. 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "tumors with genomic amplification"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0027651:Tumors [Neoplastic Process]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "high expression of the MYCN oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "had"

Phrase: "low expression of CCL2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no iNKT infiltration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]
Processing 00000000.tx.47: Last, we show that human neuroblastoma cell lines can secrete CCL2, which mediates transendothelial migration (TEM) of fresh blood iNKTs in vitro.  

Phrase: "Last,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517741:Last [Qualitative Concept]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that human neuroblastoma cell lines"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   906   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell lines [Cell]
   861   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0027819:Neuroblastoma [Neoplastic Process]
   812   C0205132:lines [Spatial Concept]
   812   C0700095:neuroblastoma [Neoplastic Process]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C3540583:Neuroblastoma [Intellectual Product]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "can"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "CCL2,"

Phrase: "which"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "transendothelial migration (TEM) of fresh blood iNKTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2936223:Transendothelial Migration [Organ or Tissue Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.48: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Neuroblastomas, Blood Specimens, and Cell Lines. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Neuroblastomas,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027819:Neuroblastomas [Neoplastic Process]
   966 E C0700095:neuroblastoma [Neoplastic Process]
   966 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "Blood Specimens,"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
   966   C0178913:Blood specimen [Body Substance]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "Cell Lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.49: 98 primary untreated stage 4 neuroblastomas were analyzed. 

Phrase: "98 primary untreated stage 4 neuroblastomas"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   850   C0278694:Stage 4 Neuroblastoma [Neoplastic Process]
   799   C0027819:Neuroblastomas [Neoplastic Process]
   766 E C0700095:neuroblastoma [Neoplastic Process]
   766 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.50: 79 tumors, which were diagnosed after 1 yr of age, were obtained from patients enrolled in Children's Cancer Group study CCG-3891 for high-risk neuroblastoma. 

Phrase: "79 tumors,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "which"

Phrase: "were"

Phrase: "diagnosed after 1 yr of age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011900:Diagnosed [Finding]
   753   C0439234:yr [Temporal Concept]

Phrase: "were"

Phrase: "obtained from patients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "enrolled in Children's Cancer Group study CCG-3891"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   800   C1516476:Children's Cancer Group [Health Care Related Organization]
           CCG
   793   C0278704:Cancer in Children [Neoplastic Process]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0008059:Children [Age Group]
   744   C0441833:Group [Idea or Concept]
   744   C0557651:Study [Manufactured Object]
   744   C0680063:Children [Family Group]
   744   C0687744:group [Population Group]
   744   C0998265:Cancer [Eukaryote]
   744   C1257890:Group [Population Group]
   744   C1306459:Cancer [Finding]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C2603343:Study [Research Activity]

Phrase: "for high-risk neuroblastoma."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C3540583:Neuroblastoma [Intellectual Product]
   734   C0332167:High Risk [Qualitative Concept]
   734   C3272283:High Risk [Finding]
Processing 00000000.tx.51: CCG-3891 used a single induction regimen consisting of cisplatin, doxorubicin, etoposide, and cyclophosphamide as well as surgery. 

Phrase: "CCG-3891"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516476:CCG [Health Care Related Organization]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a single induction regimen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040808:Regimen [Therapeutic or Preventive Procedure]
   827   C2945654:regimen [Intellectual Product]

Phrase: "consisting of cisplatin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008838:Cisplatin [Inorganic Chemical,Pharmacologic Substance]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "doxorubicin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013089:Doxorubicin [Antibiotic,Organic Chemical]

Phrase: "etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "cyclophosphamide"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0010583:Cyclophosphamide [Organophosphorus Compound,Pharmacologic Substance]
   944 E C0699319:Cytoxan [Organophosphorus Compound,Pharmacologic Substance]
   944 E C0699320:Endoxan [Organophosphorus Compound,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "surgery."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038894:Surgery [Biomedical Occupation or Discipline]
  1000   C0038895:surgery [Functional Concept]
  1000   C0543467:Surgery [Health Care Activity]
Processing 00000000.tx.52: This was followed by randomized assignment to either further chemotherapy (ifosfamide, doxorubicin, etoposide, and cisplatin) or myeloablative chemoradiotherapy (carboplatin, etoposide, melphalan, and total body irradiation) supported by purged autologous bone marrow transplantation. 

Phrase: "This"

Phrase: "was"

Phrase: "followed by randomized assignment"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0034656:randomized [Research Activity]
   770   C1516050:Assignment [Functional Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "to either further chemotherapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   827   C0013217:chemotherapy [Functional Concept]
   827   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: "(ifosfamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020823:Ifosfamide [Organophosphorus Compound,Pharmacologic Substance]

Phrase: "doxorubicin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013089:Doxorubicin [Antibiotic,Organic Chemical]

Phrase: "etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "cisplatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008838:Cisplatin [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "myeloablative chemoradiotherapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0436307:Chemoradiotherapy [Therapeutic or Preventive Procedure]

Phrase: "(carboplatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079083:Carboplatin [Organic Chemical,Pharmacologic Substance]

Phrase: "etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "melphalan,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0025241:Melphalan [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   944 E C0591063:Alkeran [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "total body irradiation"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0043162:Total Body Irradiation [Therapeutic or Preventive Procedure]
   901   C0229960:Total body [Fully Formed Anatomical Structure]
   827   C0242821:body [Human]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1282930:Irradiation [Natural Phenomenon or Process]
   827   C1522449:irradiation [Therapeutic or Preventive Procedure]
   743 E C1995017:Bodies [Cell Component]

Phrase: ")"

Phrase: "supported by purged autologous bone marrow transplantation."
Meta Candidates (Total=24; Excluded=3; Pruned=0; Remaining=21)
   853   C0194037:autologous bone marrow transplantation [Therapeutic or Preventive Procedure]
           Autologous Marrow Transplantation
   814   C0005961:Bone Marrow Transplantation [Therapeutic or Preventive Procedure]
           Marrow Transplantation
   814   C2986504:Autologous Bone Marrow [Body Substance]
   778   C0005953:Bone Marrow [Tissue]
   774   C0005976:Bone Transplantation [Therapeutic or Preventive Procedure]
   774   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   748   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   748   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   748   C0040733:transplantation [Functional Concept]
   748   C0086590:Marrow [Food]
   748   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   748   C0376152:Marrow [Body Part, Organ, or Organ Component]
   748   C0391978:Bone [Tissue]
   748   C0439859:Autologous [Qualitative Concept]
   748   C1266908:Bone [Body Part, Organ, or Organ Component]
   748   C1266909:Bone [Body System]
   748   C1521721:Supported [Conceptual Entity]
   748   C1546708:Marrow [Intellectual Product]
   748   C1548399:purged [Idea or Concept]
   746 E C1708973:Medullary Bone [Tissue]
   714 E C0183683:Support [Medical Device]
   714 E C0722910:Purge [Lipid,Pharmacologic Substance]
Processing 00000000.tx.53: Finally, patients were randomized to receive 13-cis retinoic acid beginning 100 d after autologous bone marrow transplantation or no further treatment (18). 

Phrase: "Finally,"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "randomized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034656:randomized [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "13-cis retinoic acid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0022265:13-cis-Retinoic Acid [Organic Chemical,Pharmacologic Substance]
           cis-retinoic acid
   875   C0109872:cis-acid [Organic Chemical,Pharmacologic Substance]
   861   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C1504308:Cis [Eukaryote]

Phrase: "beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "100 d after autologous bone marrow transplantation"

Phrase: "or"

Phrase: "no further treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.54: 19 tumors were obtained from children who were diagnosed before 1 yr of age and who were enrolled in protocol CCG-3881 for intermediate-risk neuroblastoma. 

Phrase: "19 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "were"

Phrase: "obtained from children"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0008059:Children [Age Group]
   790   C0680063:Children [Family Group]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "who"

Phrase: "were"

Phrase: "diagnosed before 1 yr of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011900:Diagnosed [Finding]
   753   C0439234:yr [Temporal Concept]

Phrase: "and"

Phrase: "who"

Phrase: "were"

Phrase: "enrolled in protocol CCG-3881"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0442711:Protocol [Intellectual Product]
   760   C1507394:Protocol [Intellectual Product]
   760   C1516476:CCG [Health Care Related Organization]
   760   C1522729:Protocol [Intellectual Product]
   760   C2348563:Protocol [Intellectual Product]

Phrase: "for intermediate-risk neuroblastoma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C3540583:Neuroblastoma [Intellectual Product]
   734   C3640764:Intermediate Risk [Conceptual Entity]
Processing 00000000.tx.55: After surgery at diagnosis, these patients received cyclophosphamide, cisplatin, etoposide, and doxorubicin at 28-d intervals for 9 mo. 

Phrase: "After surgery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038894:Surgery [Biomedical Occupation or Discipline]
  1000   C0038895:surgery [Functional Concept]
  1000   C0543467:Surgery [Health Care Activity]

Phrase: "at diagnosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "these patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "cyclophosphamide,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0010583:Cyclophosphamide [Organophosphorus Compound,Pharmacologic Substance]
   944 E C0699319:Cytoxan [Organophosphorus Compound,Pharmacologic Substance]
   944 E C0699320:Endoxan [Organophosphorus Compound,Pharmacologic Substance]

Phrase: "cisplatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008838:Cisplatin [Inorganic Chemical,Pharmacologic Substance]

Phrase: "etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "doxorubicin at 28-d intervals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013089:Doxorubicin [Antibiotic,Organic Chemical]

Phrase: "for 9 mo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]
Processing 00000000.tx.56: Specimens were snap frozen within 2 h of surgery in foil or after embedding in OCT compound and were maintained at 80C. 

Phrase: "Specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370003:specimens [Substance]
   966 E C2347026:Specimen [Conceptual Entity]

Phrase: "were"

Phrase: "snap"

Phrase: "frozen within 2 h of surgery"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0011744:h 2 [Element, Ion, or Isotope]
   753   C0016701:Frozen [Natural Phenomenon or Process]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0038894:Surgery [Biomedical Occupation or Discipline]
   753   C0038895:surgery [Functional Concept]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0543467:Surgery [Health Care Activity]
   753   C0564385:/h [Quantitative Concept]
   753   C0677542:Frozen [Functional Concept]

Phrase: "in foil"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1551385:Foil [Manufactured Object]
  1000   C1705857:Foil [Manufactured Object]

Phrase: "or after embedding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707903:Embedding [Laboratory Procedure]

Phrase: "in OCT compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205198:Compound [Qualitative Concept]
   861   C1706082:Compound [Chemical]

Phrase: "and"

Phrase: "were"

Phrase: "maintained at 80C."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]
Processing 00000000.tx.57: PBMCs were isolated from freshly obtained blood from normal adult donors or newly diagnosed patients with stage 4, high-risk neuroblastoma enrolled in Children's Oncology Group study A3973. 

Phrase: "PBMCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321301:PBMC [Cell]

Phrase: "were"

Phrase: "isolated from freshly obtained blood"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0205409:Isolated [Functional Concept]
   760   C0229664:Blood [Body Substance]
   760   C1301820:Obtained [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1706701:Obtain [Activity]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "from normal adult donors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0013018:Donors [Population Group]
   827   C1527169:Donors [Finding]
   793 E C0040288:Donor [Population Group]

Phrase: "or"

Phrase: "newly diagnosed patients with stage 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "high-risk neuroblastoma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C3540583:Neuroblastoma [Intellectual Product]
   734   C0332167:High Risk [Qualitative Concept]
   734   C3272283:High Risk [Finding]

Phrase: "enrolled in Children's Oncology Group study A3973."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C1516477:Children's Oncology Group [Health Care Related Organization]
   778   C1518578:Oncology Group [Professional or Occupational Group]
   748   C0008059:Children [Age Group]
   748   C0278627:Oncology [Biomedical Occupation or Discipline]
   748   C0441833:Group [Idea or Concept]
   748   C0557651:Study [Manufactured Object]
   748   C0680063:Children [Family Group]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C2603343:Study [Research Activity]
Processing 00000000.tx.58: LA-N-1 and LA-N-2 neuroblastoma cell lines were established in our laboratory (19), and CHLA-15, CHLA-20, SMS-KAN, SMS-KANR, SMS-KCN, and SMS-KCNR neuroblastoma cell lines were provided by C.P. 

Phrase: "LA-N-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023031:La [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "LA-N-2 neuroblastoma cell lines"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   827   C0007600:Cell lines [Cell]
   827   C0815000:neuroblastoma cell [Cell]
   799   C0007634:Cell [Cell]
   799   C0027819:Neuroblastoma [Neoplastic Process]
   799   C0205132:lines [Spatial Concept]
   799   C0700095:neuroblastoma [Neoplastic Process]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3540583:Neuroblastoma [Intellectual Product]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "established in our laboratory"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C0443211:Established [Qualitative Concept]
   770   C1272684:Established [Qualitative Concept]
   770   C3244292:laboratory [Functional Concept]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "CHLA-15,"

Phrase: "CHLA-20,"

Phrase: "SMS-KAN,"

Phrase: "SMS-KANR,"

Phrase: "SMS-KCN,"

Phrase: "and"

Phrase: "SMS-KCNR neuroblastoma cell lines"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C0007600:Cell lines [Cell]
   840   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0027819:Neuroblastoma [Neoplastic Process]
   804   C0205132:lines [Spatial Concept]
   804   C0700095:neuroblastoma [Neoplastic Process]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C3540583:Neuroblastoma [Intellectual Product]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "provided by C.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]
Processing 00000000.tx.59: Reynolds (Childrens Hospital, Los Angeles, CA). 

Phrase: "Reynolds"

Phrase: "(Childrens Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA)."
Processing 00000000.tx.60: All cell lines have been identity typed with the AmpliType assay (Applied Biosystems). 

Phrase: "All cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424215:Identity [Mental Process]
  1000   C2003939:Identity [Finding]

Phrase: "typed with the AmpliType assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]
   726   C0332307:Type [Qualitative Concept]
   726   C1547052:*Type [Quantitative Concept]

Phrase: "(Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.61: iNKT cell lines (>99% CD1d/GalCer-reactive) were established as described previously (20). 

Phrase: "iNKT cell lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
   734   C2350467:iNKT Cell [Cell]

Phrase: "("

Phrase: ">99% CD1d/GalCer-reactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205332:Reactive [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.62: Informed consent was obtained in accordance with institutional review board policies and procedures for research dealing with tumors and blood specimens. 

Phrase: "Informed consent"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]

Phrase: "was"

Phrase: "obtained in accordance with institutional review board policies"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0086911:Review Board, Institutional [Professional or Occupational Group]
   767   C0079630:Policies, Institutional [Intellectual Product]
   744   C0242456:Policies [Intellectual Product]
   744   C0282443:Review [Intellectual Product]
   744   C0972401:board [Medical Device]
   744   C1301820:Obtained [Functional Concept]
   744   C1552617:Review [Idea or Concept]
   744   C1948070:Board [Organization]
   711 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "procedures for research dealing"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: "with tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "blood specimens."
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
   966   C0178913:Blood specimen [Body Substance]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.63: Real-Time RT-PCR. 

Phrase: "Real-Time RT-PCR."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   861   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C1550177:Real Time [Idea or Concept]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0040223:Time [Temporal Concept]
   812   C0237400:Real [Qualitative Concept]
   812   C0677874:pCR [Finding]
   812   C3272377:REAL [Intellectual Product]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.64: TaqMan real-time RT-PCR was used to detect V24-J18 RNA with the Sequence Detection System (ABI Prism model 7700; Applied Biosystems). 

Phrase: "TaqMan real-time RT-PCR"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   888   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "V24-J18 RNA with the Sequence Detection System"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0162327:RNA Sequence [Nucleotide Sequence]
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(ABI Prism model 7700"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0814195:PRISM [Intellectual Product]
   812   C1328319:ABI [Clinical Attribute]
   812   C3161035:Model [Intellectual Product]
   756 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "; Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.65: The probe spanned the junction of V24-J18 TCR. 

Phrase: "The probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "spanned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the junction of V24-J18 TCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205144:Junction [Spatial Concept]
   753   C1706311:Junction [Medical Device]
Processing 00000000.tx.66: The forward primer was 5'-CCTCCCAGCTCAGCGATTC-3', and the reverse primer was 5'-TATAGCCTCCCCAGGGTTGA-3'. 

Phrase: "The forward primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953382:Forward primer [Cell]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "5'-CCTCCCAGCTCAGCGATTC-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "the reverse primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "5'-TATAGCCTCCCCAGGGTTGA-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.67: The probe was FAM-5'-CCTCCTACATCTGTGTGGTGAGCGACA-3'-TAMTph. 

Phrase: "The probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "FAM-5'-CCTCCTACATCTGTGTGGTGAGCGACA-3'-TAMTph."
Processing 00000000.tx.68: The probe design was based on the sequence from GenBank/EMBL/DDBJ accession nos. 

Phrase: "The probe design"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "was"

Phrase: "based on the sequence"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   802   C0004793:Base Sequence [Nucleotide Sequence]
           Sequence
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from GenBank/EMBL/DDBJ accession nos."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1518425:{NOS} [Qualitative Concept]
Processing 00000000.tx.69: HSTCRA002 for V24 and S63026 for J18, respectively. 

Phrase: "HSTCRA002 for V24"

Phrase: "and"

Phrase: "S63026 for J18,"

Phrase: "respectively."
Processing 00000000.tx.70: The probe for CCL2 was FAM-5'-CCAAGGAGATCTGTGCTGACCCCAA-3'-TAMTph, and the primers were designed between exon 2 and exon 3. 

Phrase: "The probe for CCL2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0182400:Probe [Medical Device]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "FAM-5'-CCAAGGAGATCTGTGCTGACCCCAA-3'-TAMTph,"

Phrase: "and"

Phrase: "the primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed between exon 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C1707689:Design [Activity]
   737   C2983265:DESIGN [Intellectual Product]

Phrase: "and"

Phrase: "exon 3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.71: The forward primer was 5'-GAAGAATCACCAGCAGCAAGTGT-3', and the reverse primer was 5'-TGGAATCCTGAACCCACTTCTG-3'. 

Phrase: "The forward primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953382:Forward primer [Cell]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "5'-GAAGAATCACCAGCAGCAAGTGT-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "the reverse primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "5'-TGGAATCCTGAACCCACTTCTG-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.72: The probe for MYCN was FAM-5'-AGAAGCGGCGTTCCTCCTCCAACA-3'-TAMTph, and the primers were 5'-GAAGAAATCGACGTGGTCACTG-3' (forward) and 5'-GGTGAATGTGGTGACAGCCTT-3' (reverse). 

Phrase: "The probe for MYCN"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0182400:Probe [Medical Device]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "FAM-5'-AGAAGCGGCGTTCCTCCTCCAACA-3'-TAMTph,"

Phrase: "and"

Phrase: "the primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "5'-GAAGAAATCGACGTGGTCACTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "5'-GGTGAATGTGGTGACAGCCTT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.73: The probe and primer designs were based on the sequence from GenBank/EMBL/DDBJ accession no. 

Phrase: "The probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "primer designs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1707689:Design [Activity]
   827   C2983265:DESIGN [Intellectual Product]

Phrase: "were"

Phrase: "based on the sequence"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   802   C0004793:Base Sequence [Nucleotide Sequence]
           Sequence
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from GenBank/EMBL/DDBJ accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1510755:Accession [Intellectual Product]
   812   C1706078:Accession [Activity]

Phrase: "no."
Processing 00000000.tx.74: HSMCP-1. 

Phrase: "HSMCP-1."
Processing 00000000.tx.75: All probes and primers were designed using a software program (Primer Express V1.5; Applied Biosystems) and were synthesized by Integrated DNA Technologies. 

Phrase: "All"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a software program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "(Primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Express"

Phrase: "V1.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0457422:V1 [Finding]
   861   C0507238:V1 [Body Part, Organ, or Organ Component]

Phrase: "; Applied Biosystems"

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "synthesized by Integrated DNA Technologies."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1158478:DNA Integration [Genetic Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0039421:technologies [Occupation or Discipline]
   760   C1883254:Synthesized [Activity]
Processing 00000000.tx.76: Oligonucleotide Array Expression Analysis. 

Phrase: "Oligonucleotide Array Expression Analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
Processing 00000000.tx.77: Total RNA was precipitated from samples using TRIzol (Invitrogen) and further purified with the RNeasy Mini kit (QIAGEN). 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "precipitated from samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0370003:Sample [Substance]
   756   C1882443:PRECIPITATE [Phenomenon or Process]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "purified with the RNeasy Mini kit (QIAGEN"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0445542:Mini [Organism Attribute]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C1998793:Purified [Functional Concept]
   748   C3273202:Kit [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.78: Double-stranded cDNA was synthesized from total RNA using HPLC purified T7-(dT) primer (5'-GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG-(dT)24-3' (Genset Co.) and purified using phase lock gels, phenol/chloroform extraction, and ethanol precipitation. 

Phrase: "Double-stranded cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "synthesized from total RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C1883254:Synthesized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "T7-(dT) primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG-"

Phrase: "(dT)24-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3539739:DT [Gene or Genome]
   827   C3542920:DT [Idea or Concept]

Phrase: "(Genset Co.)"

Phrase: "and"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phase lock gels,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "phenol/chloroform extraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "ethanol precipitation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032931:Precipitation [Natural Phenomenon or Process]
   861   C0032932:Precipitation [Molecular Function]
   861   C1642401:% precipitation [Quantitative Concept]
   861   C2584299:Precipitation [Natural Phenomenon or Process]
Processing 00000000.tx.79: Biotin-labeled cRNA was synthesized from cDNA (in vitro transcription) using the ENZO Bioarray High Yield RNA Transcript Labeling kit (Affymetrix) and purified with RNeasy columns (QIAGEN) and ethanol precipitation. 

Phrase: "Biotin-labeled cRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0056208:cRNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1321571:CRNA [Professional or Occupational Group]

Phrase: "was"

Phrase: "synthesized from cDNA (in vitro transcription"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0040649:Transcription [Genetic Function]
   753   C1883254:Synthesized [Activity]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ENZO Bioarray High Yield RNA Transcript Labeling kit (Affymetrix"

Phrase: ")"

Phrase: "and"

Phrase: "purified with RNeasy columns"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1998793:Purified [Functional Concept]
   737   C1185738:Column [Body Part, Organ, or Organ Component]
   737   C1706132:Column [Idea or Concept]

Phrase: "(QIAGEN"

Phrase: ")"

Phrase: "and"

Phrase: "ethanol precipitation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032931:Precipitation [Natural Phenomenon or Process]
   861   C0032932:Precipitation [Molecular Function]
   861   C1642401:% precipitation [Quantitative Concept]
   861   C2584299:Precipitation [Natural Phenomenon or Process]
Processing 00000000.tx.80: After quantification with a spectrophotometer, cRNA was fragmented and hybridized to Affymetrix U95Av2 arrays (79 patients, diagnosed after 1 yr of age) or U133A and U133B arrays (19 patients, diagnosed before 1 yr of age). 

Phrase: "After quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "with a spectrophotometer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183400:Spectrophotometer [Medical Device]

Phrase: "cRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056208:cRNA [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1321571:CRNA [Professional or Occupational Group]

Phrase: "was"

Phrase: "fragmented"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392767:Fragmented [Functional Concept]
  1000   C1708096:Fragmented [Qualitative Concept]
   966 E C0332255:fragment [Functional Concept]

Phrase: "and"

Phrase: "hybridized to Affymetrix U95Av2 arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510941:Array [Spatial Concept]

Phrase: "(79 patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "diagnosed after 1 yr of age)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011900:Diagnosed [Finding]
   753   C0439234:yr [Temporal Concept]

Phrase: "or"

Phrase: "U133A"

Phrase: "and"

Phrase: "U133B arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]

Phrase: "(19 patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "diagnosed before 1 yr of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011900:Diagnosed [Finding]
   753   C0439234:yr [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.81: Arrays were washed and scanned according to the manufacturer's instructions (Affymetrix). 

Phrase: "Arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510941:Array [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "scanned according to the manufacturer's instructions"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0302828:instructions [Intellectual Product]
   753   C0441633:scanned [Diagnostic Procedure]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0034606:Scan [Diagnostic Procedure]
   719 E C0039401:Instruction [Educational Activity]
   719 E C2826292:SCAN [Finding]

Phrase: "(Affymetrix"

Phrase: ")."
Processing 00000000.tx.82: Data from Affymetrix .cel files were preprocessed using dChip software to normalize arrays, calculate model-based expression values, and identify probe and array outliers (21). 

Phrase: "Data from Affymetrix .cel files"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0242193:Data Files [Intellectual Product]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "preprocessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882455:Preprocess [Machine Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dChip software to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "arrays,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510941:Array [Spatial Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "model-based expression values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "identify"

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "array outliers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2698674:Outlier [Quantitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.83: Genetrix software (provided by J. Buckley, University of Southern California, Los Angeles, CA) was used to obtain gene expression levels, which are termed fluorescence units (FU). 

Phrase: "Genetrix software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "("

Phrase: "provided by J. Buckley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: "University of Southern California,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006754:California [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1710133:Southern [Spatial Concept]
   812   C3146274:California [Plant]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA)"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "gene expression levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0017262:Gene Expression [Genetic Function]

Phrase: "which"

Phrase: "are"

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "fluorescence units (FU)."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C2348686:Fluorescence Units [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.84: MYCN Genomic Analysis. 

Phrase: "MYCN Genomic Analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.85: MYCN was analyzed to identify tumors with genomic amplification by Southern blot, PCR, and/or immunohistochemistry (IHC) as described previously (2224). 

Phrase: "MYCN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812287:MYCN [Gene or Genome]
  1000   C1705027:MYCN [Gene or Genome]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "tumors with genomic amplification"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0027651:Tumors [Neoplastic Process]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "by Southern blot,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005862:Southern Blot [Molecular Biology Research Technique]
  1000   C1148472:Blot, Southern [Laboratory or Test Result]
   861   C1710133:Southern [Spatial Concept]

Phrase: "PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "and/or"

Phrase: "immunohistochemistry (IHC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(2224"

Phrase: ")."
Processing 00000000.tx.86: ELISA. 

Phrase: "ELISA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.87: Kits for CCL2, CCL5, CCL21, and CXCL12 were purchased from R&D Systems, and chemokine concentration was determined in neuroblastoma cell supernatants according to the manufacturer's instructions. 

Phrase: "Kits for CCL2,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C1690540:Kits [Qualitative Concept]
   756 E C0812225:KIT [Medical Device]
   756 E C1150635:KIT [Molecular Function]
   756 E C1705212:Kit [Medical Device]
   756 E C1705213:KIT [Medical Device]
   756 E C3273202:Kit [Manufactured Object]

Phrase: "CCL5,"

Phrase: "CCL21,"

Phrase: "and"

Phrase: "CXCL12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0218504:CXCL12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332817:CXCL12 [Gene or Genome]

Phrase: "were"

Phrase: "purchased from R&D Systems,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205090:R- [Spatial Concept]
   760   C0684010:R. [Professional or Occupational Group]
   760   C0869011:purchased [Activity]
   760   C2603358:R' [Clinical Attribute]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "chemokine concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined in neuroblastoma cell supernatants"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0815000:neuroblastoma cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0027819:Neuroblastoma [Neoplastic Process]
   760   C0700095:neuroblastoma [Neoplastic Process]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3540583:Neuroblastoma [Intellectual Product]
   726   C1550101:Supernatant [Body Substance]

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.88: Flow Cytometry. 

Phrase: "Flow Cytometry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]
Processing 00000000.tx.89: To analyze CCR2 expression by blood iNKTs, PBMCs were sequentially stained with anti-CCR2 48607.121 mAb (R&D Systems), antimouse IgG-biotin and Cy-Chrome-streptavidin plus FITC anti-V11 (Beckman Coulter) and PE antiV24-J18 6B11 (25). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "CCR2 expression by blood iNKTs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "PBMCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321301:PBMC [Cell]

Phrase: "were"

Phrase: "sequentially"

Phrase: "stained with anti-CCR2 48607.121 mAb (R&D Systems"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   757   C0140430:Anti D [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0205090:R- [Spatial Concept]
   739   C0684010:R. [Professional or Occupational Group]
   739   C1413188:CCR2 [Gene or Genome]
   739   C2603358:R' [Clinical Attribute]
   739   C2986582:Stained [Qualitative Concept]
   739   C3538748:CCR2 [Amino Acid, Peptide, or Protein,Receptor]
   706 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   706   C0449913:System [Functional Concept]
   706   C1553451:System [Manufactured Object]
   706   C1704459:System [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "antimouse IgG-biotin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C2700256:Biotin [Laboratory Procedure]

Phrase: "and"

Phrase: "Cy-Chrome-streptavidin plus FITC anti-V11"

Phrase: "(Beckman Coulter"

Phrase: ")"

Phrase: "and"

Phrase: "PE antiV24-J18 6B11"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.90: T and NK cells were analyzed with FITC anti-CD3 UCHT1 and PE anti-CD56 B159 (BD Biosciences). 

Phrase: "T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "NK cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
  1000   C2363836:Natural Killer Cells [Laboratory Procedure]
   901   C0022686:Killer Cells [Cell]
   901   C2709199:Natural killer [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "analyzed with FITC anti-CD3 UCHT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0879551:Anti CD3 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0936012:Analyzed [Research Activity]
   753   C3542405:CD3 [Laboratory Procedure]

Phrase: "and"

Phrase: "PE anti-CD56 B159"

Phrase: "(BD Biosciences"

Phrase: ")."
Processing 00000000.tx.91: Isotype-matching MOPC-21 mAb was used as control (BD Biosciences). 

Phrase: "Isotype-matching MOPC-21 mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "used as control"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1273517:used [Finding]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "(BD Biosciences"

Phrase: ")."
Processing 00000000.tx.92: Samples were analyzed with a EPICS Elite flow cytometer (Beckman Coulter). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed with a EPICS Elite flow cytometer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0180279:Flow Cytometer [Medical Device]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C0936012:Analyzed [Research Activity]
   714   C1273342:EPIC [Laboratory Procedure]

Phrase: "(Beckman Coulter"

Phrase: ")."
Processing 00000000.tx.93: Data were analyzed using EXPOTM 32 Analysis software (Beckman Coulter). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "EXPOTM 32 Analysis software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Beckman Coulter"

Phrase: ")."
Processing 00000000.tx.94: Immunofluorescence Microscopy and IHC. 

Phrase: "Immunofluorescence Microscopy"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "and"

Phrase: "IHC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.95: Frozen 6-m sections were brought to room temperature, fixed in acetone (10 min), and treated with 5% goat serum supplemented with 2.5% BSA for 20 min. 

Phrase: "Frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "6-m sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "brought to room temperature,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0332302:brought [Functional Concept]
   770   C1547703:Room [Spatial Concept]

Phrase: "fixed in acetone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "(10 min),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "treated with 5% goat serum"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0018019:goat [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C1265549:goat [Mammal]
   760   C1510458:Goat [Mammal]
   760   C1522326:Treated [Functional Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "supplemented with 2.5% BSA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "for 20 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.96: Sections were incubated with Alexa Fluor 488 anti-CD3 289-13801 mAb (Molecular Probes) for 1 h at room temperature. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "with Alexa Fluor 488 anti-CD3 289-13801 mAb (Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   790   C0182400:Probes [Medical Device]
   756 E C1704681:Probe [Gene or Genome]
   756 E C2347609:Probe [Chemical Viewed Functionally]
   756 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.97: The sections were washed with PBS containing 0.5% BSA and counterstained with 4',6-diamidine-2'-phenylindole dihydrochloride (DAPI; Vector Laboratories). 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% BSA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "counterstained with 4',"

Phrase: "6-diamidine-2'-phenylindole dihydrochloride"

Phrase: "(DAPI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "; Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")."
Processing 00000000.tx.98: Where indicated, tissue sections were sequentially stained with antiV24-J18 6B11 mAb (26, 27) followed by CyTM3-antimouse IgG (Jackson ImmunoResearch Laboratories) and Alexa Fluor 488-anti-CD3 mAb. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2316368:Tissue section [Tissue]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "sequentially"

Phrase: "stained with antiV24-J18 6B11 mAb (26,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "27"

Phrase: ")"

Phrase: "followed by CyTM3-antimouse IgG (Jackson ImmunoResearch Laboratories"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0022877:Laboratories [Manufactured Object,Organization]
   744   C1619828:Laboratories [Intellectual Product]
   744   C1979849:Antimouse [Immunologic Factor]
   711 E C1719822:Follow [Intellectual Product]
   711 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Alexa Fluor 488-anti-CD3 mAb."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0879551:Anti CD3 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C3542405:CD3 [Laboratory Procedure]
Processing 00000000.tx.99: Digital images of fluorescent microscope fields of tumor sections were acquired with a HCX Plan Apochromat 40x/1.25NA oil immersion objective lens with 1.6x optivar on a DM RXA microscope (Leica), Lambda LS175 Xenon arc lamp (Sutter Instrument Co.), using HQ Cy3, HQ fluorescein, and DAPI filter sets (Chroma Technology Corp.) with a SKYTM SD-300/VDS1300 spectral imager and EasyFish software (Applied Spectral Imaging). 

Phrase: "Digital images of fluorescent microscope fields of tumor sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1704254:Image [Intellectual Product]
   708   C1704922:Image [Entity]
   708   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "with a HCX Plan Apochromat 40x/1.25NA oil immersion objective lens"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0023317:Lens [Body Part, Organ, or Organ Component]
   790   C0023318:Lens [Medical Device]
   790   C0996842:Lens [Plant]
   790   C1278892:Lens [Body Part, Organ, or Organ Component]

Phrase: "with 1.6x optivar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0876112:Optivar [Organic Chemical,Pharmacologic Substance]

Phrase: "on a DM RXA microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0181839:Microscope [Medical Device]
   827   C1706379:Microscope [Medical Device]

Phrase: "(Leica"

Phrase: ")"

Phrase: ","

Phrase: "Lambda LS175 Xenon arc lamp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0043339:Xenon [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0392223:Lamp [Manufactured Object]
   804   C1705111:Lamp [Medical Device]
   804   C3539922:LAMP [Laboratory Procedure]

Phrase: "(Sutter Instrument Co."

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HQ Cy3,"

Phrase: "HQ fluorescein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "DAPI filter sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]

Phrase: "(Chroma Technology Corp.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "with a SKYTM SD-300/VDS1300 spectral imager"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1708466:Imager [Manufactured Object]

Phrase: "and"

Phrase: "EasyFish software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Applied Spectral Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0011923:Imaging [Diagnostic Procedure]
   827   C0079595:Imaging [Diagnostic Procedure]
   793 E C1704254:Image [Intellectual Product]
   793 E C1704922:Image [Entity]
   793 E C3542466:Image [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: All nucleated (DAPI+) and T cells (CD3+) were counted in four randomly selected fields and the percentage of T cells was calculated as CD3+/DAPI+ x 100. 

Phrase: "All nucleated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979936:Nucleated [Qualitative Concept]

Phrase: "(DAPI+)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(CD3+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3542405:CD3 [Laboratory Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "counted in four randomly selected fields"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205450:Four [Quantitative Concept]
   719   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   719   C0750480:Count [Activity]
   719   C1521738:Field [Conceptual Entity]
   719   C1705566:Count [Quantitative Concept]
   719   C1707391:Select [Activity]
   719   C2346620:Field [Conceptual Entity]
   719   C2349184:Field [Conceptual Entity]
   719   C3539073:FIELD [Spatial Concept]

Phrase: "and"

Phrase: "the percentage of T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "calculated as CD3+/DAPI+ x 100."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C3542405:CD3 [Laboratory Procedure]
Processing 00000000.tx.101: For immunohistochemical detection of CCL2, we used goat antihuman CCL2 Ab followed by Cell and Tissue Staining Kit (R&D Systems). 

Phrase: "For immunohistochemical detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of CCL2,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "goat antihuman CCL2 Ab"

Phrase: "followed by Cell"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0007634:Cell [Cell]
   790   C1269647:Cell [Cell]
   790   C1704653:Cell [Medical Device]
   790   C1948049:Cell [Spatial Concept]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "Tissue Staining Kit (R&D Systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0205090:R- [Spatial Concept]
   799   C0684010:R. [Professional or Occupational Group]
   799   C2603358:R' [Clinical Attribute]
   766   C0449913:System [Functional Concept]
   766   C1553451:System [Manufactured Object]
   766   C1704459:System [Medical Device]
   716 E C0205373:Systemic [Functional Concept]

Phrase: ")."
Processing 00000000.tx.102: IHC for CD1d was performed using 42.1 anti-hCD1d mAb (provided by S. Porcelli, Albert Einstein College of Medicine, Bronx, NY). 

Phrase: "IHC for CD1d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "42.1 anti-hCD1d mAb ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "provided by S. Porcelli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: "Albert Einstein College of Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0013227:Medicine, NOS [Pharmacologic Substance]
   804   C0025118:Medicine [Biomedical Occupation or Discipline]
   804   C0557806:College [Manufactured Object]

Phrase: "Bronx,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: TEM Assay. 

Phrase: "TEM Assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1513300:Migration Assay [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C2936223:Transendothelial Migration [Organ or Tissue Function]
Processing 00000000.tx.104: Polycarbonate transwell filters with 5-m pore size (Costar Corning) were precoated with human umbilical vein endothelial cells (American Type Culture Collection) using F-12K medium (American Type Culture Collection) supplemented with 10% FCS and 0.03 mg/ml endothelial cell growth supplement (BD Biosciences). 

Phrase: "Polycarbonate transwell"

Phrase: "filters with 5-m pore size"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C1440942:M-5 [Immunologic Factor]
   753   C0180860:Filter [Manufactured Object]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0456389:size [Spatial Concept]
   753   C0581406:Filter [Medical Device]
   753   C1325742:Pore [Cell Component]
   753   C1522664:Filter [Intellectual Product]
   753   C1704449:Filter [Conceptual Entity]
   753   C1704684:Filter [Medical Device]
   753   C1875155:FILTER [Medical Device]

Phrase: "(Costar Corning"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0010046:corning [Acquired Abnormality]
   827 E C0010028:Corn [Plant]
   827 E C0087179:Corn [Plant]
   827 E C1095906:corn [Pharmacologic Substance]
   827 E C1138842:Corn [Food]

Phrase: ")"

Phrase: "were"

Phrase: "precoated with human umbilical vein endothelial cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   897   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   778   C0041637:Umbilical vein [Embryonic Structure]
   778   C0221313:Umbilical vein [Embryonic Structure]
   778   C0225336:Endothelial Cells [Cell]
   778   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   774   C0427861:Human cells [Laboratory or Test Result]
   748   C0007634:Cells [Cell]
   748   C0014257:Endothelial [Tissue]
   748   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   748   C0042449:Vein [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C1278960:Vein [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   743   C1179027:Vein Endothelium [Tissue]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(American Type Culture Collection"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0598079:American Type Culture Collection [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0596070:American [Population Group]
   812   C1516698:Collection [Functional Concept]
   812   C1547052:*Type [Quantitative Concept]
   812   C1704814:Collection [Idea or Concept]
   812   C2242979:Culture [Laboratory Procedure]
   741 E C1516695:Collected [Idea or Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "F-12K medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(American Type Culture Collection"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0598079:American Type Culture Collection [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0596070:American [Population Group]
   812   C1516698:Collection [Functional Concept]
   812   C1547052:*Type [Quantitative Concept]
   812   C1704814:Collection [Idea or Concept]
   812   C2242979:Culture [Laboratory Procedure]
   741 E C1516695:Collected [Idea or Concept]

Phrase: ")"

Phrase: "supplemented with 10% FCS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "0.03 mg/ml endothelial cell growth supplement"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   812   C0007595:Cell Growth [Cell Function]
   812   C0225336:Endothelial cell [Cell]
   793   C0007634:Cell [Cell]
   793   C0014257:Endothelial [Tissue]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0220844:growth [Physiologic Function]
   793   C0242295:Supplement [Food]
   793   C1269647:Cell [Cell]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C1704653:Cell [Medical Device]
   793   C1947943:Supplement [Intellectual Product]
   793   C1948049:Cell [Spatial Concept]
   793   C2348609:Supplement [Functional Concept]
   793   C2911660:Growth [Activity]

Phrase: "(BD Biosciences"

Phrase: ")."
Processing 00000000.tx.105: After rinsing once in RPMI 1640, transwell inserts were transferred to new wells (lower chambers) containing 600 l RPMI 1640 with 5 mg/ml human serum albumin. 

Phrase: "After rinsing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882955:Rinsing [Activity]

Phrase: "once in RPMI 1640,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720092:Once [Intellectual Product]
   770   C1948045:Once [Temporal Concept]

Phrase: "transwell inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0813036:Inserts [Medical Device]
   827 E C0441587:Insert [Health Care Activity]
   827 E C1743766:Insert [Medical Device]
   827 E C1883719:Insert [Functional Concept]

Phrase: "were"

Phrase: "transferred to new wells"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205314:New [Temporal Concept]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737   C0205170:Well [Qualitative Concept]
   737 E C1705822:Transfer [Activity]
   737   C3146287:Well [Manufactured Object]

Phrase: "(lower chambers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0179874:chambers [Medical Device]
   827 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "600 l RPMI 1640 with 5 mg/ml human serum albumin."
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   775   C0304925:Human serum albumin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           ALBUMIN HUMAN
   775   C3537198:Human Serum Albumin [Pharmacologic Substance]
   770   C2984062:mg/5 ml [Quantitative Concept]
   756   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   756   C0439294:mg ml [Quantitative Concept]
   756   C0728877:serum albumin [Laboratory or Test Result]
   754   C0439268:mg/L [Quantitative Concept]
   754 E C0523465:Albumin - serum [Laboratory Procedure]
   754   C1635169:mL/L [Quantitative Concept]
   738   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0086418:Human [Human]
   738   C0229671:Serum [Body Substance]
   738   C0439269:mg% [Quantitative Concept]
   738   C0439526:/mL [Quantitative Concept]
   738   C1546774:Serum [Intellectual Product]
   738   C1550100:Serum [Body Substance]
   738   C1960952:mg % [Quantitative Concept]
   738   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.106: Recombinant chemokines or supernatants from neuroblastoma cell lines were added to the lower chambers. 

Phrase: "Recombinant chemokines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1527036:Recombinant Chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Chemokines
   861   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "supernatants from neuroblastoma cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "added to the lower chambers."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0179874:chambers [Medical Device]
   760   C0441994:Lower [Spatial Concept]
   760   C1524062:Added [Functional Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   726 E C0935616:Chamber [Body Part, Organ, or Organ Component]
   726 E C1883712:Add [Functional Concept]
Processing 00000000.tx.107: An iNKT cell line (20) or PBMCs depleted of monocytes were added to the upper chamber (106 cells in 100 l), and the transwell chambers were incubated at 37C in 5% CO2. 

Phrase: "An iNKT cell line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   734   C2350467:iNKT Cell [Cell]

Phrase: "(20"

Phrase: ")"

Phrase: "or"

Phrase: "PBMCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321301:PBMC [Cell]

Phrase: "depleted of monocytes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0026473:Monocytes [Cell]
   790   C0333668:Depleted [Functional Concept]
   718 E C1550032:Unload [Idea or Concept]
   718 E C1880497:Empty [Qualitative Concept]
   718 E C1996907:Emptying [Activity]

Phrase: "were"

Phrase: "added to the upper chamber"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   760   C1282910:Upper [Spatial Concept]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "(106 cells in 100 l),"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   797   C0347983:cells/L [Quantitative Concept]
   797   C1441340:100 cells [Cell]
   781 E C0022827:cell l [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the transwell chambers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0179874:chambers [Medical Device]
   827 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.108: After 4 h, initial input cells (from a nonpermeable well) and migrated cells from the lower chambers were stained with fluorochrome-conjugated mAbs (see flow cytometry section). 

Phrase: "After 4 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "initial input cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0017471:initial cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "from a nonpermeable well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0332242:Non-permeable [Functional Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "migrated cells from the lower chambers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with fluorochrome-conjugated mAbs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]
   760   C0522529:Conjugated [Spatial Concept]
   760   C2986582:Stained [Qualitative Concept]
   726   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "flow cytometry section"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]
   734   C0016263:Flow Cytometry [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.109: iNKTs were identified using FITC anti-V11 C21 mAb (Beckman Coulter) with PE anti-V24-J18 6B11. 

Phrase: "iNKTs"

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "FITC anti-V11 C21 mAb (Beckman Coulter"

Phrase: ")"

Phrase: "with PE anti-V24-J18 6B11."
Processing 00000000.tx.110: After suspension in TruCOUNTTM tubes (Becton Dickinson), multicolor immunofluorescence was analyzed by flow cytometry to determine relative and absolute numbers of cells in subpopulations of interest. 

Phrase: "After suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038960:Suspension [Biomedical or Dental Material]
  1000   C1382107:Suspension [Substance]
  1000   C1705537:Suspension [Functional Concept]

Phrase: "in TruCOUNTTM tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0175730:tubes [Medical Device]
   861   C1547937:Tubes [Intellectual Product]
   861   C1704474:Tubes [Quantitative Concept]
   827 E C1561954:tube [Conceptual Entity]
   827 E C1704730:TUBE [Medical Device]

Phrase: "(Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "multicolor immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "analyzed by flow cytometry to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0016263:Flow Cytometry [Laboratory Procedure]
   760   C0806140:Flow [Natural Phenomenon or Process]
   760   C0814048:Cytometry [Laboratory Procedure]
   760   C0936012:Analyzed [Research Activity]

Phrase: "determine"

Phrase: "relative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080103:Relative [Family Group]
  1000   C0205345:Relative [Qualitative Concept]
  1000   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "absolute numbers of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in subpopulations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1257890:Subpopulation [Population Group]

Phrase: "of interest."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]
Processing 00000000.tx.111: The percent migration for each subset was calculated as migrated cells/input cells x 100. 

Phrase: "The percent migration for each subset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "calculated as migrated cells/input cells x 100."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   767   C1441340:100 cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0232902:Migrated [Functional Concept]
   744   C0444686:Calculated [Functional Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1708517:Input [Conceptual Entity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.112: Specific migration was calculated by subtracting migration to control medium from migration to the experimental medium. 

Phrase: "Specific migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "calculated by subtracting migration to control medium"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   748   C0009458:Medium [Intellectual Product]
   748   C0243148:control [Qualitative Concept]
   748   C0439536:Medium [Quantitative Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C0600210:Migration [Social Behavior]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1533574:Migration [Physiologic Function]
   748   C1550141:Control [Substance]
   748   C1705217:Medium [Substance]
   748   C1881827:MIGRATION [Phenomenon or Process]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3244283:medium [Intellectual Product]
   748   C3274648:Control [Qualitative Concept]
   714   C1719767:Subtract [Intellectual Product]
   714   C2348589:Subtract [Phenomenon or Process]

Phrase: "from migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to the experimental medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.113: Data Analyses. 

Phrase: "Data Analyses."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analyses [Occupational Activity]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.114: Flow cytometry data were analyzed with EXPOTM 32 Analysis software (Beckman Coulter). 

Phrase: "Flow cytometry data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0016263:Flow Cytometry [Laboratory Procedure]

Phrase: "were"

Phrase: "analyzed with EXPOTM 32 Analysis software"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0037585:Software [Intellectual Product,Manufactured Object]
   753   C0936012:Analysis [Research Activity]
           Analyzed
   753   C1524024:analysis [Functional Concept]

Phrase: "(Beckman Coulter"

Phrase: ")."
Processing 00000000.tx.115: SigmaPlot 8.0 (Jandell Scientific) was used to create graphs, and GraphPad PrismTM 4.0 (GraphPad Software) was used to perform Student's t test, Mann-Whitney test, or one-way analysis of variance with the Tukey-Kramer posttest comparison of group means. 

Phrase: "SigmaPlot 8.0"

Phrase: "(Jandell"

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "graphs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0681493:graphs [Intellectual Product]
   966 E C2698021:Graph [Conceptual Entity]

Phrase: "and"

Phrase: "GraphPad PrismTM 4.0"

Phrase: "(GraphPad Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "Student's t test,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "Mann-Whitney test,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1708930:Mann-Whitney Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "or"

Phrase: "one-way analysis of variance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1709320:One-way Analysis of Variance [Quantitative Concept]
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "with the Tukey-Kramer posttest comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707455:Comparison [Activity]

Phrase: "of group means."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1704970:Means [Conceptual Entity]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   827 E C0444504:Mean [Quantitative Concept]
   827 E C2347634:Mean [Quantitative Concept]
   827 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.116: Correlation was analyzed by the Spearman correlation analysis. 

Phrase: "Correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlation [Qualitative Concept]

Phrase: "was"

Phrase: "analyzed by the Spearman correlation analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0010101:correlation analysis [Intellectual Product,Research Activity]
   790   C1710141:Spearman Correlation [Intellectual Product]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
           Analyzed
   753   C1524024:analysis [Functional Concept]
   753   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.117: Significance was accepted when P < 0.05. 

Phrase: "Significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "when"

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.118: To determine the optimum cutoff value, the maximally selected 2 method of Miller and Halpern was adapted. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the optimum cutoff value,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1442160:Cutoff [Functional Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "the maximally"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "2 method of Miller"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Halpern"

Phrase: "was"

Phrase: "adapted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2937289:adapted [Organic Chemical]
Processing 00000000.tx.119: To determine the p-value associated with the maximum 2 statistics, we performed 2,000 bootstrap-like simulations. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the p-value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709380:P-Value [Quantitative Concept]
   861   C1522609:Value [Quantitative Concept]

Phrase: "associated with the maximum 2 statistics,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0038215:Statistics [Occupation or Discipline]
   753   C0600673:Statistics [Intellectual Product]
   753   C0806909:Maximum [Quantitative Concept]
   753   C1552615:maximum [Quantitative Concept]
   753   C2826546:MAXIMUM [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
   719 E C2348149:Statistic [Quantitative Concept]
   719 E C2828391:Statistic [Quantitative Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "2,000 bootstrap-"

Phrase: "like simulations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679083:simulations [Research Activity]
   916 E C0284447:simulated [Biomedical or Dental Material]
Processing 00000000.tx.120: For each simulation, a randomly selected expression value was drawn from the set of observed expression values and assigned to each of the observed responses (i.e., presence of iNKTs). 

Phrase: "For each simulation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679083:Simulation [Research Activity]
   928 E C0284447:simulated [Biomedical or Dental Material]

Phrase: "a randomly selected expression value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "drawn from the set of observed expression values"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0036849:Set [Mental Process]
   744   C0042295:Values [Qualitative Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C1441672:Observed [Functional Concept]
   744   C1442518:Set [Functional Concept]
   744   C1705195:Set [Conceptual Entity]
   711   C0013113:Draw [Intellectual Product]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "assigned to each of the observed responses"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0871261:responses [Organism Attribute]
   748   C1441672:Observed [Functional Concept]
   748   C1516050:Assigned [Functional Concept]
   748   C1552601:assigned [Intellectual Product]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "(i.e., presence of iNKTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.121: The corrected p-value was calculated as the proportion of the 2,000 simulated maximal 2 statistics that was larger than the original maximal 2 test statistic.  

Phrase: "The corrected p-value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "calculated as the proportion of the 2,000 simulated maximal 2 statistics"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   736   C0038215:Statistics [Occupation or Discipline]
   736   C0205289:Maximal [Qualitative Concept]
   736   C0284447:simulated [Biomedical or Dental Material]
   736   C0444686:Calculated [Functional Concept]
   736   C0600673:Statistics [Intellectual Product]
   736   C0806909:Maximal [Quantitative Concept]
   736   C1441506:Calculated [Activity]
   736   C1443182:Calculated [Laboratory Procedure]
   736   C1709707:Proportion [Quantitative Concept]
   709   C0033105:statistical proportion [Quantitative Concept]
   703 E C2348149:Statistic [Quantitative Concept]
   703 E C2828391:Statistic [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "larger than the original maximal 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0443228:larger [Quantitative Concept]
   753   C0549177:Larger [Quantitative Concept]
   753   C1704243:Larger [Quantitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "statistic."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2348149:Statistic [Quantitative Concept]
  1000   C2828391:Statistic [Quantitative Concept]
   928 E C0038215:Statistical [Occupation or Discipline]
Processing 00000000.tx.122: Results Top Abstract Introduction Materials and Methods Results Discussion References  Detection and Enumeration of iNKTs Infiltrating Primary Untreated Neuroblastomas. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Enumeration of iNKTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707927:Enumeration [Qualitative Concept]

Phrase: "Infiltrating"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332448:Infiltrating [Pathologic Function]
   966 E C1546677:Infiltrate [Intellectual Product]
   966 E C1549537:Infiltrate [Functional Concept]

Phrase: "Primary Untreated Neuroblastomas."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027819:Neuroblastomas [Neoplastic Process]
   793 E C0700095:neuroblastoma [Neoplastic Process]
   793 E C3540583:Neuroblastoma [Intellectual Product]
Processing 00000000.tx.123: Because the invariant V24-J18 rearrangement specifically identifies iNKTs, we designed a Taqman probe/primer set to span and amplify a V24-J18 sequence. 

Phrase: "Because"

Phrase: "the invariant V24-J18 rearrangement specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1511695:Rearrangement [Genetic Function]

Phrase: "identifies"

Phrase: "iNKTs,"

Phrase: "we"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "a Taqman probe/primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "span"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "and"

Phrase: "amplify"

Phrase: "a V24-J18 sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.124: The strict specificity and high sensitivity of this set were established using GalCer-reactive iNKT and neuroblastoma cell lines as positive and negative controls, respectively (unpublished data). 

Phrase: "The strict specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "high sensitivity of this set"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C1441604:High sensitivity [Laboratory Procedure]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1299351:High [Qualitative Concept]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GalCer-reactive iNKT"

Phrase: "and"

Phrase: "neuroblastoma cell lines as positive"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0007600:Cell lines [Cell]
   806   C0815000:neuroblastoma cell [Cell]
   797   C0439178:positive cell [Quantitative Concept]
   760   C0007634:Cell [Cell]
   760   C0027819:Neuroblastoma [Neoplastic Process]
   760   C0205132:lines [Spatial Concept]
   760   C0700095:neuroblastoma [Neoplastic Process]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3540583:Neuroblastoma [Intellectual Product]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "respectively"

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.125: To standardize RT-PCRbased iNKT cell quantification, purified iNKTs were serially diluted with neuroblastoma cells (LA-N-1 cell line) and analyzed with RT-PCR and flow cytometry to determine iNKT cell RNA concentration and frequency, respectively (Fig. 1 A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "standardize"

Phrase: "RT-PCRbased iNKT cell quantification,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1709793:Quantification [Quantitative Concept]

Phrase: "purified iNKTs"

Phrase: "were"

Phrase: "serially"

Phrase: "diluted with neuroblastoma cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   816   C0815000:neuroblastoma cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0027819:Neuroblastoma [Neoplastic Process]
   770   C0700095:neuroblastoma [Neoplastic Process]
   770   C3282337:Cells [Cell]
   770   C3540583:Neuroblastoma [Intellectual Product]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(LA-N-1 cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "analyzed with RT-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "flow cytometry to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0016263:Flow Cytometry [Laboratory Procedure]
   827   C0806140:Flow [Natural Phenomenon or Process]
   827   C0814048:Cytometry [Laboratory Procedure]

Phrase: "determine"

Phrase: "iNKT cell RNA concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "frequency,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "respectively"

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.126: iNKT RNA concentration linearly correlated with iNKT cell frequency in the range from 0.01 to 25% (r = 0.99, P < 0.001), which provided a standard curve for subsequent analyses of iNKT cell frequency in tumor specimens by RT-PCR. 

Phrase: "iNKT RNA concentration linearly"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "correlated with iNKT cell frequency"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C2350467:iNKT Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705502:Frequency [Quantitative Concept]
   760   C1707520:Correlated [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "from 0.01"

Phrase: "to 25%"

Phrase: "(r = 0.99,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "a standard curve for subsequent analyses of iNKT cell frequency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205134:Curve [Spatial Concept]

Phrase: "in tumor specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]

Phrase: "by RT-PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
Processing 00000000.tx.127: View larger version (18K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.128: Detection and enumeration of tumor-infiltrating iNKTs. 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "enumeration of tumor-infiltrating iNKTs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707927:Enumeration [Qualitative Concept]
Processing 00000000.tx.129: (A) iNKT cells (>99% pure) were serially diluted with neuroblastoma cells (LA-N-1 cell line) from 1:5 to 1:50,000, a iNKT/neuroblastoma cell ratio. 

Phrase: "(A) iNKT cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2350467:iNKT Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: ">99% pure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2247561:PurE [Molecular Function]
   789 E C1882508:Purity [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "serially"

Phrase: "diluted with neuroblastoma cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   816   C0815000:neuroblastoma cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0027819:Neuroblastoma [Neoplastic Process]
   770   C0700095:neuroblastoma [Neoplastic Process]
   770   C3282337:Cells [Cell]
   770   C3540583:Neuroblastoma [Intellectual Product]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(LA-N-1 cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "from 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5 to 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "50,000,"

Phrase: "a iNKT/neuroblastoma cell ratio."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]
   708   C2350467:iNKT Cell [Cell]
Processing 00000000.tx.130: RT-PCR for V24-J18 RNA and flow cytometry for iNKT TCR antigens were performed using cells from the same preparations. 

Phrase: "RT-PCR for V24-J18 RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "flow cytometry for iNKT TCR antigens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016263:Flow Cytometry [Laboratory Procedure]
   753   C0806140:Flow [Natural Phenomenon or Process]
   753   C0814048:Cytometry [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cells from the same preparations."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   764   C0920433:cell preparation [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.131: iNKT RNA percentage (y axis) is calculated as iNKT RNA ng/500 ng (total sample) x 100 and plotted against iNKT cell frequency detected by flow cytometry (x axis). 

Phrase: "iNKT RNA percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439165:Percentage [Quantitative Concept]
   827   C1549488:Percentage [Idea or Concept]
   827   C1561533:Percentage [Idea or Concept]

Phrase: "(y axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "is"

Phrase: "calculated as iNKT RNA ng/500 ng (total sample"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0370003:Sample [Substance]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0444686:Calculated [Functional Concept]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "x 100"

Phrase: "and"

Phrase: "plotted against iNKT cell frequency"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C2350467:iNKT Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705502:Frequency [Quantitative Concept]
   760   C1948049:Cell [Spatial Concept]

Phrase: "detected by flow cytometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(x axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.132: Solid line is a linear regression, and dashed lines mark 95% confidence interval, P < 0.0001. 

Phrase: "Solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "a linear regression,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023733:Linear Regression [Quantitative Concept]
  1000   C2346679:Linear Regression [Intellectual Product]
   861   C0205132:Linear [Spatial Concept]
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]

Phrase: "and"

Phrase: "dashed lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "95% confidence interval,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "P < 0.0001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.133: (B) iNKT cell frequency in neuroblastoma tumors (n = 98) was calculated from detected iNKT RNA amount per 500 ng total sample RNA using the standard curve shown in A. 

Phrase: "(B) iNKT cell frequency in neuroblastoma tumors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "(n = 98"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "calculated from detected iNKT RNA amount"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442726:Detected [Finding]
   753   C0444686:Calculated [Functional Concept]
   753   C1265611:Amount [Quantitative Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "per 500 ng total sample RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the standard curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "shown in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.134: (C) Frozen 6-m sections were stained with Alexa Fluor 488 anti-CD3 289-13801 (green), Cy-3 antiV24-J18 6B11 (red) mAbs, and DAPI (blue). 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "6-m sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with Alexa Fluor 488 anti-CD3 289-13801"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0879551:Anti CD3 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   764   C3272928:Alexa Fluor [Indicator, Reagent, or Diagnostic Aid]
   742   C0235665:FLUOR [Pathologic Function]
   742   C1071616:Alexa [Plant]
   742   C2986582:Stained [Qualitative Concept]
   742   C3542405:CD3 [Laboratory Procedure]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Cy-3 antiV24-J18 6B11"

Phrase: "(red) mAbs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "DAPI (blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1260957:Blue [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.135: Digital image of microscopic field of tumor tissue (magnification, 64) is one representative from five analyzed iNKT+ tumors (four to six fields per tumor) with green-circled T cells and yellow (green + red)-circled iNKT among blue nucleated cells.  

Phrase: "Digital image of microscopic field of tumor tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1704254:Image [Intellectual Product]
   744   C1704922:Image [Entity]
   744   C3542466:Image [Intellectual Product]

Phrase: "(magnification,"

Phrase: "64"

Phrase: ")"

Phrase: "is"

Phrase: "one representative from five analyzed iNKT+ tumors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1882932:Representative [Activity]

Phrase: "(four to six fields"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205450:Four [Quantitative Concept]
   770   C0205452:Six [Quantitative Concept]
   737   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   737   C1521738:Field [Conceptual Entity]
   737   C2346620:Field [Conceptual Entity]
   737   C2349184:Field [Conceptual Entity]
   737   C3539073:FIELD [Spatial Concept]

Phrase: "per tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027651:Tumor [Neoplastic Process]
  1000   C1578706:Tumor [Intellectual Product]
  1000   C3273930:Tumor [Finding]

Phrase: ")"

Phrase: "with green-circled T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "yellow (green + red)-circled iNKT among blue nucleated cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C2350467:iNKT Cells [Cell]
Processing 00000000.tx.136: RT-PCR analysis of 98 primary untreated stage 4 neuroblastomas revealed that 52 (53%) contained iNKTs. 

Phrase: "RT-PCR analysis of 98 primary untreated stage 4 neuroblastomas"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0200931:PCR analysis [Laboratory Procedure]
   760   C0599161:RT-PCR [Molecular Biology Research Technique]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   739   C0677874:pCR [Finding]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that 52"

Phrase: "(53%"

Phrase: ")"

Phrase: "contained iNKTs."
Processing 00000000.tx.137: Their frequency among all cells was calculated from specific iNKT RNA concentration (Fig. 1 B), and it ranged from <0.01 (not detectable) to 0.52%. 

Phrase: "Their frequency among all cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "was"

Phrase: "calculated from specific iNKT RNA concentration"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086045:Concentration [Mental Process]
   753   C0205369:Specific [Qualitative Concept]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "(Fig. 1 B"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "ranged from"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1514721:Range [Quantitative Concept]
   799   C2348147:Range [Quantitative Concept]
   799   C3542016:Range [Intellectual Product]

Phrase: "<0.01"

Phrase: "("

Phrase: "not detectable"

Phrase: ")"

Phrase: "to 0.52%."
Processing 00000000.tx.138: Tumors from all 19 patients who were younger than 1 yr at diagnosis contained iNKTs, whereas only 33 of 79 tumors (42%) from older patients were iNKT+. 

Phrase: "Tumors from all 19 patients"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0027651:Tumors [Neoplastic Process]
   726 E C1578706:Tumor [Intellectual Product]
   726 E C3273930:Tumor [Finding]

Phrase: "who"

Phrase: "were"

Phrase: "younger than 1 yr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0332239:Young [Temporal Concept]

Phrase: "at diagnosis contained iNKTs,"

Phrase: "whereas"

Phrase: "only 33 of 79 tumors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0027651:Tumors [Neoplastic Process]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C1578706:Tumor [Intellectual Product]
   726 E C3273930:Tumor [Finding]

Phrase: "(42%"

Phrase: ")"

Phrase: "from older patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "iNKT+."
Processing 00000000.tx.139: iNKT frequency was similarly distributed in positive tumors regardless of the age of patients with a median of 0.06% and 25th and 75th percentiles of 0.015 and 0.14%. 

Phrase: "iNKT frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "similarly"

Phrase: "distributed in positive tumors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0027651:Tumors [Neoplastic Process]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1704711:Distributed [Functional Concept]
   770   C2825490:Positive [Qualitative Concept]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "regardless of the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with a median"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "of 0.06%"

Phrase: "and"

Phrase: "25th"

Phrase: "and"

Phrase: "75th percentiles of 0.015"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1264641:percentiles [Quantitative Concept]

Phrase: "and"

Phrase: "0.14%."
Processing 00000000.tx.140: To confirm their presence in tumor tissues, we performed three-color immunofluorescence microscopy on five iNKT+ and five iNKT specimens (as determined by RT-PCR) using DAPI for nuclear staining, anti-CD3 mAb for T cells, and antiV24-J18 CDR3 mAb 6B11 for iNKTs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "their presence in tumor tissues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "three-color immunofluorescence microscopy on five iNKT+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   748   C0026018:Microscopy [Laboratory Procedure]

Phrase: "and"

Phrase: "five iNKT specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]

Phrase: "("

Phrase: "as"

Phrase: "determined by RT-PCR)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DAPI for nuclear staining,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "anti-CD3 mAb for T cells,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0879551:Anti CD3 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   783   C0076533:anti-T [Immunologic Factor,Organic Chemical]
   783   C0882828:Cells.CD3 [Cell]
   753   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C3542405:CD3 [Laboratory Procedure]

Phrase: "and"

Phrase: "antiV24-J18 CDR3 mAb 6B11 for iNKTs."
Processing 00000000.tx.141: iNKT specimens contained only T cells (green fluorescence; not depicted), whereas iNKT+ specimens contained T cells and iNKTs (yellow fluorescence due to green and red fluorescence colocalization; Fig. 1 C). 

Phrase: "iNKT specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "only T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(green fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depicted"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "iNKT+ specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "iNKTs"

Phrase: "(yellow fluorescence due to green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "red fluorescence colocalization"

Phrase: "; Fig. 1 C)."
Processing 00000000.tx.142: iNKT Infiltration and Chemokine Expression by Neuroblastoma Tumors and Cell Lines. 

Phrase: "iNKT Infiltration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]

Phrase: "and"

Phrase: "Chemokine Expression by Neuroblastoma Tumors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Cell Lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.143: To examine whether iNKT cell localization to neuroblastomas was associated with expression of chemokines in tumor tissues, we analyzed oligonucleotide microarray expression data (U95Av2 arrays; Affymetrix) for the 79 tumors diagnosed after 1 yr of age. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "iNKT cell localization to neuroblastomas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1660153:cell localization [Biologic Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "associated with expression of chemokines"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in tumor tissues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0475358:Tumor tissue [Tissue]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "oligonucleotide microarray expression data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "(U95Av2 arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]

Phrase: "; Affymetrix"

Phrase: ")"

Phrase: "for the 79 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "diagnosed after 1 yr of age."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011900:Diagnosed [Finding]
   753   C0439234:yr [Temporal Concept]
Processing 00000000.tx.144: Among 43 chemokine genes evaluated, expression of CCL2 (r = 0.52, P < 0.001), CXCL12 (r = 0.46, P < 0.001), CCL5 (r = 0.43, P < 0.001), and CCL21 (r = 0.38, P = 0.005) correlated with iNKT infiltration into tumors (Fig. 2 A). 

Phrase: "Among 43 chemokine genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: ","

Phrase: "expression of CCL2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(r = 0.52,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0139815:R-52 [Organic Chemical,Pharmacologic Substance]
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "CXCL12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0218504:CXCL12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332817:CXCL12 [Gene or Genome]

Phrase: "(r = 0.46,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "CCL5"

Phrase: "(r = 0.43,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "CCL21"

Phrase: "(r = 0.38,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P = 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "correlated with iNKT infiltration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332448:Infiltration [Pathologic Function]
   770   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   770   C1523986:Infiltration [Functional Concept]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "into tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "(Fig. 2 A"

Phrase: ")."
Processing 00000000.tx.145: In contrast, CD3+ T cell infiltration correlated only with expression of CCL21 (r = 0.42, P < 0.001). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "CD3+ T cell infiltration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0332448:Infiltration [Pathologic Function]
   812   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   812   C1523986:Infiltration [Functional Concept]
   708   C0882828:CD3+ cell [Cell]

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "only with expression of CCL21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "(r = 0.42,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.146: View larger version (42K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.147: Chemokine expression in primary untreated neuroblastomas. 

Phrase: "Chemokine expression in primary untreated neuroblastomas."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.148: (A) Expression profiles were generated from 79 untreated stage 4 neuroblastomas from patients using Affymetrix U95Av2 oligonucleotide microarrays. 

Phrase: "(A) Expression profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "were"

Phrase: "generated from 79 untreated stage 4 neuroblastomas"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   802   C0278694:Stage 4 Neuroblastoma [Neoplastic Process]
   778   C0441772:Stage 4 [Intellectual Product]
   757   C0280216:stage, neuroblastoma [Neoplastic Process]
   748   C0027819:Neuroblastomas [Neoplastic Process]
   748   C0205390:Stage [Temporal Concept]
   748   C0332155:untreated [Finding]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   748   C3146294:Generated [Activity]
   714 E C0700095:neuroblastoma [Neoplastic Process]
   714 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Affymetrix U95Av2 oligonucleotide microarrays."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600597:Oligonucleotide Microarrays [Medical Device,Research Device]
   779   C1709016:Microarray [Manufactured Object]
Processing 00000000.tx.149: All genes (black) are plotted according to their average level of expression in tumors with undetectable (x axis) versus detectable (y axis) V24-J18 RNA (iNKT TCR). 

Phrase: "All genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "(black"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "plotted according to their average level of expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C3244092:expression level [Idea or Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C0680240:according [Social Behavior]
   744   C1510992:Average [Quantitative Concept]
   744   C1547707:Level [Geographic Area]
   744   C2825518:AVERAGE [Quantitative Concept]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "with undetectable"

Phrase: "(x axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "versus"

Phrase: "detectable"

Phrase: "(y axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "V24-J18 RNA (iNKT TCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0034790:TCR [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C1158557:TCR [Genetic Function]
   804   C1167203:TCR [Cell Component]

Phrase: ")."
Processing 00000000.tx.150: Gene probe sets for 43 chemokines are enlarged and labeled in red. 

Phrase: "Gene probe sets for 43 chemokines"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0441088:Gene probe [Medical Device]
   783   C1366517:SET gene [Gene or Genome]
   753   C0036849:Set [Mental Process]
   753   C0182400:Probe [Medical Device]
   753   C1442518:Set [Functional Concept]
   753   C1704681:Probe [Gene or Genome]
   753   C1705195:Set [Conceptual Entity]
   753   C2347609:Probe [Chemical Viewed Functionally]
   753   C3536729:Probe [Manufactured Object]

Phrase: "are"

Phrase: "enlarged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442800:Enlarged [Qualitative Concept]
  1000   C1293134:Enlarged [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "labeled in red."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0332575:Red [Finding]
   790   C1260956:Red [Qualitative Concept]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.151: Yellow dashed lines mark 95% confident interval. 

Phrase: "Yellow dashed lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "95% confident interval."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C0009667:Confidence Interval [Quantitative Concept]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
Processing 00000000.tx.152: Names of chemokine genes that positively correlate with iNKT RNA expression are shown. 

Phrase: "Names of chemokine genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1706509:Gene Name [Intellectual Product]
   802   C1706510:Gene Name [Intellectual Product]
   770   C0027365:Name [Intellectual Product]
   770   C1547383:Name [Intellectual Product]

Phrase: "that positively"

Phrase: "correlate with iNKT RNA expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0040649:RNA Expression [Genetic Function]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.153: (B) A tumor that expressed CCL2 mRNA was immunostained with goat antihuman CCL2 followed by the Cell and Tissue Staining Kit (R&D Systems). 

Phrase: "(B) A tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]

Phrase: "that expressed CCL2 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "immunostained with goat antihuman CCL2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018019:goat [Mammal]
   760   C1265549:goat [Mammal]
   760   C1510458:Goat [Mammal]

Phrase: "followed by the Cell"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "Tissue Staining Kit (R&D Systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0205090:R- [Spatial Concept]
   799   C0684010:R. [Professional or Occupational Group]
   799   C2603358:R' [Clinical Attribute]
   766   C0449913:System [Functional Concept]
   766   C1553451:System [Manufactured Object]
   766   C1704459:System [Medical Device]
   716 E C0205373:Systemic [Functional Concept]

Phrase: ")."
Processing 00000000.tx.154: Tumor cells expressing CCL2 have brown cytoplasm.  

Phrase: "Tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "CCL2"

Phrase: "have"

Phrase: "brown cytoplasm."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010834:Cytoplasm [Cell Component]
   789 E C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.155: Supernatants from eight neuroblastoma cell lines were analyzed by ELISA for these four chemokines, and they secreted a range of CCL2 (021.6 ng/ml) and little CXCL12 (0.1 ng/ml), but no detectable CCL5 or CCL21 (Table I) . Quantitative RT-PCR analysis of CCL2 expression by 17 neuroblastomas diagnosed after 1 yr revealed strong correlation with microarray data for two out of three CCL2 probe sets (r = 0.98, P < 0.001), and CCL2 expression by tumor cells was detected by IHC in two representative tumors with high levels of mRNA (Fig. 2 B). 

Phrase: "Supernatants from eight neuroblastoma cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "analyzed by ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "for these four chemokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "they"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "a range of CCL2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "(021.6 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "little CXCL12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0218504:CXCL12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1332817:CXCL12 [Gene or Genome]

Phrase: "(0.1 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "no detectable CCL5"

Phrase: "or"

Phrase: "CCL21"

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ") . Quantitative RT-PCR analysis of CCL2 expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C2733022:Quantitative PCR analysis [Laboratory Procedure]
   778   C0200931:PCR analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "by 17 neuroblastomas"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027819:Neuroblastomas [Neoplastic Process]
   827 E C0700095:neuroblastoma [Neoplastic Process]
   827 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "diagnosed after 1 yr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011900:Diagnosed [Finding]
   770   C0439234:yr [Temporal Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "strong correlation with microarray data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0010100:Data Correlation [Quantitative Concept]
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "for two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "out of three CCL2 probe sets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0036849:Set [Mental Process]
   812   C0182400:Probe [Medical Device]
   812   C1442518:Set [Functional Concept]
   812   C1704681:Probe [Gene or Genome]
   812   C1705195:Set [Conceptual Entity]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]

Phrase: "(r = 0.98,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "CCL2 expression by tumor cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected by IHC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in two representative tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]

Phrase: "with high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of mRNA (Fig. 2 B"

Phrase: ")."
Processing 00000000.tx.156: Comparison of iNKT+ versus iNKT tumors diagnosed after 1 yr demonstrated significantly greater expression of CCL2 in the former (iNKT+: median, 464 microarray FU; 

Phrase: "Comparison of iNKT+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "versus"

Phrase: "iNKT tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "diagnosed after 1 yr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011900:Diagnosed [Finding]
   770   C0439234:yr [Temporal Concept]

Phrase: "demonstrated"

Phrase: "significantly greater expression of CCL2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "(iNKT+"

Phrase: ":"

Phrase: "median,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "464 microarray FU"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C2348686:Fluorescence Units [Quantitative Concept]
   812   C0439148:Units [Quantitative Concept]
   812   C1519795:Units [Quantitative Concept]
   779 E C1704753:Unit [Manufactured Object]
   779 E C1880519:Unit [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.157: 25th and 75th percentiles, 158 and 532 FU; 

Phrase: "25th"

Phrase: "and"

Phrase: "75th percentiles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1264641:percentiles [Quantitative Concept]

Phrase: "158"

Phrase: "and"

Phrase: "532 FU"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C2348686:Fluorescence Units [Quantitative Concept]
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.158: iNKT: median, 189 FU; 

Phrase: "iNKT"

Phrase: ":"

Phrase: "median,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "189 FU"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C2348686:Fluorescence Units [Quantitative Concept]
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.159: 25th and 75th percentiles, 103 and 265 FU; 

Phrase: "25th"

Phrase: "and"

Phrase: "75th percentiles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1264641:percentiles [Quantitative Concept]

Phrase: "103"

Phrase: "and"

Phrase: "265 FU"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C2348686:Fluorescence Units [Quantitative Concept]
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.160: P < 0.001, Wilcoxon test). 

Phrase: "P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Wilcoxon test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871608:Wilcoxon Test [Intellectual Product]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.161: Importantly, iNKTs could not be detected by RT-PCR in 21 neuroblastoma specimens with CCL2 gene expression <106 FU. 

Phrase: "Importantly,"

Phrase: "iNKTs"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "detected by RT-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0442726:Detected [Finding]
   770   C0677874:pCR [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in 21 neuroblastoma specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]

Phrase: "with CCL2 gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337092:CCL2 gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "<106 FU."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C2348686:Fluorescence Units [Quantitative Concept]
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.162: For iNKT+ tumors, the level of CCL2 correlated with the extent of infiltration (r = 0.4, P = 0.018). 

Phrase: "For iNKT+ tumors,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "the level of CCL2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "correlated with the extent of infiltration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0332448:Infiltration [Pathologic Function]
   753   C0439792:Extent [Spatial Concept]
   753   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   753   C1523986:Infiltration [Functional Concept]
   753   C1707520:Correlated [Qualitative Concept]

Phrase: "(r = 0.4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P = 0.018"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450304:0.018" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.163: View this table: [in this window] [in a new window]  Table I. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.164: Chemokine Secretion by Neuroblastoma Cell Linesa  TEM of iNKTs to Supernatants of Neuroblastoma Cell Lines Producing CCL2. 

Phrase: "Chemokine Secretion by Neuroblastoma Cell Linesa  TEM of iNKTs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   777   C1327616:secretion by cell [Cell Function]
           Cell secretion
   760   C2755608:chemokine secretion [Cell Function]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]

Phrase: "to Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "of Neuroblastoma Cell Lines"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   901   C0007600:Cell lines [Cell]
   901   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0205132:lines [Spatial Concept]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C3540583:Neuroblastoma [Intellectual Product]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "Producing"

Phrase: "CCL2."
Processing 00000000.tx.165: We examined whether supernatants from neuroblastoma cell lines were chemoattractants for iNKT cell lines. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "supernatants from neuroblastoma cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "chemoattractants for iNKT cell lines."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0008013:Chemoattractants [Biologically Active Substance]
Processing 00000000.tx.166: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.167: 3 A demonstrates that supernatants from six out of eight tested neuroblastoma cell lines induced iNKT cell TEM. 

Phrase: "3 A"

Phrase: "demonstrates"

Phrase: "that supernatants from six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1550101:Supernatant [Body Substance]

Phrase: "out of eight tested neuroblastoma cell lines"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C0007600:Cell lines [Cell]
   840   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0027819:Neuroblastoma [Neoplastic Process]
   804   C0205132:lines [Spatial Concept]
   804   C0700095:neuroblastoma [Neoplastic Process]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C3540583:Neuroblastoma [Intellectual Product]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "iNKT cell TEM."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1622501:Migration, Cell [Cell Function]
   861   C2936223:Transendothelial Migration [Organ or Tissue Function]
   812   C0600210:Migration [Social Behavior]
   812   C1533574:Migration [Physiologic Function]
   812   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.168: Almost half of input iNKTs migrated toward supernatants of CHLA-20 and SMS-KCN cell lines, which secreted the highest levels of CCL2. 

Phrase: "Almost half of input iNKTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2825407:Half [Quantitative Concept]

Phrase: "migrated toward supernatants of CHLA-20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0232902:Migrated [Functional Concept]
   719   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "SMS-KCN cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "which"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "the highest levels of CCL2."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.169: In contrast, iNKTs did not significantly migrate toward supernatant of SMS-KCNR cells, which produced no CCL2 (Table I). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "iNKTs"

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "migrate toward supernatant of SMS-KCNR cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0007634:Cells [Cell]
   748   C0232902:migrate [Functional Concept]
   748   C1550101:Supernatant [Body Substance]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "produced"

Phrase: "no CCL2"

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.170: These experiments demonstrated a correlation between the quantity of CCL2 in supernatants and the percentage of migrating iNKTs (r = 0.98, P < 0.001). 

Phrase: "These experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "a correlation between the quantity of CCL2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "in supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "the percentage of migrating iNKTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "(r = 0.98,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.171: Next, we examined the effect of neutralizing mAbs against the four candidate chemokines (CCL2, CXCL12, CCL5, and CCL21) on iNKT cell TEM toward supernatants from neuroblastoma cell lines CHLA-20 and SMS-KCN (Fig. 3 B). 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of neutralizing mAbs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "against the four candidate chemokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(CCL2,"

Phrase: "CXCL12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0218504:CXCL12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332817:CXCL12 [Gene or Genome]

Phrase: "CCL5,"

Phrase: "and"

Phrase: "CCL21"

Phrase: ")"

Phrase: "on iNKT cell TEM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1622501:Migration, Cell [Cell Function]
   861   C2936223:Transendothelial Migration [Organ or Tissue Function]
   812   C0600210:Migration [Social Behavior]
   812   C1533574:Migration [Physiologic Function]
   812   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "toward supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "from neuroblastoma cell lines CHLA-20"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C0007600:Cell lines [Cell]
   840   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0027819:Neuroblastoma [Neoplastic Process]
   804   C0205132:lines [Spatial Concept]
   804   C0700095:neuroblastoma [Neoplastic Process]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C3540583:Neuroblastoma [Intellectual Product]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "SMS-KCN"

Phrase: "(Fig. 3 B"

Phrase: ")."
Processing 00000000.tx.172: Anti-CCL2 mAb abrogated iNKT cell chemotaxis, whereas anti-CXCL12, anti-CCL21, and anti-CCL5 mAbs had no effect. 

Phrase: "Anti-CCL2 mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "abrogated"

Phrase: "iNKT cell chemotaxis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2610454:cell chemotaxis [Cell Function]
   827   C0008018:Chemotaxis [Cell Function]
   734   C2350467:iNKT Cell [Cell]

Phrase: "whereas"

Phrase: "anti-CXCL12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0218504:CXCL12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1332817:CXCL12 [Gene or Genome]

Phrase: "anti-CCL21,"

Phrase: "and"

Phrase: "anti-CCL5 mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "had"

Phrase: "no effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.173: View larger version (25K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.174: iNKT cell migration to neuroblastoma cell line supernatants. 

Phrase: "iNKT cell migration to neuroblastoma cell line supernatants."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1622501:Migration, Cell [Cell Function]
   744   C0600210:Migration [Social Behavior]
   744   C1533574:Migration [Physiologic Function]
   744   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.175: (A) Medium alone or supernatants from neuroblastoma cell lines were used to assess TEM of an iNKT cell line. 

Phrase: "(A) Medium alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205171:Alone [Quantitative Concept]
   827   C0439044:alone [Finding]
   827   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "supernatants from neuroblastoma cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "TEM of an iNKT cell line."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C2936223:Transendothelial Migration [Organ or Tissue Function]
   774   C1622501:Migration, Cell [Cell Function]
   748   C0600210:Migration [Social Behavior]
   748   C1533574:Migration [Physiologic Function]
   748   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.176: Percentage of migrating cells is indicated on the x axis. 

Phrase: "Percentage of migrating cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "is"

Phrase: "indicated on the x axis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004457:Axis [Body Part, Organ, or Organ Component]
   760   C0999597:Axis [Mammal]
   760   C1444656:Indicated [Finding]
   760   C1522496:Axis [Spatial Concept]
Processing 00000000.tx.177: (B) Supernatants from neuroblastoma cell lines mixed with 10 g/ml of neutralizing mAbs against indicated chemokines, or mouse IgG1 isotype control mAbs were tested for chemotactic activity using the same iNKT cell line and the TEM assay. 

Phrase: "(B) Supernatants from neuroblastoma cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1550101:Supernatant [Body Substance]

Phrase: "mixed with 10 g/ml of neutralizing mAbs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C1300565:g/mL [Quantitative Concept]
   767 E C1637390:mL/g [Quantitative Concept]
   744   C0205430:Mixed [Functional Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C3160715:Mixed [Finding]
   711   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   711 E C1421951:MIX [Gene or Genome]
   711 E C1720722:Mix [Qualitative Concept]

Phrase: "against indicated chemokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "mouse IgG1 isotype control mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "tested for chemotactic activity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205177:Activity [Functional Concept]
   770   C0392366:tested [Intellectual Product]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same iNKT cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "the TEM assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1513300:Migration Assay [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C2936223:Transendothelial Migration [Organ or Tissue Function]
Processing 00000000.tx.178: Specific migration (x axis) is shown as net migration after subtraction of migration to medium alone. 

Phrase: "Specific migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "(x axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "is"

Phrase: "shown as net migration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]
   737   C1547282:Show [Intellectual Product]
   715   C0439739:Reticular [Spatial Concept]

Phrase: "after subtraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348589:Subtraction [Phenomenon or Process]

Phrase: "of migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to medium alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]
Processing 00000000.tx.179: Results are mean  SD from duplicates of four experiments.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "mean  SD from duplicates of four experiments."
Processing 00000000.tx.180: iNKT Frequency, CCR2 Expression, and CCL2-dependent TEM of Blood iNKTs from Children with Metastatic Neuroblastoma. 

Phrase: "iNKT Frequency,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "CCR2 Expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CCL2-dependent TEM of Blood iNKTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2936223:Transendothelial Migration [Organ or Tissue Function]
   748   C0600210:Migration [Social Behavior]
   748   C1533574:Migration [Physiologic Function]
   748   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "from Children"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008059:Children [Age Group]
  1000   C0680063:Children [Family Group]

Phrase: "with Metastatic Neuroblastoma."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0278694:metastatic neuroblastoma [Neoplastic Process]
  1000   C1135161:neuroblastoma, metastatic [Neoplastic Process]
   861   C0027819:Neuroblastoma [Neoplastic Process]
   861   C0700095:neuroblastoma [Neoplastic Process]
   861   C3540583:Neuroblastoma [Intellectual Product]
Processing 00000000.tx.181: It has been reported recently that CCR2, which is the only known functional receptor for CCL2, is expressed on human iNKTs (15). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that CCR2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413188:CCR2 [Gene or Genome]
  1000   C3538748:CCR2 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "which"

Phrase: "is"

Phrase: "the only known functional receptor for CCL2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "expressed on human iNKTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Human [Human]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.182: To examine the effect of metastatic disease (stage 4), we evaluated iNKTs from blood of neuroblastoma patients diagnosed after 1 yr with respect to frequency (Fig. 4 A), expression of CCR2 (Fig. 4, B and C), and TEM in response to CCL2 (Fig. 4 D). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effect of metastatic disease (stage 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "iNKTs from blood of neuroblastoma patients"

Phrase: "diagnosed after 1 yr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011900:Diagnosed [Finding]
   770   C0439234:yr [Temporal Concept]

Phrase: "with respect to frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "(Fig. 4 A"

Phrase: ")"

Phrase: ","

Phrase: "expression of CCR2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "TEM in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2936223:Transendothelial Migration [Organ or Tissue Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to CCL2"

Phrase: "(Fig. 4 D"

Phrase: ")."
Processing 00000000.tx.183: We found no significant difference either in iNKT cell frequency or CCR2 expression on the iNKT, NK, and T cells between normal adults and neuroblastoma patients. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant difference either in iNKT cell frequency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "CCR2 expression on the iNKT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "NK,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2709199:Natural killer [Cell]
   861   C0205296:Natural [Functional Concept]
   861   C1336644:KILLER [Gene or Genome]
   861   C1705132:KILLER [Gene or Genome]

Phrase: "and"

Phrase: "T cells between normal adults"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   811   C0279592:adult t-cell [Neoplastic Process]
   806   C0039194:T-Cells [Cell]
   781   C0007634:Normal cell [Cell]
           Cells
   781   C1268443:Normal cell [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "neuroblastoma patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.184: Combining both groups of subjects demonstrated that iNKTs more frequently expressed CCR2 (median, 78%; range, 4098%) compared with NK cells (median, 5%; range, 111%) and T cells (median, 21%; range, 1037%; P < 0.001, paired signed rank test; Fig. 4 C). 

Phrase: "Combining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0336789:Combine [Manufactured Object]

Phrase: "both"

Phrase: "groups of subjects"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "demonstrated"

Phrase: "that iNKTs more frequently expressed CCR2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1413188:CCR2 [Gene or Genome]
   804   C3538748:CCR2 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(median,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "78%"

Phrase: "; range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "4098%"

Phrase: ")"

Phrase: "compared with NK cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   862   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   862   C2363836:Natural Killer Cells [Laboratory Procedure]
   806   C0022686:Killer Cells [Cell]
   806   C2709199:Natural killer [Cell]
   760   C0007634:Cells [Cell]
   760   C0205296:Natural [Functional Concept]
   760   C1336644:KILLER [Gene or Genome]
   760   C1705132:KILLER [Gene or Genome]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(median,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "; range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "111%"

Phrase: ")"

Phrase: "and"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(median,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "21%"

Phrase: "; range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "1037%"

Phrase: "; P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "paired"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Paired [Qualitative Concept]

Phrase: "signed rank test"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   896   C0871907:sign test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C0699794:Rank [Intellectual Product]
   827   C1519316:Signed [Intellectual Product]
   827   C1561610:signed [Idea or Concept]
   793 E C0311392:Sign [Finding]
   793 E C1547188:Sign [Idea or Concept]

Phrase: "; Fig. 4 C)."
Processing 00000000.tx.185: Migration of blood iNKTs from neuroblastoma patients and normal adults in response to CCL2 and CHLA-20 neuroblastoma cell line supernatant also was not different, with both recombinant CCL2 and supernatant from CHLA-20 cells inducing up to 55% TEM of iNKTs from both patients and normal donors. 

Phrase: "Migration of blood iNKTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "from neuroblastoma patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "normal adults in response"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0001675:Adults [Age Group]
   737 E C1706450:Adult [Human]

Phrase: "to CCL2"

Phrase: "and"

Phrase: "CHLA-20 neuroblastoma cell line supernatant also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "not different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "with both recombinant CCL2"

Phrase: "and"

Phrase: "supernatant from CHLA-20 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1550101:Supernatant [Body Substance]

Phrase: "inducing up to 55% TEM of iNKTs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C2936223:Transendothelial Migration [Organ or Tissue Function]
   744   C0205263:Inducing [Functional Concept]
   744   C0450382:55 [Intellectual Product]
   744   C0600210:Migration [Social Behavior]
   744   C1533574:Migration [Physiologic Function]
   744   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "from both patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "normal donors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013018:Donors [Population Group]
   861   C1527169:Donors [Finding]
   827 E C0040288:Donor [Population Group]
Processing 00000000.tx.186: As expected, migration in response to supernatant was specifically prevented by anti-CCL2 neutralizing mAb. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "migration in response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0600210:Migration [Social Behavior]
   790   C1533574:Migration [Physiologic Function]
   790   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "specifically"

Phrase: "prevented by anti-CCL2 neutralizing mAb."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   719   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.187: In contrast to iNKTs, T and NK cells from patients and normal adults migrated minimally (Fig. 4 D). 

Phrase: "In contrast to iNKTs,"

Phrase: "T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "NK cells from patients"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   862   C2363836:Natural Killer Cells [Laboratory Procedure]
   806   C0022686:Killer Cells [Cell]
   806   C2709199:Natural killer [Cell]
   760   C0007634:Cells [Cell]
   760   C0205296:Natural [Functional Concept]
   760   C1336644:KILLER [Gene or Genome]
   760   C1705132:KILLER [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "normal adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001675:Adults [Age Group]
   827 E C1706450:Adult [Human]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "minimally"

Phrase: "(Fig. 4 D"

Phrase: ")."
Processing 00000000.tx.188: View larger version (15K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.189: CCR2 expression and migratory response of blood iNKTs from neuroblastoma patients. 

Phrase: "CCR2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "migratory response of blood iNKTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "from neuroblastoma patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.190: (A) iNKT cell frequency in blood T cells of normal donors (n = 36) and neuroblastoma (NB) patients (n = 8) was determined by three-color flow cytometry. 

Phrase: "(A) iNKT cell frequency in blood T cells of normal donors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   738   C0376249:frequency [Quantitative Concept]
   738   C0439603:Frequency [Temporal Concept]
   738   C0871396:Frequency [Quantitative Concept]
   738   C1561548:Frequency [Qualitative Concept]
   738   C1705502:Frequency [Quantitative Concept]

Phrase: "(n = 36"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "neuroblastoma (NB) patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "determined by three-color flow cytometry."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0016263:Flow Cytometry [Laboratory Procedure]
   753   C0009393:Color [Natural Phenomenon or Process]
   753   C0205449:Three [Quantitative Concept]
   753   C0806140:Flow [Natural Phenomenon or Process]
   753   C0814048:Cytometry [Laboratory Procedure]
   753   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   753   C1705245:Color [Pharmacologic Substance]
Processing 00000000.tx.191: (B) Representative flow cytometry diagrams demonstrating iNKT frequency in patient PBLs (left) and CCR2 expression in this iNKT subset (right). 

Phrase: "(B) Representative flow cytometry diagrams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0681494:diagrams [Intellectual Product]

Phrase: "demonstrating"

Phrase: "iNKT frequency in patient PBLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "CCR2 expression in this iNKT subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.192: (C) Mean  SD of CCR2 expression in indicated lymphocyte subpopulations from normal adults (n = 10) and neuroblastoma patients (n = 6). 

Phrase: "(C) Mean  SD of CCR2 expression"

Phrase: "in indicated lymphocyte subpopulations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0079720:Lymphocyte Subpopulations [Classification]
   793   C1257890:Subpopulation [Population Group]

Phrase: "from normal adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001675:Adults [Age Group]
   827 E C1706450:Adult [Human]

Phrase: "(n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "neuroblastoma patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.193: (D) TEM of monocyte-depleted peripheral blood lymphocytes from neuroblastoma patients (n = 4) and normal adults (n = 4) was evaluated with indicated conditions. 

Phrase: "("

Phrase: "D)"

Phrase: "TEM of monocyte-depleted peripheral blood lymphocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C2936223:Transendothelial Migration [Organ or Tissue Function]
   750   C3156756:lymphocyte migration [Cell Function]
   744   C0600210:Migration [Social Behavior]
   744   C1533574:Migration [Physiologic Function]
   744   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "from neuroblastoma patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "normal adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001675:Adults [Age Group]
   827 E C1706450:Adult [Human]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "evaluated with indicated conditions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0220825:Evaluated [Functional Concept]
   770   C1444656:Indicated [Finding]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.194: Results are mean  SD from duplicates of four experiments.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "mean  SD from duplicates of four experiments."
Processing 00000000.tx.195: Patient Survival, iNKT Infiltration, MYCN Amplification/Expression, and CCL2 Expression. 

Phrase: "Patient Survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "iNKT Infiltration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]

Phrase: "MYCN Amplification/Expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CCL2 Expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.196: We evaluated iNKT infiltration in relationship to clinical and molecular biologic variables. 

Phrase: "We"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "iNKT infiltration in relationship"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332448:Infiltration [Pathologic Function]
   770   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   770   C1523986:Infiltration [Functional Concept]

Phrase: "to clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "molecular biologic variables."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439828:variables [Qualitative Concept]
Processing 00000000.tx.197: Patients diagnosed after 1 yr of age with metastases (stage 4) have high-risk disease, and the 79 studied patients received intensive chemotherapy or myeloablative chemoradiotherapy (18). 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "diagnosed after 1 yr of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011900:Diagnosed [Finding]
   753   C0439234:yr [Temporal Concept]

Phrase: "with metastases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0027627:Metastases [Neoplastic Process]
  1000   C2939419:Metastases [Neoplastic Process]
   966 E C2939420:metastasis [Neoplastic Process]
   916 E C0036525:Metastatic [Functional Concept]
   916 E C1522484:metastatic [Quantitative Concept]

Phrase: "(stage 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441772:Stage 4 [Intellectual Product]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: ")"

Phrase: "have"

Phrase: "high-risk disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   734   C0332167:High Risk [Qualitative Concept]
   734   C3272283:High Risk [Finding]

Phrase: "and"

Phrase: "the 79 studied patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "intensive chemotherapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   861   C0013217:chemotherapy [Functional Concept]
   861   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "myeloablative chemoradiotherapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0436307:Chemoradiotherapy [Therapeutic or Preventive Procedure]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.198: Their estimated survival 3 and 5 yr after diagnosis was 48 and 33%. 

Phrase: "Their estimated survival 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   827   C0750572:Estimated [Quantitative Concept]

Phrase: "and"

Phrase: "5 yr after diagnosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439234:yr [Temporal Concept]

Phrase: "was"

Phrase: "48"

Phrase: "and"

Phrase: "33%."
Processing 00000000.tx.199: Examination of iNKT infiltration and survival demonstrated a trend toward better outcome for those with iNKT-infiltrated tumors, but the difference was not significant (P = 0.32). 

Phrase: "Examination of iNKT infiltration"

Phrase: "and"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "demonstrated"

Phrase: "a trend toward better outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521798:trend [Temporal Concept]

Phrase: "for those with iNKT-infiltrated tumors,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0027651:Tumors [Neoplastic Process]
   779 E C1578706:Tumor [Intellectual Product]
   779 E C3273930:Tumor [Finding]

Phrase: "but"

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P = 0.32"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0069881:P-32 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   913   C0851287:P-32 [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.200: Of note, therapy received by all patients was immunosuppressive with unknown effects on iNKT cell number and function, which precludes a clear analysis of correlation between only iNKT infiltration and survival. 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "received by all patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1709850:Received By [Qualitative Concept]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1514756:Received [Qualitative Concept]

Phrase: "was"

Phrase: "immunosuppressive with unknown effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0021080:Immunosuppressive Effect [Organism Function]
   770   C0021081:immunosuppressive [Immunologic Factor,Pharmacologic Substance]

Phrase: "on iNKT cell number"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007584:Cell Number [Laboratory Procedure]
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]
   734   C2350467:iNKT Cell [Cell]

Phrase: "and"

Phrase: "function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "which"

Phrase: "precludes"

Phrase: "a clear analysis of correlation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0010101:correlation analysis [Intellectual Product,Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "between only iNKT infiltration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332448:Infiltration [Pathologic Function]
   827   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   827   C1523986:Infiltration [Functional Concept]

Phrase: "and"

Phrase: "survival."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]
Processing 00000000.tx.201: Patients diagnosed before 1 yr of age with stage 4 neuroblastoma without MYCN gene amplification have intermediate-risk disease (28). 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "diagnosed before 1 yr of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011900:Diagnosed [Finding]
   753   C0439234:yr [Temporal Concept]

Phrase: "with stage 4 neuroblastoma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0278694:Stage 4 Neuroblastoma [Neoplastic Process]
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C3540583:Neuroblastoma [Intellectual Product]
   734   C0441772:Stage 4 [Intellectual Product]

Phrase: "without MYCN gene amplification"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1522020:MYCN Gene Amplification [Cell or Molecular Dysfunction]
   901   C0017256:Gene Amplification [Genetic Function]
   901   C0812287:MYCN gene [Gene or Genome]
   901   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   827   C0017337:Gene [Gene or Genome]
   827   C1517480:Amplification [Molecular Biology Research Technique]
   827   C1521871:Amplification [Phenomenon or Process]

Phrase: "have"

Phrase: "intermediate-risk disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   734   C3640764:Intermediate Risk [Conceptual Entity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.202: The 19 studied patients received much less intensive chemotherapy, and all survived for >56 mo after diagnosis. 

Phrase: "The 19 studied patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "much less intensive chemotherapy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   812   C0013217:chemotherapy [Functional Concept]
   812   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "all"

Phrase: "survived for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: ">56 mo after diagnosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538743:MO [Idea or Concept]
Processing 00000000.tx.203: Analysis of outcome for all 98 patients in relationship to iNKT infiltration showed that survival was 64 and 35% at 5 yr for iNKT+ and iNKT tumors (P = 0.007; Fig. 5 A). 

Phrase: "Analysis of outcome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "for all 98 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "in relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "to iNKT infiltration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "64"

Phrase: "and"

Phrase: "35% at 5 yr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439234:yr [Temporal Concept]

Phrase: "for iNKT+"

Phrase: "and"

Phrase: "iNKT tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "(P = 0.007"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 5 A"

Phrase: ")."
Processing 00000000.tx.204: View larger version (15K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.205: Patient survival, iNKT infiltration, MYCN amplification/expression, and CCL2 expression. 

Phrase: "Patient survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "iNKT infiltration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]

Phrase: "MYCN amplification/expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CCL2 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.206: (A) Survival for 98 patients whose tumors did or did not have iNKT infiltration (P = 0.007). 

Phrase: "(A) Survival for 98 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "whose tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "did"

Phrase: "or"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "iNKT infiltration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]

Phrase: "(P = 0.007"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.207: (B) Survival for 98 patients whose tumors did or did not have MYCN amplification (P = 0.001). 

Phrase: "(B) Survival for 98 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "whose tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "did"

Phrase: "or"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "MYCN amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "(P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.208: (C) MYCN expression and iNKT infiltration in primary neuroblastomas. 

Phrase: "(C) MYCN expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "iNKT infiltration in primary neuroblastomas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332448:Infiltration [Pathologic Function]
   760   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   760   C1523986:Infiltration [Functional Concept]
Processing 00000000.tx.209: MYCN RNA expression (y axis) was quantified by Affymetrix U95Av2 oligonucleotide microarrays and V24-J18 RNA was detected by Taqman RT-PCR in 79 untreated neuroblastomas. 

Phrase: "MYCN RNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0040649:RNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(y axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "quantified by Affymetrix U95Av2 oligonucleotide microarrays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0600597:Oligonucleotide Microarrays [Medical Device,Research Device]
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   719   C1709016:Microarray [Manufactured Object]
   719   C1709793:Quantify [Quantitative Concept]

Phrase: "and"

Phrase: "V24-J18 RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "detected by Taqman RT-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0442726:Detected [Finding]
   760   C0677874:pCR [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in 79 untreated neuroblastomas."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027819:Neuroblastomas [Neoplastic Process]
   793 E C0700095:neuroblastoma [Neoplastic Process]
   793 E C3540583:Neuroblastoma [Intellectual Product]
Processing 00000000.tx.210: Tumors with detectable (NKT+) and undetectable (NKT). 

Phrase: "Tumors with detectable"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0027651:Tumors [Neoplastic Process]
   756 E C1578706:Tumor [Intellectual Product]
   756 E C3273930:Tumor [Finding]

Phrase: "(NKT+)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C2709199:Natural killer [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]

Phrase: "and"

Phrase: "undetectable"

Phrase: "(NKT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2709199:Natural killer [Cell]

Phrase: ")."
Processing 00000000.tx.211: iNKTs expressed 434.6  100.0 (n = 33) and 1,378  139.5 (n = 46) MYCN FU, respectively (Student's t test, P < 0.001). 

Phrase: "iNKTs"

Phrase: "expressed"

Phrase: "434.6  100.0"

Phrase: "(n = 33"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "1,378  139.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0450316:1/5 [Quantitative Concept]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "(n = 46"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "MYCN FU,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C2348686:Fluorescence Units [Quantitative Concept]
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: "respectively"

Phrase: "(Student's t test,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.212: (D) Correlation between MYCN and CCL2 expression. 

Phrase: "("

Phrase: "D)"

Phrase: "Correlation between MYCN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "CCL2 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.213: MYCN (x axis) and CCL2 (y axis) RNA were quantified by Affymetrix U95Av2 oligonucleotide microarrays in 79 untreated tumors. 

Phrase: "MYCN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812287:MYCN [Gene or Genome]
  1000   C1705027:MYCN [Gene or Genome]

Phrase: "(x axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "CCL2"

Phrase: "(y axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "quantified by Affymetrix U95Av2 oligonucleotide microarrays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0600597:Oligonucleotide Microarrays [Medical Device,Research Device]
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   719   C1709016:Microarray [Manufactured Object]
   719   C1709793:Quantify [Quantitative Concept]

Phrase: "in 79 untreated tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]
Processing 00000000.tx.214: Regression line demonstrates an inverse correlation between MYCN and CCL2 (r = 0.5, P < 0.001, Spearman correlation analysis).  

Phrase: "Regression line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205132:Line [Spatial Concept]
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "demonstrates"

Phrase: "an inverse correlation between MYCN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "CCL2"

Phrase: "(r = 0.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0444499:0/5 [Quantitative Concept]
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Spearman correlation analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0010101:correlation analysis [Intellectual Product,Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1710141:Spearman Correlation [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.215: Genomic amplification of MYCN is associated with aggressive tumor behavior (22). 

Phrase: "Genomic amplification of MYCN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "associated with aggressive tumor behavior"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0001807:Aggressive behavior [Mental or Behavioral Dysfunction]
           aggressive
   760   C0004927:Behavior [Individual Behavior]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0580822:Aggressive [Temporal Concept]
   760   C1578706:Tumor [Intellectual Product]
   760   C2707008:Behavior [Clinical Attribute]
   760   C3273930:Tumor [Finding]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.216: Survival for all 98 patients in relationship to MYCN gene status was 65 and 30% for MYCN nonamplified and amplified tumors (Fig. 5 B; P = 0.001). 

Phrase: "Survival for all 98 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "in relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "to MYCN gene status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449438:Status [Qualitative Concept]
   734   C0812287:MYCN gene [Gene or Genome]

Phrase: "was"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "and"

Phrase: "30% for MYCN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0812287:MYCN [Gene or Genome]
   790   C1705027:MYCN [Gene or Genome]

Phrase: "nonamplified"

Phrase: "and"

Phrase: "amplified tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "(Fig. 5 B"

Phrase: "; P = 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.217: The 19 tumors diagnosed before 1 yr that were studied were all nonamplified and all contained iNKTs. 

Phrase: "The 19 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "diagnosed before 1 yr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011900:Diagnosed [Finding]
   770   C0439234:yr [Temporal Concept]

Phrase: "that"

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "all nonamplified"

Phrase: "and"

Phrase: "all contained iNKTs."
Processing 00000000.tx.218: Tumors diagnosed after 1 yr with MYCN amplification and high-level expression surprisingly almost always lacked iNKTs, whereas those in this group without amplification accounted for nearly all with infiltration (P < 0.001; Fig. 5 C). 

Phrase: "Tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "diagnosed after 1 yr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011900:Diagnosed [Finding]
   770   C0439234:yr [Temporal Concept]

Phrase: "with MYCN amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "high-level expression surprisingly almost always lacked iNKTs,"

Phrase: "whereas"

Phrase: "those in this group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "without amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "accounted for nearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1551359:account [Idea or Concept]
   756   C2741673:Account # [Clinical Attribute]
   756   C2981730:Account [Classification]

Phrase: "all with infiltration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332448:Infiltration [Pathologic Function]
   790   C0444868:All [Quantitative Concept]
   790   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   790   C1523986:Infiltration [Functional Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 5 C)."
Processing 00000000.tx.219: Furthermore, for patients diagnosed after 1 yr of age, MYCN and CCL2 expression were inversely correlated (Spearman correlation r = 0.5, P < 0.001; Fig. 5 D). 

Phrase: "Furthermore,"

Phrase: "for patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "diagnosed after 1 yr of age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011900:Diagnosed [Finding]
   753   C0439234:yr [Temporal Concept]

Phrase: "MYCN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812287:MYCN [Gene or Genome]
  1000   C1705027:MYCN [Gene or Genome]

Phrase: "and"

Phrase: "CCL2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "inversely"

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "(Spearman correlation r = 0.5,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0444499:0/5 [Quantitative Concept]
   840   C1710141:Spearman Correlation [Intellectual Product]
   804   C0205090:R- [Spatial Concept]
   804   C0684010:R. [Professional or Occupational Group]
   804   C1707520:Correlation [Qualitative Concept]
   804   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D)."
Processing 00000000.tx.220: When MYCN and CCL2 RNA expression were categorized according to optimal cut-points, iNKTs infiltrated 76% of MYCN-low/CCL2-high tumors but none of the MYCN-high/CCL2-low tumors (P < 0.001; Table II). 

Phrase: "When"

Phrase: "MYCN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812287:MYCN [Gene or Genome]
  1000   C1705027:MYCN [Gene or Genome]

Phrase: "and"

Phrase: "CCL2 RNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0040649:RNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "categorized according to optimal cut-points,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0000925:Cut [Injury or Poisoning]
   753   C0680240:according [Social Behavior]
   753   C0871968:categorized [Activity]
   753   C1883724:CUT [Phenomenon or Process]
   753   C2698651:Optimal [Qualitative Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "iNKTs"

Phrase: "infiltrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332448:infiltrated [Pathologic Function]
   966 E C1546677:Infiltrate [Intellectual Product]
   966 E C1549537:Infiltrate [Functional Concept]

Phrase: "76% of MYCN-low/CCL2-high tumors"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   748   C0027651:Tumors [Neoplastic Process]
   748   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205250:High [Qualitative Concept]
   748   C0205251:low [Qualitative Concept]
   748   C0812287:MYCN [Gene or Genome]
   748   C1299351:High [Qualitative Concept]
   748   C1299352:Low [Qualitative Concept]
   748   C1550472:low [Idea or Concept]
   748   C1705027:MYCN [Gene or Genome]
   748   C2700149:HIGH [Intellectual Product]
   714 E C1578706:Tumor [Intellectual Product]
   714 E C3273930:Tumor [Finding]

Phrase: "but"

Phrase: "none of the MYCN-high/CCL2-low tumors"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   744   C0027651:Tumors [Neoplastic Process]
   744   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205250:High [Qualitative Concept]
   744   C0205251:low [Qualitative Concept]
   744   C0456148:None [Quantitative Concept]
   744   C0549184:None [Quantitative Concept]
   744   C0812287:MYCN [Gene or Genome]
   744   C1299351:High [Qualitative Concept]
   744   C1299352:Low [Qualitative Concept]
   744   C1550472:low [Idea or Concept]
   744   C1705027:MYCN [Gene or Genome]
   744   C2700149:HIGH [Intellectual Product]
   711 E C1578706:Tumor [Intellectual Product]
   711 E C3273930:Tumor [Finding]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Table II"

Phrase: ")."
Processing 00000000.tx.221: The association of iNKT infiltration also was tested with MYCN and CCL2 jointly using a multivariate logistic regression model containing the categorized expression of MYCN and CCL2. 

Phrase: "The association of iNKT infiltration also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "tested with MYCN"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0392366:tested [Intellectual Product]
   790   C0812287:MYCN [Gene or Genome]
   790   C1705027:MYCN [Gene or Genome]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "CCL2 jointly"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a multivariate logistic regression model"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0023965:Logistic Model [Intellectual Product,Quantitative Concept]
   861   C0206031:Logistic Regression [Research Activity]
   812   C0242415:logistic [Occupational Activity]
   812   C0684320:Regression [Pathologic Function]
   812   C0684321:Regression [Mental Process]
   812   C3161035:Model [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the categorized expression of MYCN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CCL2."
Processing 00000000.tx.222: In this model, the effects of both genes on iNKT cell infiltration were independently significant (P 0.01) and were additive but not synergistic. 

Phrase: "In this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "the effects of both genes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on iNKT cell infiltration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332448:Infiltration [Pathologic Function]
   827   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   827   C1523986:Infiltration [Functional Concept]
   734   C2350467:iNKT Cell [Cell]

Phrase: "were"

Phrase: "independently significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "additive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442796:Additive [Qualitative Concept]
  1000   C1550602:Additive [Substance]

Phrase: "but"

Phrase: "not synergistic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986495:Synergistic [Qualitative Concept]
Processing 00000000.tx.223: Thus, MYCN-low/CCL2-high and MYCN-high/CCL2-low were estimated to have 76 and 100% accuracy in predicting iNKT presence and absence, respectively. 

Phrase: "Thus,"

Phrase: "MYCN-low/CCL2-high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205250:High [Qualitative Concept]
   812   C1299351:High [Qualitative Concept]
   812   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "MYCN-high/CCL2-low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205251:low [Qualitative Concept]
   812   C1299352:Low [Qualitative Concept]
   812   C1550472:low [Idea or Concept]

Phrase: "were"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "76"

Phrase: "and"

Phrase: "100% accuracy in predicting iNKT presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443131:Accuracy [Qualitative Concept]

Phrase: "and"

Phrase: "absence,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "respectively."
Processing 00000000.tx.224: View this table: [in this window] [in a new window]  Table II. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II."
Processing 00000000.tx.225: Relationship between MYCN and CCL2 Expression and iNKT Cell Presence in 79 Neuroblastomas Diagnosed after 1 yr of Age   Discussion Top Abstract Introduction Materials and Methods Results Discussion References  This paper demonstrates infiltration of iNKTs into 53% of primary untreated metastatic neuroblastomas and correlation of infiltration with expression of CCL2, CCL5, CCL21, and CXCL12. 

Phrase: "Relationship between MYCN"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439849:Relationship [Qualitative Concept]
   790   C1705630:Relationship [Idea or Concept]
   790   C1706279:Relationship [Idea or Concept]
   790   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "CCL2 Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "iNKT Cell Presence in 79 Neuroblastomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "Diagnosed after 1 yr of Age   Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   738   C0000857:Abstract [Occupational Activity]
   738   C0001779:Age [Organism Attribute]
   738   C0011900:Diagnosed [Finding]
   738   C0439234:yr [Temporal Concept]
   738   C0520510:Materials [Substance]
   738   C0557061:Discussion [Therapeutic or Preventive Procedure]
   738   C0600678:Abstract [Intellectual Product]
   738   C1293116:Introduction [Health Care Activity]
   738   C1552863:Abstract [Idea or Concept]
   738   C1704458:Top [Spatial Concept]
   738   C1875307:INTRODUCTION [Manufactured Object]
   738   C2584313:Discussion [Social Behavior]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "demonstrates"

Phrase: "infiltration of iNKTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332448:Infiltration [Pathologic Function]
   790   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   790   C1523986:Infiltration [Functional Concept]

Phrase: "into 53%"

Phrase: "of primary untreated metastatic neuroblastomas"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   844   C0278694:metastatic neuroblastoma [Neoplastic Process]
   844   C1135161:neuroblastoma, metastatic [Neoplastic Process]
   812   C0027819:Neuroblastomas [Neoplastic Process]
   779 E C0700095:neuroblastoma [Neoplastic Process]
   779 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "and"

Phrase: "correlation of infiltration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707520:Correlation [Qualitative Concept]

Phrase: "with expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of CCL2,"

Phrase: "CCL5,"

Phrase: "CCL21,"

Phrase: "and"

Phrase: "CXCL12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0218504:CXCL12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332817:CXCL12 [Gene or Genome]
Processing 00000000.tx.226: iNKT localization most likely was primarily due to CCL2 because six out of eight neuroblastoma cell lines secreted CCL2, which was required and sufficient for TEM of iNKTs in vitro. 

Phrase: "iNKT localization most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0332148:Likely [Qualitative Concept]
   812   C0475264:Localisation [Functional Concept]
   812   C0750492:Likely [Idea or Concept]
   812   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "primarily due to CCL2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0678226:Due to [Functional Concept]
           due
   770   C3146286:Due [Idea or Concept]

Phrase: "because"

Phrase: "six out of eight neuroblastoma cell lines"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   778   C0007600:Cell lines [Cell]
   778   C0815000:neuroblastoma cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0027819:Neuroblastoma [Neoplastic Process]
   748   C0205132:lines [Spatial Concept]
   748   C0205452:Six [Quantitative Concept]
   748   C0205454:Eight [Quantitative Concept]
   748   C0439787:Out [Spatial Concept]
   748   C0700095:neuroblastoma [Neoplastic Process]
   748   C0849355:Out [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3540583:Neuroblastoma [Intellectual Product]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "CCL2,"

Phrase: "which"

Phrase: "was"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "sufficient for TEM of iNKTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205410:Sufficient [Qualitative Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.227: CCL2 expression was inversely associated with MYCN gene amplification and expression, and MYCN-high/CCL2-low expression accurately predicted the absence of iNKTs in tumors. 

Phrase: "CCL2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "inversely"

Phrase: "associated with MYCN gene amplification"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   862   C1522020:MYCN Gene Amplification [Cell or Molecular Dysfunction]
   806   C0017256:Gene Amplification [Genetic Function]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0812287:MYCN gene [Gene or Genome]
           MYCN
   806   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   760   C0017337:Gene [Gene or Genome]
   760   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705027:MYCN [Gene or Genome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "MYCN-high/CCL2-low expression accurately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "the absence of iNKTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]
Processing 00000000.tx.228: This is the first correlation between oncogene activation, CCL2 expression, and iNKT cell infiltration. 

Phrase: "This"

Phrase: "is"

Phrase: "the first correlation between oncogene activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "CCL2 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "iNKT cell infiltration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332448:Infiltration [Pathologic Function]
   827   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   827   C1523986:Infiltration [Functional Concept]
   734   C2350467:iNKT Cell [Cell]
Processing 00000000.tx.229: Together, our data suggest that iNKTs migrate into neuroblastomas, particularly those without MYCN amplification, in response to CCL2. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that iNKTs"

Phrase: "migrate into neuroblastomas,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0027819:Neuroblastomas [Neoplastic Process]
   790   C0232902:migrate [Functional Concept]
   756 E C0700095:neuroblastoma [Neoplastic Process]
   756 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "particularly"

Phrase: "those without MYCN amplification,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0812287:MYCN [Gene or Genome]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705027:MYCN [Gene or Genome]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to CCL2."
Processing 00000000.tx.230: The chemokine milieu in the tumor microenvironment is likely to be a major determinant of infiltration and possibly function of specific types of lymphoid and myeloid cells. 

Phrase: "The chemokine milieu in the tumor microenvironment"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "a major determinant of infiltration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521761:Determinant [Functional Concept]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "function of specific types of lymphoid"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0031843:function [Physiologic Function]
   753   C0205369:Specific [Qualitative Concept]
   753   C0332307:Types [Qualitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1518071:Lymphoid [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1705273:Function [Intellectual Product]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "myeloid cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0887899:Myeloid Cells [Cell]
   966 E C0596993:Myeloid cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0439677:Myeloid [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.231: Although CCL2 alone mediated iNKT cell migration to neuroblastoma cell line supernatants in vitro, tumors expressed three additional chemokines (CXCL12, CCL21, and CCL5) that also correlated with iNKT cell infiltration. 

Phrase: "Although"

Phrase: "CCL2 alone mediated iNKT cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1622501:Migration, Cell [Cell Function]
   799   C0600210:Migration [Social Behavior]
   799   C1533574:Migration [Physiologic Function]
   799   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to neuroblastoma cell line supernatants in vitro, tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0027651:Tumors [Neoplastic Process]
   762 E C1578706:Tumor [Intellectual Product]
   762 E C3273930:Tumor [Finding]

Phrase: "expressed"

Phrase: "three additional chemokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(CXCL12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0218504:CXCL12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332817:CXCL12 [Gene or Genome]

Phrase: "CCL21,"

Phrase: "and"

Phrase: "CCL5"

Phrase: ")"

Phrase: "that also"

Phrase: "correlated with iNKT cell infiltration."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C2350467:iNKT Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0332448:Infiltration [Pathologic Function]
   760   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   760   C1269647:Cell [Cell]
   760   C1523986:Infiltration [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1707520:Correlated [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.232: These other chemokines could have contributed to localization in vivo because iNKTs express receptors for them. 

Phrase: "These"

Phrase: "other chemokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "could"

Phrase: "have"

Phrase: "contributed to localization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0475264:Localisation [Functional Concept]
   790   C1744691:localisation [Biologic Function]
   756   C1880177:Contribute [Activity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "because"

Phrase: "iNKTs"

Phrase: "express"

Phrase: "receptors for them."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.233: The receptors for all four chemokines are equally expressed among functionally distinct CD4+ and CD4 iNKT subsets, and so it is not likely that a subset of iNKTs preferentially infiltrated neuroblastomas (2931). 

Phrase: "The receptors for all four chemokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0524914:Receptors, Chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "equally"

Phrase: "expressed among functionally distinct CD4+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD4 iNKT subsets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1515021:Subset [Classification]

Phrase: "and"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "it"

Phrase: "is"

Phrase: "not likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "that"

Phrase: "a subset of iNKTs preferentially infiltrated neuroblastomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515021:Subset [Classification]

Phrase: "(2931"

Phrase: ")."
Processing 00000000.tx.234: Chemokines also may influence the type of immune response in a microenvironment by recruiting specific types of myeloid and lymphoid cells. 

Phrase: "Chemokines also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282554:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527036:Chemokines [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "may"

Phrase: "influence"

Phrase: "the type of immune response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "in a microenvironment"

Phrase: "by recruiting specific types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332307:Types [Qualitative Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "of myeloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439677:Myeloid [Qualitative Concept]

Phrase: "and"

Phrase: "lymphoid cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086574:Lymphoid Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1518071:Lymphoid [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.235: Indeed, murine iNKTs recruited to lungs by CCL2 after infection with Cryptococcus neoformans were important for development of Th1 immune responses because both lung IFN- production and specific delayed-type hypersensitivity were significantly greater in wild-type mice than in V14 NKT celldeficient mice (32). 

Phrase: "Indeed,"

Phrase: "murine iNKTs"

Phrase: "recruited to lungs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   756 E C0819757:LUNG [Tissue]
   756 E C1278908:Lung [Body Part, Organ, or Organ Component]
   718 E C2707265:Pulmonary [Clinical Attribute]
   718 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "by CCL2"

Phrase: "after infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]

Phrase: "with Cryptococcus neoformans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010414:cryptococcus neoformans [Disease or Syndrome]
  1000   C0010416:Cryptococcus neoformans [Fungus]
   861   C0010415:Cryptococcus [Fungus]

Phrase: "were"

Phrase: "important for development of Th1 immune responses"

Phrase: "because"

Phrase: "both lung IFN- production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "specific delayed-type hypersensitivity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0020522:Delayed-Type Hypersensitivity [Pathologic Function]
           Delayed Hypersensitivity
   812   C0020517:Hypersensitivity [Pathologic Function]
   812   C0205421:Delayed [Temporal Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C0520946:Hypersensitivity [Finding]
   812   C1547052:*Type [Quantitative Concept]
   812   C3272602:Delayed [Qualitative Concept]

Phrase: "were"

Phrase: "significantly greater in wild-type mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]

Phrase: "than"

Phrase: "in V14 NKT celldeficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.236: Thus, the repertoire of chemokines expressed by tumors could determine localization of lymphocyte subsets and have a functional effect on immune responses. 

Phrase: "Thus,"

Phrase: "the repertoire of chemokines"

Phrase: "expressed by tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0027651:Tumors [Neoplastic Process]
   756 E C1578706:Tumor [Intellectual Product]
   756 E C3273930:Tumor [Finding]

Phrase: "could"

Phrase: "determine"

Phrase: "localization of lymphocyte subsets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "have"

Phrase: "a functional effect on immune responses."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.237: Our paper is the first to correlate iNKT cell infiltration into a human tumor with CCL2 expression. 

Phrase: "Our paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "is"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "correlate"

Phrase: "iNKT cell infiltration into a human tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332448:Infiltration [Pathologic Function]
   748   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   748   C1523986:Infiltration [Functional Concept]

Phrase: "with CCL2 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.238: Another investigation of 60 squamous cell carcinomas and adenocarcinomas of the lung demonstrated the presence of iNKTs with a PCR assay for invariant V24-J18, but did not address mechanisms of localization (13). 

Phrase: "Another investigation of 60 squamous cell carcinomas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1261322:Investigation [Health Care Activity]
   748   C1552578:investigation [Idea or Concept]

Phrase: "and"

Phrase: "adenocarcinomas of the lung"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   991   C0152013:adenocarcinoma of the lung [Neoplastic Process]
           Adenocarcinoma of lung
           adenocarcinomas lung
   770   C0001418:Adenocarcinomas [Neoplastic Process]

Phrase: "demonstrated"

Phrase: "the presence of iNKTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "with a PCR assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0243073:assay [Qualitative Concept]
   861   C0677874:pCR [Finding]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "for invariant V24-J18,"

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "mechanisms of localization"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0441712:Mechanisms [Functional Concept]
   756 E C1706376:Mechanism [Manufactured Object]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.239: Correlation of CCL2 expression and iNKT infiltration suggests that many types of human tumors that express CCL2 also may contain iNKTs (33). 

Phrase: "Correlation of CCL2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "iNKT infiltration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "many types of human tumors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0332307:Types [Qualitative Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "that"

Phrase: "express"

Phrase: "CCL2 also"

Phrase: "may"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "iNKTs"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.240: However, effects of CCL2 may be different depending on chemokine level. 

Phrase: "However,"

Phrase: "effects of CCL2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "depending on chemokine level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]
   737   C0725813:depend [Medical Device]
Processing 00000000.tx.241: For example, low expression of CCL2 after gene transfection into a nontumorigenic human melanoma cell line stimulated tumor formation in SCID mice, whereas transfection that caused 100-fold higher expression was associated with large infiltration of inflammatory cells (presumably monocytes) and tumor necrosis (34). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "low expression of CCL2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "after gene transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "into a nontumorigenic human melanoma cell line"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   888   C0682523:Human Cell Line [Cell]
   853   C0427861:human cell [Laboratory or Test Result]
   840   C0007600:Cell Line [Cell]
   840   C1513095:Melanoma Cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "tumor formation in SCID mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "whereas"

Phrase: "transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "that"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "100-fold higher expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "associated with large infiltration of inflammatory cells"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   788   C0302158:Inflammatory cell infiltration [Pathologic Function]
           Inflammatory infiltration
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0440752:inflammatory cells [Cell]
   757   C0699040:cell associated [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0332448:Infiltration [Pathologic Function]
   748   C0333348:Inflammatory [Functional Concept]
   748   C0549177:Large [Quantitative Concept]
   748   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   748   C1523986:Infiltration [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(presumably monocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026473:Monocytes [Cell]

Phrase: ")"

Phrase: "and"

Phrase: "tumor necrosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0333516:Tumor necrosis [Neoplastic Process]
   861   C0027540:Necrosis [Organ or Tissue Function]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1334928:Necrosis [Finding]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.242: Expression of CD1d on APCs is required for iNKT cell functional responses (35), and it has been demonstrated recently that ganglioside GD3 derived from human melanoma cells can be effectively cross-presented to murine iNKTs by syngeneic APCs in a CD1d-dependent manner (36). 

Phrase: "Expression of CD1d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "on APCs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033036:apcs [Disease or Syndrome]
  1000   C1456795:APCS [Gene or Genome]
   966 E C3540812:APC [Gene or Genome]

Phrase: "is"

Phrase: "required for iNKT cell functional responses"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C2350467:iNKT Cell [Cell]
   767   C2985857:Required Response [Idea or Concept]
   753   C0007634:Cell [Cell]
   753   C0205245:Functional [Functional Concept]
   753   C0542341:Functional [Functional Concept]
   753   C0871261:responses [Organism Attribute]
   753   C1269647:Cell [Cell]
   753   C1514873:Required [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2700217:Functional [Conceptual Entity]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that ganglioside GD3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0061105:ganglioside GD3 [Biologically Active Substance,Lipid]

Phrase: "derived from human melanoma cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   797   C0427861:Human cells [Laboratory or Test Result]
   790   C1513095:Melanoma Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0025202:melanoma [Neoplastic Process]
   760   C0086418:Human [Human]
   760   C1441547:Derived [Qualitative Concept]
   760   C2984289:Melanoma [Functional Concept]
   760   C3245521:derived [Idea or Concept]
   760   C3282337:Cells [Cell]
   760   C3539018:Melanoma [Intellectual Product]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "effectively"

Phrase: "cross-presented to murine iNKTs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0026809:Murine [Mammal]
   760   C0449450:Presented [Idea or Concept]
   760   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   760   C2828360:Cross [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "by syngeneic APCs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033036:apcs [Disease or Syndrome]
   861   C1456795:APCS [Gene or Genome]
   827 E C3540812:APC [Gene or Genome]

Phrase: "in a CD1d-dependent manner"

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.243: Similar to melanoma, neuroblastoma cells do not express CD1d (20), but do produce a variety of gangliosides, including GD3 (37). 

Phrase: "Similar to melanoma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0815000:neuroblastoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "CD1d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413210:CD1D [Gene or Genome]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "do"

Phrase: "produce"

Phrase: "a variety of gangliosides,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "GD3"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.244: Our oligonucleotide microarray analysis revealed variable, but usually low level CD1d expression, which did not correlate with iNKT infiltration. 

Phrase: "Our oligonucleotide microarray analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1449575:Microarray Analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0600597:Oligonucleotide Microarray [Medical Device,Research Device]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "variable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]

Phrase: "but"

Phrase: "usually low level CD1d expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlate with iNKT infiltration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332448:Infiltration [Pathologic Function]
   770   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   770   C1523986:Infiltration [Functional Concept]
Processing 00000000.tx.245: IHC of two representative tumors expressing CCL2 and containing iNKTs confirmed that tumor cells do not express CD1d, but showed CD1d+ cells, especially in stromal areas (unpublished data). 

Phrase: "IHC of two representative tumors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "expressing"

Phrase: "CCL2"

Phrase: "and"

Phrase: "containing iNKTs"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "CD1d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413210:CD1D [Gene or Genome]

Phrase: "but"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "CD1d+ cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "especially in stromal areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0205146:areas [Spatial Concept]
   737 E C0017446:Area [Geographic Area]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.246: This indicates that iNKTs might function in the tumor microenvironment. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that iNKTs"

Phrase: "might"

Phrase: "function in the tumor microenvironment."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C2936626:Tumor Microenvironment [Natural Phenomenon or Process]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1578706:Tumor [Intellectual Product]
   760   C1705273:Function [Intellectual Product]
   760   C3273930:Tumor [Finding]
Processing 00000000.tx.247: Animal models suggest that in the absence of exogenous stimulation, iNKTs may activate (6, 38) or suppress antitumor immune responses (9, 10). 

Phrase: "Animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in the absence of exogenous stimulation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205101:Exogenous [Spatial Concept]
   748   C0205228:Exogenous [Functional Concept]
   748   C0332197:absence [Quantitative Concept]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "iNKTs"

Phrase: "may"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "(6,"

Phrase: "38"

Phrase: ")"

Phrase: "or"

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "antitumor immune responses"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0301872:immune responses [Organ or Tissue Function]
   896   C1516031:Antitumor Response [Organ or Tissue Function]
   827   C0439662:Immune [Functional Concept]
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.248: However, treatment with the iNKT cell ligand GalCer (KRN7000), which provides strong stimulation, unequivocally induces potent antitumor responses in mice (4). 

Phrase: "However,"

Phrase: "treatment with the iNKT cell ligand GalCer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "(KRN7000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0534775:KRN7000 [Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "strong stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "unequivocally"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "potent antitumor responses in mice"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1516031:Antitumor Response [Organ or Tissue Function]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.249: Thus, understanding mechanisms of localization and stimulation of iNKTs in the tumor microenvironment is important for planning of iNKT cellmediated immunotherapy. 

Phrase: "Thus,"

Phrase: "understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "mechanisms of localization"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0441712:Mechanisms [Functional Concept]
   756 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "stimulation of iNKTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in the tumor microenvironment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2936626:Tumor Microenvironment [Natural Phenomenon or Process]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]

Phrase: "is"

Phrase: "important for planning of iNKT cellmediated immunotherapy."
Processing 00000000.tx.250: Disease and therapy could affect infiltration of iNKTs into tumors. 

Phrase: "Disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "could"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "infiltration of iNKTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332448:Infiltration [Pathologic Function]
   790   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   790   C1523986:Infiltration [Functional Concept]

Phrase: "into tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]
Processing 00000000.tx.251: In this regard, we found no effect of metastatic neuroblastoma at diagnosis (before therapy) on blood iNKT cell frequency, CCR2 expression, or migratory response to CCL2. 

Phrase: "In this regard,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no effect of metastatic neuroblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "at diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "("

Phrase: "before therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: ")"

Phrase: "on blood iNKT cell frequency,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0376249:frequency [Quantitative Concept]
   812   C0439603:Frequency [Temporal Concept]
   812   C0871396:Frequency [Quantitative Concept]
   812   C1561548:Frequency [Qualitative Concept]
   812   C1705502:Frequency [Quantitative Concept]
   741 E C0332183:Frequent [Temporal Concept]
   708   C0005773:Blood cell [Cell]

Phrase: "CCR2 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "migratory response to CCL2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]
Processing 00000000.tx.252: Other studies of patients with cancer have evaluated iNKT cell number in peripheral blood but have not investigated their migration. 

Phrase: "Other studies of patients"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "with cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "have"

Phrase: "evaluated iNKT cell number in peripheral blood"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0005771:Blood Cell Number [Laboratory Procedure]
   778   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "but"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "their migration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.253: One analysis of patients with advanced gastrointestinal cancers at diagnosis found normal frequencies of iNKTs in blood, which is in agreement with our observations (39). 

Phrase: "One analysis of patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "with advanced gastrointestinal cancers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0877373:Advanced Cancer [Neoplastic Process]
   901   C0685938:Gastrointestinal Cancers [Neoplastic Process]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0521362:gastrointestinal [Spatial Concept]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]

Phrase: "at diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "normal frequencies of iNKTs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "in blood,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "which"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.254: Two others of patients that had been previously treated reported lower than normal iNKT cell frequency in blood of patients with androgen-independent metastatic prostate cancer (26) or with chemotherapy-resistant solid tumors (40). 

Phrase: "Two others of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1955473:Others [Finding]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "previously"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "reported lower than normal iNKT cell frequency"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "in blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with androgen-independent metastatic prostate cancer"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   924   C1654637:androgen independent prostate cancer [Neoplastic Process]
   884   C0936223:Metastatic Prostate Cancer [Neoplastic Process]
   853   C0027627:metastatic cancer [Neoplastic Process]
   853   C0346957:metastatic cancer [Neoplastic Process]
   853   C2939419:Metastatic cancer [Neoplastic Process]
   853   C2939420:metastatic cancer [Neoplastic Process]
   840   C0376358:Prostate Cancer [Neoplastic Process]
   840   C0600139:Prostate Cancer [Neoplastic Process]
   840   C2984325:Prostate cancer [Functional Concept]
   840   C3541264:Prostate Cancer [Intellectual Product]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0033572:Prostate [Body Part, Organ, or Organ Component]
   804   C0998265:Cancer [Eukaryote]
   804   C1278980:Prostate [Body Part, Organ, or Organ Component]
   804   C1306459:Cancer [Finding]

Phrase: "(26"

Phrase: ")"

Phrase: "or with chemotherapy-resistant solid tumors"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0280100:solid tumors [Neoplastic Process]
   753   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   753   C0013217:chemotherapy [Functional Concept]
   753   C0027651:Tumors [Neoplastic Process]
   753   C0205208:Solid [Qualitative Concept]
   753   C0302909:Solid [Substance]
   753   C0332325:Resistant [Functional Concept]
   753   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
   753   C1378566:Solid [Biomedical or Dental Material]
   753   C2827757:RESISTANT [Laboratory or Test Result]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.255: These observations suggest that developing clinical immunotherapy with iNKTs will require examination of effects of disease and therapies on circulating iNKT cell number and function and, when possible, of tumors for chemokine expression and iNKT cell infiltration. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that developing clinical immunotherapy with iNKTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0021083:Immunotherapy [Therapeutic or Preventive Procedure]

Phrase: "will"

Phrase: "require"

Phrase: "examination of effects of disease"

Phrase: "and"

Phrase: "therapies on circulating iNKT cell number"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0302189:cell therapies [Therapeutic or Preventive Procedure]
   753   C0087111:therapies [Therapeutic or Preventive Procedure]
   719 E C0039798:therapy [Functional Concept]
   719 E C1363945:Therapy [Finding]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: ","

Phrase: "when"

Phrase: "possible,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "of tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "for chemokine expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "iNKT cell infiltration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332448:Infiltration [Pathologic Function]
   827   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   827   C1523986:Infiltration [Functional Concept]
   734   C2350467:iNKT Cell [Cell]
Processing 00000000.tx.256: Survival for patients whose tumors did or did not have iNKT cell infiltration at diagnosis was significantly different, but immunosuppressive chemotherapy or myeloablative chemoradiotherapy renders interpretation of this data difficult. 

Phrase: "Survival for patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038952:Survival [Activity]
   790   C0220921:survival [Functional Concept]

Phrase: "whose tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "did"

Phrase: "or"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "iNKT cell infiltration at diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332448:Infiltration [Pathologic Function]
   760   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   760   C1523986:Infiltration [Functional Concept]

Phrase: "was"

Phrase: "significantly different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "but"

Phrase: "immunosuppressive chemotherapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   861   C0013217:chemotherapy [Functional Concept]
   861   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "myeloablative chemoradiotherapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0436307:Chemoradiotherapy [Therapeutic or Preventive Procedure]

Phrase: "renders"

Phrase: "interpretation of this data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0459471:Interpretation [Intellectual Product]
   770   C3173575:Interpretation [Clinical Attribute]

Phrase: "difficult."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]
Processing 00000000.tx.257: However, the survival curves for iNKT+ versus iNKT groups were similar to those for MYCN amplified versus nonamplified subgroups. 

Phrase: "However,"

Phrase: "the survival curves for iNKT+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   726   C0205134:Curve [Spatial Concept]

Phrase: "versus"

Phrase: "iNKT groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "similar to those for MYCN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "amplified"

Phrase: "versus"

Phrase: "nonamplified subgroups."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1079230:subgroups [Virus]
   827 E C1515021:Subgroup [Classification]
Processing 00000000.tx.258: This suggested a relationship between iNKT infiltration and MYCN gene status. 

Phrase: "This suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a relationship between iNKT infiltration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "MYCN gene status."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449438:Status [Qualitative Concept]
   734   C0812287:MYCN gene [Gene or Genome]
Processing 00000000.tx.259: Our analysis demonstrated for the first time an inverse correlation between MYCN amplification and tumor infiltration by iNKTs that appears to be due, at least in part, to decreased CCL2 production. 

Phrase: "Our analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "demonstrated for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "an inverse correlation between MYCN amplification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "tumor infiltration by iNKTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332448:Infiltration [Pathologic Function]
   770   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   770   C1523986:Infiltration [Functional Concept]

Phrase: "that"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "due,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678226:due [Functional Concept]
  1000   C3146286:Due [Idea or Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "to decreased CCL2 production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2754810:CCL2 production [Molecular Function]
   827   C0033268:production [Occupational Activity]
Processing 00000000.tx.260: MYCN amplification, which causes protein overexpression, is independently associated with aggressive tumor behavior in neuroblastoma (22), and laboratory studies demonstrate that MYCN can have a direct role in progression of neuroblastoma by activating or repressing transcription of other genes (41, 42). 

Phrase: "MYCN amplification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "protein overexpression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "is"

Phrase: "independently"

Phrase: "associated with aggressive tumor behavior"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0001807:Aggressive behavior [Mental or Behavioral Dysfunction]
           aggressive
   760   C0004927:Behavior [Individual Behavior]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0580822:Aggressive [Temporal Concept]
   760   C1578706:Tumor [Intellectual Product]
   760   C2707008:Behavior [Clinical Attribute]
   760   C3273930:Tumor [Finding]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in neuroblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027819:Neuroblastoma [Neoplastic Process]
  1000   C0700095:neuroblastoma [Neoplastic Process]
  1000   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "laboratory studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0681827:Laboratory studies [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "that MYCN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079885:MYCN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812287:MYCN [Gene or Genome]
  1000   C1705027:MYCN [Gene or Genome]

Phrase: "can"

Phrase: "have"

Phrase: "a direct role in progression of neuroblastoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "by activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "or"

Phrase: "repressing transcription of other genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.261: Because myc family oncoproteins, which include c-myc, N-myc, and L-myc, have roles in the pathogenesis of many human malignancies (43), our finding may have implications for inflammatory and immune responses to several neoplasms.  

Phrase: "Because"

Phrase: "myc family oncoproteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029005:Oncoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "c-myc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "N-myc,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812287:N-myc [Gene or Genome]
  1000   C1705027:N-myc [Gene or Genome]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "L-myc,"

Phrase: "have"

Phrase: "roles in the pathogenesis of many human malignancies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0035820:Roles [Social Behavior]
   711 E C1705810:Role [Conceptual Entity]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "our finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "may"

Phrase: "have"

Phrase: "implications for inflammatory"

Phrase: "and"

Phrase: "immune responses to several neoplasms."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0301872:immune responses [Organ or Tissue Function]
   760   C0439662:Immune [Functional Concept]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]
Processing 00000000.tx.262: Acknowledgments  We thank Dr. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.263: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.264: McNamara of the Childrens Hospital Los Angeles Congressman Julian Dixon Cellular Imaging Core for excellent technical assistance with digital image microscopy. 

Phrase: "McNamara of the Childrens Hospital Los Angeles Congressman Julian Dixon Cellular Imaging Core"

Phrase: "for excellent technical assistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018896:Assistance [Social Behavior]
   827   C0449851:Technical [Functional Concept]

Phrase: "with digital image microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1547107:Digital microscopy [Diagnostic Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   755 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.265: This work was supported in part by National Institutes of Health grants CA81403 and CA22794 (to R.C. Seeger); 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institutes of Health grants CA81403"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "and"

Phrase: "CA22794"

Phrase: "("

Phrase: "to R.C. Seeger"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.266: by grants from Stop Cancer and Concern Foundations (to L.S. Metelitsa); 

Phrase: "by grants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018173:Grants [Quantitative Concept]
   966 E C1548284:Grant [Idea or Concept]

Phrase: "from Stop Cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "Concern Foundations"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundations [Organization]
   768 E C0002055:base [Inorganic Chemical]
   768 E C0178499:Base [Chemical Viewed Functionally]
   768 E C1626935:Bases [Quantitative Concept]
   768 E C1880279:Base [Biomedical or Dental Material]
   750 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to L.S. Metelitsa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0439394:L/s [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.267: and by the Neil Bogart Memorial Fund of the T.J. 

Phrase: "and by the Neil Bogart Memorial Fund of the T.J."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0016820:Fund [Quantitative Concept]
   738   C1515981:And [Idea or Concept]
Processing 00000000.tx.268: Martell Foundation for Leukemia, Cancer, and AIDS Research. 

Phrase: "Martell Foundation for Leukemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016617:Foundation [Organization]

Phrase: "Cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "AIDS Research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
Processing 00000000.tx.269: Submitted: 26 August 2003 Accepted: 24 March 2004  References Top Abstract Introduction Materials and Methods Results Discussion References  Bendelac, A., M.N. 

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ":"

Phrase: "26 August 2003"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "24 March 2004"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Bendelac,"

Phrase: "A.,"

Phrase: "M."

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.270: Rivera, S.H. 

Phrase: "Rivera,"

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.271: Park, and J.H. 

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "and"

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.272: Roark. 

Phrase: "Roark."
Processing 00000000.tx.273: 1997. 

Phrase: "1997."
Processing 00000000.tx.274: Mouse CD1-specific NK1 T cells: development, specificity, and function. 

Phrase: "Mouse CD1-specific NK1 T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   887   C1522131:Mouse T Cell [Cell]
   827   C0039194:T-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.275: Annu. 

Phrase: "Annu."
Processing 00000000.tx.276: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.277: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.278: 15:535562.[CrossRef][Medline] Godfrey, D.I., K.J. 

Phrase: "15"

Phrase: ":"

Phrase: "535562."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Godfrey,"

Phrase: "D."

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "K.J."
Processing 00000000.tx.279: Hammond, L.D. 

Phrase: "Hammond,"

Phrase: "L.D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.280: Poulton, M.J. 

Phrase: "Poulton,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.281: Smyth, and A.G. 

Phrase: "Smyth,"

Phrase: "and"

Phrase: "A.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.282: Baxter. 

Phrase: "Baxter."
Processing 00000000.tx.283: 2000. 

Phrase: "2000."
Processing 00000000.tx.284: NKT cells: facts, functions and fallacies. 

Phrase: "NKT cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C2350466:Natural Killer T-Cells [Cell]
   923   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   923   C0039195:killer t cells [Cell]
   923   C2363836:Natural Killer Cells [Laboratory Procedure]
   875   C0022686:Killer Cells [Cell]
   861   C0039194:T-Cells [Cell]
   861   C2709199:Natural killer [Cell]
   812   C0007634:Cells [Cell]
   812   C0205296:Natural [Functional Concept]
   812   C1336644:KILLER [Gene or Genome]
   812   C1705132:KILLER [Gene or Genome]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "facts,"

Phrase: "functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "fallacies."
Processing 00000000.tx.285: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.286: Today. 

Phrase: "Today."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0310367:Today [Antibiotic,Organic Chemical]
  1000   C0750526:Today [Temporal Concept]
Processing 00000000.tx.287: 21:573583.[CrossRef][Medline] Joyce, S. 

Phrase: "21"

Phrase: ":"

Phrase: "573583."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Joyce,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.288: 2001. 

Phrase: "2001."
Processing 00000000.tx.289: CD1d and natural T cells: how their properties jump-start the immune system. 

Phrase: "CD1d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413210:CD1D [Gene or Genome]

Phrase: "and"

Phrase: "natural T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "how"

Phrase: "their properties jump-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0221189:jump [Daily or Recreational Activity]
   861   C0560453:jump [Finding]
   861   C3244298:jump [Functional Concept]

Phrase: "start"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "the immune system."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0020962:Immune system [Body System]
  1000   C1291764:IMMUNE SYSTEM [Finding]
   861   C0439662:Immune [Functional Concept]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.290: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.291: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.292: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.293: 58:442469.[Medline] Smyth, M.J., N.Y. 

Phrase: "58"

Phrase: ":"

Phrase: "442469."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Smyth,"

Phrase: "M."

Phrase: "J.,"

Phrase: "N.Y."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.294: Crowe, Y. 

Phrase: "Crowe,"

Phrase: "Y."
Processing 00000000.tx.295: Hayakawa, K. 

Phrase: "Hayakawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.296: Takeda, H. 

Phrase: "Takeda,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.297: Yagita, and D.I. 

Phrase: "Yagita,"

Phrase: "and"

Phrase: "D."

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.298: Godfrey. 

Phrase: "Godfrey."
Processing 00000000.tx.299: 2002. 

Phrase: "2002."
Processing 00000000.tx.300: NKT cells - conductors of tumor immunity? 

Phrase: "NKT cells - conductors of tumor immunity?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0684021:conductors [Professional or Occupational Group]
Processing 00000000.tx.301: Curr. 

Phrase: "Curr."
Processing 00000000.tx.302: Opin. 

Phrase: "Opin."
Processing 00000000.tx.303: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.304: 14:165171.[CrossRef][Medline] Brutkiewicz, R.R., and V. 

Phrase: "14"

Phrase: ":"

Phrase: "165171."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brutkiewicz,"

Phrase: "R.R.,"

Phrase: "and"

Phrase: "V."
Processing 00000000.tx.305: Sriram. 

Phrase: "Sriram."
Processing 00000000.tx.306: 2002. 

Phrase: "2002."
Processing 00000000.tx.307: Natural killer T (NKT) cells and their role in antitumor immunity. 

Phrase: "Natural killer T (NKT) cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C2350466:Natural Killer T-Cells [Cell]
   923   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   923   C0039195:killer t cells [Cell]
   923   C2363836:Natural Killer Cells [Laboratory Procedure]
   875   C0022686:Killer Cells [Cell]
   861   C0039194:T-Cells [Cell]
   861   C2709199:Natural killer [Cell]
   812   C0007634:Cells [Cell]
   812   C0205296:Natural [Functional Concept]
   812   C1336644:KILLER [Gene or Genome]
   812   C1705132:KILLER [Gene or Genome]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "their role in antitumor immunity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.308: Crit. 

Phrase: "Crit."
Processing 00000000.tx.309: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.310: Oncol. 

Phrase: "Oncol."
Processing 00000000.tx.311: Hematol. 

Phrase: "Hematol."
Processing 00000000.tx.312: 41:287298.[Medline] Smyth, M.J., K.Y. 

Phrase: "41"

Phrase: ":"

Phrase: "287298."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Smyth,"

Phrase: "M."

Phrase: "J.,"

Phrase: "K.Y."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.313: Thia, S.E. 

Phrase: "Thia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2652182:Thia [Eukaryote]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.314: Street, E. 

Phrase: "Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442658:Street [Manufactured Object]
  1000   C1301826:Street [Finding]

Phrase: "E."
Processing 00000000.tx.315: Cretney, J.A. 

Phrase: "Cretney,"

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.316: Trapani, M. 

Phrase: "Trapani,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.317: Taniguchi, T. 

Phrase: "Taniguchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.318: Kawano, S.B. 

Phrase: "Kawano,"

Phrase: "S."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.319: Pelikan, N.Y. 

Phrase: "Pelikan,"

Phrase: "N.Y."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.320: Crowe, and D.I. 

Phrase: "Crowe,"

Phrase: "and"

Phrase: "D."

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.321: Godfrey. 

Phrase: "Godfrey."
Processing 00000000.tx.322: 2000. 

Phrase: "2000."
Processing 00000000.tx.323: Differential tumor surveillance by natural killer (NK) and NKT cells. 

Phrase: "Differential tumor surveillance by natural killer (NK)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220920:surveillance [Functional Concept]
   753   C0733511:Surveillance [Health Care Activity]

Phrase: "and"

Phrase: "NKT cells."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C2350466:Natural Killer T-Cells [Cell]
   923   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   923   C0039195:killer t cells [Cell]
   923   C2363836:Natural Killer Cells [Laboratory Procedure]
   875   C0022686:Killer Cells [Cell]
   861   C0039194:T-Cells [Cell]
   861   C2709199:Natural killer [Cell]
   812   C0007634:Cells [Cell]
   812   C0205296:Natural [Functional Concept]
   812   C1336644:KILLER [Gene or Genome]
   812   C1705132:KILLER [Gene or Genome]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.324: J. 

Phrase: "J."
Processing 00000000.tx.325: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.326: Med. 

Phrase: "Med."
Processing 00000000.tx.327: 191:661668.[Abstract/Free FullText] Crowe, N.Y., M.J. 

Phrase: "191"

Phrase: ":"

Phrase: "661668."

Phrase: "[Abstract/Free FullText"

Phrase: "] Crowe,"

Phrase: "N.Y.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.328: Smyth, and D.I. 

Phrase: "Smyth,"

Phrase: "and"

Phrase: "D."

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.329: Godfrey. 

Phrase: "Godfrey."
Processing 00000000.tx.330: 2002. 

Phrase: "2002."
Processing 00000000.tx.331: A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. 

Phrase: "A critical role for natural killer T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in immunosurveillance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026428:Immunosurveillance [Health Care Activity]

Phrase: "of methylcholanthrene-induced sarcomas."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000325:Methylcholanthrene [Hazardous or Poisonous Substance,Organic Chemical]
   827   C0025732:Methylcholanthrene [Hazardous or Poisonous Substance,Organic Chemical]
   827   C0205263:Induced [Functional Concept]
   827   C1261473:Sarcomas [Neoplastic Process]
Processing 00000000.tx.332: J. 

Phrase: "J."
Processing 00000000.tx.333: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.334: Med. 

Phrase: "Med."
Processing 00000000.tx.335: 196:119127.[Abstract/Free FullText] Smyth, M.J., N.Y. 

Phrase: "196"

Phrase: ":"

Phrase: "119127."

Phrase: "[Abstract/Free FullText"

Phrase: "] Smyth,"

Phrase: "M."

Phrase: "J.,"

Phrase: "N.Y."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.336: Crowe, D.G. 

Phrase: "Crowe,"

Phrase: "D."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.337: Pellicci, K. 

Phrase: "Pellicci,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.338: Kyparissoudis, J.M. 

Phrase: "Kyparissoudis,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.339: Kelly, K. 

Phrase: "Kelly,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.340: Takeda, H. 

Phrase: "Takeda,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.341: Yagita, and D.I. 

Phrase: "Yagita,"

Phrase: "and"

Phrase: "D."

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.342: Godfrey. 

Phrase: "Godfrey."
Processing 00000000.tx.343: 2002. 

Phrase: "2002."
Processing 00000000.tx.344: Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. 

Phrase: "Sequential production of interferon-gamma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1819433:interferon-gamma production [Organism Function]
   797   C3159140:interferon production [Organism Function]
   760   C0033268:production [Occupational Activity]

Phrase: "by NK1.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412716:NK-1 [Gene or Genome]
   861   C1424685:NK1 [Gene or Genome]
   861   C3539622:NK-1 [Gene or Genome]

Phrase: "(+"

Phrase: ")"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "natural killer cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
  1000   C2363836:Natural Killer Cells [Laboratory Procedure]
   901   C0022686:Killer Cells [Cell]
   901   C2709199:Natural killer [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "essential for the antimetastatic effect of alpha-galactosylceramide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.345: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.346: 99:12591266.[Abstract/Free FullText] Terabe, M., S. 

Phrase: "99"

Phrase: ":"

Phrase: "12591266."

Phrase: "[Abstract/Free FullText"

Phrase: "] Terabe,"

Phrase: "M."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.347: Matsui, N. 

Phrase: "Matsui,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.348: Noben-Trauth, H. 

Phrase: "Noben-Trauth,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.349: Chen, C. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "C."
Processing 00000000.tx.350: Watson, D.D. 

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.351: Donaldson, D.P. 

Phrase: "Donaldson,"

Phrase: "D.P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.352: Carbone, W.E. 

Phrase: "Carbone,"

Phrase: "W.E."
Processing 00000000.tx.353: Paul, and J.A. 

Phrase: "Paul,"

Phrase: "and"

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.354: Berzofsky. 

Phrase: "Berzofsky."
Processing 00000000.tx.355: 2000. 

Phrase: "2000."
Processing 00000000.tx.356: NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. 

Phrase: "NKT cell-mediated repression of tumor immunosurveillance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0035143:Repression [Mental Process]

Phrase: "by IL-13"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0214743:IL 13 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "the IL-4R-STAT6 pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.357: Nat. 

Phrase: "Nat."
Processing 00000000.tx.358: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.359: 1:515520.[CrossRef][Medline] Terabe, M., S. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "515520."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Terabe,"

Phrase: "M."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.360: Matsui, J.M. 

Phrase: "Matsui,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.361: Park, M. 

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.362: Mamura, N. 

Phrase: "Mamura,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.363: Noben-Trauth, D.D. 

Phrase: "Noben-Trauth,"

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.364: Donaldson, W. 

Phrase: "Donaldson,"

Phrase: "W."
Processing 00000000.tx.365: Chen, S.M. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.366: Wahl, S. 

Phrase: "Wahl,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.367: Ledbetter, B. 

Phrase: "Ledbetter,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.368: Pratt, et al. 

Phrase: "Pratt,"

Phrase: "et al."
Processing 00000000.tx.369: 2003. 

Phrase: "2003."
Processing 00000000.tx.370: Transforming growth factor- production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocytemediated tumor immunosurveillance: abrogation prevents tumor recurrence. 

Phrase: "Transforming growth factor- production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0033268:production [Occupational Activity]
   756   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "myeloid cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0887899:Myeloid Cells [Cell]
   966 E C0596993:Myeloid cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0439677:Myeloid [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "an effector mechanism through which CD1d-restricted T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "cytotoxic T lymphocytemediated tumor immunosurveillance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0026428:Immunosurveillance [Health Care Activity]

Phrase: ":"

Phrase: "abrogation"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "tumor recurrence."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0521158:tumor recurrence [Neoplastic Process]
   861   C0034897:Recurrence [Phenomenon or Process]
   861   C1458156:recurrence [Neoplastic Process]
   861   C2825055:Recurrence [Pathologic Function]
   789 E C2945760:Recurrent [Temporal Concept]
Processing 00000000.tx.371: J. 

Phrase: "J."
Processing 00000000.tx.372: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.373: Med. 

Phrase: "Med."
Processing 00000000.tx.374: 198:17411752.[Abstract/Free FullText] Okai, M., M. 

Phrase: "198"

Phrase: ":"

Phrase: "17411752."

Phrase: "[Abstract/Free FullText"

Phrase: "] Okai,"

Phrase: "M."

Phrase: ","

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: Nieda, A. 

Phrase: "Nieda,"

Phrase: "A."
Processing 00000000.tx.376: Tazbirkova, D. 

Phrase: "Tazbirkova,"

Phrase: "D."
Processing 00000000.tx.377: Horley, A. 

Phrase: "Horley,"

Phrase: "A."
Processing 00000000.tx.378: Kikuchi, S. 

Phrase: "Kikuchi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.379: Durrant, T. 

Phrase: "Durrant,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.380: Takahashi, A. 

Phrase: "Takahashi,"

Phrase: "A."
Processing 00000000.tx.381: Boyd, R. 

Phrase: "Boyd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347048:Boyd [Intellectual Product]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.382: Abraham, H. 

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.383: Yagita, T. 

Phrase: "Yagita,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.384: Juji, and A. 

Phrase: "Juji,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.385: Nicol. 

Phrase: "Nicol."
Processing 00000000.tx.386: 2002. 

Phrase: "2002."
Processing 00000000.tx.387: Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. 

Phrase: "Human peripheral blood Valpha24+ Vbeta11+ NKT cells"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   891   C0427861:Human cells [Laboratory or Test Result]
   866   C0005773:Blood Cells [Cell]
           Peripheral blood cell
   849   C2350466:Natural Killer T-Cells [Cell]
   834   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   834   C2363836:Natural Killer Cells [Laboratory Procedure]
   827   C0039195:killer t cells [Cell]
   822 E C2328697:Hemal cell [Cell]
   817   C0022686:Killer Cells [Cell]
   807   C0039194:T-Cells [Cell]
   807   C2709199:Natural killer [Cell]
   791   C0007634:Cells [Cell]
   791   C0205296:Natural [Functional Concept]
   791   C1336644:KILLER [Gene or Genome]
   791   C1705132:KILLER [Gene or Genome]
   791   C3282337:Cells [Cell]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]

Phrase: "expand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "administration of alpha-galactosylceramide-pulsed dendritic cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.388: Vox Sang. 

Phrase: "Vox Sang."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1864650:SANG [Gene or Genome]
Processing 00000000.tx.389: 83:250253.[CrossRef][Medline] Nieda, M., M. 

Phrase: "83"

Phrase: ":"

Phrase: "250253."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nieda,"

Phrase: "M."

Phrase: ","

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.390: Okai, A. 

Phrase: "Okai,"

Phrase: "A."
Processing 00000000.tx.391: Tazbirkova, H. 

Phrase: "Tazbirkova,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.392: Lin, A. 

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "A."
Processing 00000000.tx.393: Yamaura, K. 

Phrase: "Yamaura,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.394: Ide, R. 

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.395: Abraham, T. 

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.396: Juji, D.J. 

Phrase: "Juji,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.397: Macfarlane, and A.J. 

Phrase: "Macfarlane,"

Phrase: "and"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.398: Nicol. 

Phrase: "Nicol."
Processing 00000000.tx.399: 2004. 

Phrase: "2004."
Processing 00000000.tx.400: Therapeutic activation of V{alpha}24+V{beta}11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. 

Phrase: "Therapeutic activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of V{alpha}24+V{beta}11+ NKT cells"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   880   C0040210:V T [Finding]
   863   C0030280:Alpha cell [Cell]
   840   C2350466:Natural Killer T-Cells [Cell]
   830   C0030281:Beta cell [Cell]
   827   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   827   C2363836:Natural Killer Cells [Laboratory Procedure]
   821   C0039195:killer t cells [Cell]
   813   C0022686:Killer Cells [Cell]
   804   C0039194:T-Cells [Cell]
   804   C2709199:Natural killer [Cell]
   790   C0007634:Cells [Cell]
   790   C0205296:Natural [Functional Concept]
   790   C1336644:KILLER [Gene or Genome]
   790   C1705132:KILLER [Gene or Genome]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "in human subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0178693:human subjects [Research Activity]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "results in highly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205250:Highly [Qualitative Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "coordinated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0427184:Coordinated [Finding]
  1000   C0700114:Coordinated [Functional Concept]
   966 E C1707511:Coordinate [Spatial Concept]

Phrase: "secondary activation of acquired"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "innate immunity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0020969:Immunity, Innate [Organism Attribute,Pathologic Function]
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.401: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.402: 103:383389.[Abstract/Free FullText] Motohashi, S., S. 

Phrase: "103"

Phrase: ":"

Phrase: "383389."

Phrase: "[Abstract/Free FullText"

Phrase: "] Motohashi,"

Phrase: "S."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.403: Kobayashi, T. 

Phrase: "Kobayashi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.404: Ito, K.K. 

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "K.K."
Processing 00000000.tx.405: Magara, O. 

Phrase: "Magara,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.406: Mikuni, N. 

Phrase: "Mikuni,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.407: Kamada, T. 

Phrase: "Kamada,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.408: Iizasa, T. 

Phrase: "Iizasa,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.409: Nakayama, T. 

Phrase: "Nakayama,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.410: Fujisawa, and M. 

Phrase: "Fujisawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331815:Fujisawa [Health Care Related Organization]

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.411: Taniguchi. 

Phrase: "Taniguchi."
Processing 00000000.tx.412: 2002. 

Phrase: "2002."
Processing 00000000.tx.413: Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients. 

Phrase: "Preserved IFN-alpha production of circulating Valpha24 NKT cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   775   C1819431:IFN-alpha production [Organism Function]
   738   C0033268:production [Occupational Activity]

Phrase: "in primary lung cancer patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1516213:Cancer Patient [Patient or Disabled Group]
   812   C0030705:Patients [Patient or Disabled Group]
   708   C1306459:primary cancer [Finding]
Processing 00000000.tx.414: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.415: J. 

Phrase: "J."
Processing 00000000.tx.416: Cancer. 

Phrase: "Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.417: 102:159165.[CrossRef][Medline] Dhodapkar, M.V., M.D. 

Phrase: "102"

Phrase: ":"

Phrase: "159165."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dhodapkar,"

Phrase: "M."

Phrase: "V., M.D."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0231965:V D [Laboratory or Test Result]
   901   C1512018:M.D. [Intellectual Product]
   901   C2349138:V/m [Quantitative Concept]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.418: Geller, D.H. 

Phrase: "Geller,"

Phrase: "D."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.419: Chang, K. 

Phrase: "Chang,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.420: Shimizu, S. 

Phrase: "Shimizu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.421: Fujii, K.M. 

Phrase: "Fujii,"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.422: Dhodapkar, and J. 

Phrase: "Dhodapkar,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.423: Krasovsky. 

Phrase: "Krasovsky."
Processing 00000000.tx.424: 2003. 

Phrase: "2003."
Processing 00000000.tx.425: A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. 

Phrase: "A reversible defect in natural killer T cell function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1457869:Defect [Functional Concept]
   742   C1861101:DEFECT [Disease or Syndrome]

Phrase: "characterizes"

Phrase: "the progression of premalignant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]

Phrase: "to malignant multiple myeloma."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0848076:malignant myeloma [Neoplastic Process]
   901   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   827   C0439064:Multiple [Quantitative Concept]
   827   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.426: J. 

Phrase: "J."
Processing 00000000.tx.427: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.428: Med. 

Phrase: "Med."
Processing 00000000.tx.429: 197:16671676.[Abstract/Free FullText] Kim, C.H., B. 

Phrase: "197"

Phrase: ":"

Phrase: "16671676."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "C.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.430: Johnston, and E.C. 

Phrase: "Johnston,"

Phrase: "and"

Phrase: "E.C."
Processing 00000000.tx.431: Butcher. 

Phrase: "Butcher."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335755:BUTCHER [Professional or Occupational Group]
  1000   C1706208:Butcher [Activity]
Processing 00000000.tx.432: 2002. 

Phrase: "2002."
Processing 00000000.tx.433: Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. 

Phrase: "Trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "machinery of NKT cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0337076:machinery [Manufactured Object]
   716   C2350466:Natural Killer T-Cells [Cell]

Phrase: ":"

Phrase: "shared"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]

Phrase: "and"

Phrase: "differential chemokine receptor expression among V alpha 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(+"

Phrase: ")"

Phrase: "V beta 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "NKT cell subsets with distinct cytokine-producing capacity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   782   C0080202:T-Cell Subsets [Cell]
   782   C2362651:T cell subsets [Finding]
   706   C1515021:Subset [Classification]
Processing 00000000.tx.434: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.435: 100:1116.[Abstract/Free FullText] Lauder, I., and W. 

Phrase: "100"

Phrase: ":"

Phrase: "1116."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lauder,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.436: Aherne. 

Phrase: "Aherne."
Processing 00000000.tx.437: 1972. 

Phrase: "1972."
Processing 00000000.tx.438: The significance of lymphocytic infiltration in neuroblastoma. 

Phrase: "The significance of lymphocytic infiltration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "in neuroblastoma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027819:Neuroblastoma [Neoplastic Process]
  1000   C0700095:neuroblastoma [Neoplastic Process]
  1000   C3540583:Neuroblastoma [Intellectual Product]
Processing 00000000.tx.439: Br. 

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.440: J. 

Phrase: "J."
Processing 00000000.tx.441: Cancer. 

Phrase: "Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.442: 26:321330.[Medline] Facchetti, P., I. 

Phrase: "26"

Phrase: ":"

Phrase: "321330."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Facchetti,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.443: Prigione, F. 

Phrase: "Prigione,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.444: Ghiotto, P. 

Phrase: "Ghiotto,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.445: Tasso, A. 

Phrase: "Tasso,"

Phrase: "A."
Processing 00000000.tx.446: Garaventa, and V. 

Phrase: "Garaventa,"

Phrase: "and"

Phrase: "V."
Processing 00000000.tx.447: Pistoia. 

Phrase: "Pistoia."
Processing 00000000.tx.448: 1996. 

Phrase: "1996."
Processing 00000000.tx.449: Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma. 

Phrase: "Functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "molecular characterization of tumour-infiltrating lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "thereof from a major-histocompatibility-complex-negative human tumour"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0024518:Major Histocompatibility Complex [Gene or Genome]
   790   C1753349:Major histocompatibility complex [Cell Component]
   742   C0019627:Histocompatibility [Qualitative Concept]
   742   C0027651:Tumor [Neoplastic Process]
   742   C0086418:Human [Human]
   742   C0205160:Negative [Qualitative Concept]
   742   C0205164:Major [Qualitative Concept]
   742   C0439855:Complex [Qualitative Concept]
   742   C1513916:Negative [Finding]
   742   C1578706:Tumor [Intellectual Product]
   742   C1704241:Complex [Chemical Viewed Structurally]
   742   C2825415:Negative [Conceptual Entity]
   742   C2825491:Negative [Qualitative Concept]
   742   C3273930:Tumor [Finding]

Phrase: ":"

Phrase: "neuroblastoma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027819:Neuroblastoma [Neoplastic Process]
  1000   C0700095:neuroblastoma [Neoplastic Process]
  1000   C3540583:Neuroblastoma [Intellectual Product]
Processing 00000000.tx.450: Cancer Immunol. 

Phrase: "Cancer Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.451: Immunother. 

Phrase: "Immunother."
Processing 00000000.tx.452: 42:170178.[CrossRef][Medline] Matthay, K.K., J.G. 

Phrase: "42"

Phrase: ":"

Phrase: "170178."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matthay,"

Phrase: "K.K.,"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.453: Villablanca, R.C. 

Phrase: "Villablanca,"

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.454: Seeger, D.O. 

Phrase: "Seeger,"

Phrase: "D.O."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512020:D.O. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.455: Stram, R.E. 

Phrase: "Stram,"

Phrase: "R.E."
Processing 00000000.tx.456: Harris, N.K. 

Phrase: "Harris,"

Phrase: "N.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.457: Ramsay, P. 

Phrase: "Ramsay,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.458: Swift, H. 

Phrase: "Swift,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326117:Swift, NOS [Bird]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.459: Shimada, C.T. 

Phrase: "Shimada,"

Phrase: "C.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.460: Black, G.M. 

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.461: Brodeur, et al. 

Phrase: "Brodeur,"

Phrase: "et al."
Processing 00000000.tx.462: 1999. 

Phrase: "1999."
Processing 00000000.tx.463: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. 

Phrase: "Treatment of high-risk neuroblastoma"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with intensive chemotherapy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   861   C0013217:chemotherapy [Functional Concept]
   861   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: "radiotherapy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034619:radiotherapy [Intellectual Product]
  1000   C0243005:Radiotherapy [Biomedical Occupation or Discipline]
  1000   C1522449:Radiotherapy [Therapeutic or Preventive Procedure]

Phrase: "autologous bone marrow transplantation,"
Meta Candidates (Total=24; Excluded=5; Pruned=0; Remaining=19)
  1000   C0194037:autologous bone marrow transplantation [Therapeutic or Preventive Procedure]
           Autologous Marrow Transplantation
   923   C0005961:Bone Marrow Transplantation [Therapeutic or Preventive Procedure]
           Marrow Transplantation
   923   C2986504:Autologous Bone Marrow [Body Substance]
   902   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   875   C0005976:Bone Transplantation [Therapeutic or Preventive Procedure]
   861   C0005953:Bone Marrow [Tissue]
   812   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040733:transplantation [Functional Concept]
   812   C0086590:Marrow [Food]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C0439859:Autologous [Qualitative Concept]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   812   C1546708:Marrow [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   741 E C0443157:Bony [Functional Concept]
   729 E C0330477:Marrows [Plant]

Phrase: "and"

Phrase: "13-cis-retinoic acid."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0022265:13-cis-Retinoic Acid [Organic Chemical,Pharmacologic Substance]
           cis-retinoic acid
   875   C0109872:cis-acid [Organic Chemical,Pharmacologic Substance]
   861   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C1504308:Cis [Eukaryote]
Processing 00000000.tx.464: Children's Cancer Group. 

Phrase: "Children's Cancer Group."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C1516476:Children's Cancer Group [Health Care Related Organization]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0008059:Children [Age Group]
   827   C0441833:Group [Idea or Concept]
   827   C0680063:Children [Family Group]
   827   C0687744:group [Population Group]
   827   C0998265:Cancer [Eukaryote]
   827   C1257890:Group [Population Group]
   827   C1306459:Cancer [Finding]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
Processing 00000000.tx.465: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.466: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.467: J. 

Phrase: "J."
Processing 00000000.tx.468: Med. 

Phrase: "Med."
Processing 00000000.tx.469: 341:11651173.[Abstract/Free FullText] Seeger, R.C., S.A. 

Phrase: "341"

Phrase: ":"

Phrase: "11651173."

Phrase: "[Abstract/Free FullText"

Phrase: "] Seeger,"

Phrase: "R.C., S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.470: Rayner, A. 

Phrase: "Rayner,"

Phrase: "A."
Processing 00000000.tx.471: Banerjee, H. 

Phrase: "Banerjee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.472: Chung, W.E. 

Phrase: "Chung,"

Phrase: "W.E."
Processing 00000000.tx.473: Laug, H.B. 

Phrase: "Laug,"

Phrase: "H.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919534:H-B [Gene or Genome]
Processing 00000000.tx.474: Neustein, and W.F. 

Phrase: "Neustein,"

Phrase: "and"

Phrase: "W.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.475: Benedict. 

Phrase: "Benedict."
Processing 00000000.tx.476: 1977. 

Phrase: "1977."
Processing 00000000.tx.477: Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. 

Phrase: "Morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "growth,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "chromosomal pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "fibrinolytic activity of two new human neuroblastoma cell lines."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0020115:Human Activity [Activity]
   742   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.478: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.479: 37:13641371.[Abstract] Metelitsa, L.S., O.V. 

Phrase: "37"

Phrase: ":"

Phrase: "13641371."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Metelitsa,"

Phrase: "L.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "O.V."
Processing 00000000.tx.480: Naidenko, A. 

Phrase: "Naidenko,"

Phrase: "A."
Processing 00000000.tx.481: Kant, H.W. 

Phrase: "Kant,"

Phrase: "H.W."
Processing 00000000.tx.482: Wu, M.J. 

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.483: Loza, B. 

Phrase: "Loza,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.484: Perussia, M. 

Phrase: "Perussia,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: Kronenberg, and R.C. 

Phrase: "Kronenberg,"

Phrase: "and"

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.486: Seeger. 

Phrase: "Seeger."
Processing 00000000.tx.487: 2001. 

Phrase: "2001."
Processing 00000000.tx.488: Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. 

Phrase: "Human NKT cells"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   937   C2350466:Natural Killer T-Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   888   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   888   C2363836:Natural Killer Cells [Laboratory Procedure]
   884   C0039195:killer t cells [Cell]
   853   C0022686:Killer Cells [Cell]
   840   C0039194:T-Cells [Cell]
   840   C2709199:Natural killer [Cell]
   804   C0007634:Cells [Cell]
   804   C0205296:Natural [Functional Concept]
   804   C1336644:KILLER [Gene or Genome]
   804   C1705132:KILLER [Gene or Genome]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "antitumor cytotoxicity directly by recognizing target cell CD1d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   731   C0022686:Cytotoxic cell [Cell]

Phrase: "with bound ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "or"

Phrase: "indirectly by producing IL-2 to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0021756:IL2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0879590:IL2 [Gene or Genome]
   753   C0020898:IL [Geographic Area]
   753   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0022271:IL [Geographic Area]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "NK cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
  1000   C2363836:Natural Killer Cells [Laboratory Procedure]
   901   C0022686:Killer Cells [Cell]
   901   C2709199:Natural killer [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.489: J. 

Phrase: "J."
Processing 00000000.tx.490: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.491: 167:31143122.[Abstract/Free FullText] Li, C., and W.H. 

Phrase: "167"

Phrase: ":"

Phrase: "31143122."

Phrase: "[Abstract/Free FullText"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.492: Wong. 

Phrase: "Wong."
Processing 00000000.tx.493: 2001. 

Phrase: "2001."
Processing 00000000.tx.494: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. 

Phrase: "Model-based analysis of oligonucleotide arrays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "expression index computation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1880157:Computation [Activity]
   755 E C1516769:Computational [Research Activity]

Phrase: "and"

Phrase: "outlier detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.495: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.496: Natl. 

Phrase: "Natl."
Processing 00000000.tx.497: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.498: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.499: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.500: 98:3136.[Abstract/Free FullText] Seeger, R.C., G.M. 

Phrase: "98"

Phrase: ":"

Phrase: "3136."

Phrase: "[Abstract/Free FullText"

Phrase: "] Seeger,"

Phrase: "R.C., G.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0456715:g m [Quantitative Concept]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.501: Brodeur, H. 

Phrase: "Brodeur,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.502: Sather, A. 

Phrase: "Sather,"

Phrase: "A."
Processing 00000000.tx.503: Dalton, S.E. 

Phrase: "Dalton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678223:dalton [Quantitative Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.504: Siegel, K.Y. 

Phrase: "Siegel,"

Phrase: "K.Y."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.505: Wong, and D. 

Phrase: "Wong,"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.506: Hammond. 

Phrase: "Hammond."
Processing 00000000.tx.507: 1985. 

Phrase: "1985."
Processing 00000000.tx.508: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. 

Phrase: "Association of multiple copies of the N-myc oncogene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "with rapid progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1838681:Rapid progression [Finding]
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "of neuroblastomas."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027819:Neuroblastomas [Neoplastic Process]
   966 E C0700095:neuroblastoma [Neoplastic Process]
   966 E C3540583:Neuroblastoma [Intellectual Product]
Processing 00000000.tx.509: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.510: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.511: J. 

Phrase: "J."
Processing 00000000.tx.512: Med. 

Phrase: "Med."
Processing 00000000.tx.513: 313:11111116.[Abstract] Crabbe, D.C., J. 

Phrase: "313"

Phrase: ":"

Phrase: "11111116."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Crabbe,"

Phrase: "D.C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "J."
Processing 00000000.tx.514: Peters, and R.C. 

Phrase: "Peters,"

Phrase: "and"

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.515: Seeger. 

Phrase: "Seeger."
Processing 00000000.tx.516: 1992. 

Phrase: "1992."
Processing 00000000.tx.517: Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. 

Phrase: "Rapid detection of MYCN gene amplification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in neuroblastomas"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027819:Neuroblastomas [Neoplastic Process]
   966 E C0700095:neuroblastoma [Neoplastic Process]
   966 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polymerase chain reaction."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.518: Diagn. 

Phrase: "Diagn."
Processing 00000000.tx.519: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.520: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.521: 1:229234.[Medline] Slamon, D.J., T.C. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "229234."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Slamon,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "T.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.522: Boone, R.C. 

Phrase: "Boone,"

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.523: Seeger, D.E. 

Phrase: "Seeger,"

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.524: Keith, V. 

Phrase: "Keith,"

Phrase: "V."
Processing 00000000.tx.525: Chazin, H.C. 

Phrase: "Chazin,"

Phrase: "H.C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.526: Lee, and L.M. 

Phrase: "Lee,"

Phrase: "and"

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.527: Souza. 

Phrase: "Souza."
Processing 00000000.tx.528: 1986. 

Phrase: "1986."
Processing 00000000.tx.529: Identification and characterization of the protein encoded by the human N-myc oncogene. 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "encoded by the human N-myc oncogene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0086661:myc Oncogene [Gene or Genome]
   748   C0029016:Oncogene [Gene or Genome]
   748   C0086418:Human [Human]
   748   C0679058:encoded [Mental Process]
   748   C2700640:Encoded [Activity]
Processing 00000000.tx.530: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.531: 232:768772.[Medline] Thomas, S.Y., R. 

Phrase: "232"

Phrase: ":"

Phrase: "768772."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Thomas,"

Phrase: "S."

Phrase: "Y.,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.532: Hou, J.E. 

Phrase: "Hou,"

Phrase: "J.E."
Processing 00000000.tx.533: Boyson, T.K. 

Phrase: "Boyson,"

Phrase: "T.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.534: Means, C. 

Phrase: "Means,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.535: Hess, D.P. 

Phrase: "Hess,"

Phrase: "D.P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.536: Olson, J.L. 

Phrase: "Olson,"

Phrase: "J.L."
Processing 00000000.tx.537: Strominger, M.B. 

Phrase: "Strominger,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.538: Brenner, J.E. 

Phrase: "Brenner,"

Phrase: "J.E."
Processing 00000000.tx.539: Gumperz, S.B. 

Phrase: "Gumperz,"

Phrase: "S."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.540: Wilson, and A.D. 

Phrase: "Wilson,"

Phrase: "and"

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.541: Luster. 

Phrase: "Luster."
Processing 00000000.tx.542: 2003. 

Phrase: "2003."
Processing 00000000.tx.543: CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. 

Phrase: "CD1d-restricted NKT cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   901   C2350466:Natural Killer T-Cells [Cell]
   867   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   867   C2363836:Natural Killer Cells [Laboratory Procedure]
   861   C0039195:killer t cells [Cell]
   839   C0022686:Killer Cells [Cell]
   827   C0039194:T-Cells [Cell]
   827   C2709199:Natural killer [Cell]
   799   C0007634:Cells [Cell]
   799   C0205296:Natural [Functional Concept]
   799   C1336644:KILLER [Gene or Genome]
   799   C1705132:KILLER [Gene or Genome]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "a chemokine receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524914:chemokine receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979963:Profile [Laboratory Procedure]
  1000   C2003903:Profile [Functional Concept]

Phrase: "indicative of Th1-type inflammatory homing cells."
Processing 00000000.tx.544: J. 

Phrase: "J."
Processing 00000000.tx.545: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.546: 171:25712580.[Abstract/Free FullText] Tahir, S.M., O. 

Phrase: "171"

Phrase: ":"

Phrase: "25712580."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tahir,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.547: Cheng, A. 

Phrase: "Cheng,"

Phrase: "A."
Processing 00000000.tx.548: Shaulov, Y. 

Phrase: "Shaulov,"

Phrase: "Y."
Processing 00000000.tx.549: Koezuka, G.J. 

Phrase: "Koezuka,"

Phrase: "G.J."
Processing 00000000.tx.550: Bubley, S.B. 

Phrase: "Bubley,"

Phrase: "S."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.551: Wilson, S.P. 

Phrase: "Wilson,"

Phrase: "S.P."
Processing 00000000.tx.552: Balk, and M.A. 

Phrase: "Balk,"

Phrase: "and"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.553: Exley. 

Phrase: "Exley."
Processing 00000000.tx.554: 2001. 

Phrase: "2001."
Processing 00000000.tx.555: Loss of IFN-gamma production by invariant NK T cells in advanced cancer. 

Phrase: "Loss of IFN-gamma production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "by invariant NK T cells"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
  1000   C2350467:Invariant Natural Killer T-Cells [Cell]
   937   C2350466:Natural Killer T-Cells [Cell]
   888   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   888   C2363836:Natural Killer Cells [Laboratory Procedure]
   884   C0039195:killer t cells [Cell]
   853   C0022686:Killer Cells [Cell]
   840   C0039194:T-Cells [Cell]
   840   C2709199:Natural killer [Cell]
   804   C0007634:Cells [Cell]
   804   C0205296:Natural [Functional Concept]
   804   C1336644:KILLER [Gene or Genome]
   804   C1705132:KILLER [Gene or Genome]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "in advanced cancer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0877373:Advanced Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.556: J. 

Phrase: "J."
Processing 00000000.tx.557: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.558: 167:40464050.[Abstract/Free FullText] Kukreja, A., G. 

Phrase: "167"

Phrase: ":"

Phrase: "40464050."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kukreja,"

Phrase: "A.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.559: Cost, J. 

Phrase: "Cost,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010186:Cost [Quantitative Concept]
  1000   C0220812:cost [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.560: Marker, C. 

Phrase: "Marker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "C."
Processing 00000000.tx.561: Zhang, Z. 

Phrase: "Zhang,"

Phrase: "Z."
Processing 00000000.tx.562: Sun, K. 

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.563: Lin-Su, S. 

Phrase: "Lin-Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705534:SU [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.564: Ten, M. 

Phrase: "Ten,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014518:TEN [Disease or Syndrome]
  1000   C0205456:Ten [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.565: Sanz, M. 

Phrase: "Sanz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.566: Exley, B. 

Phrase: "Exley,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.567: Wilson, et al. 

Phrase: "Wilson,"

Phrase: "et al."
Processing 00000000.tx.568: 2002. 

Phrase: "2002."
Processing 00000000.tx.569: Multiple immuno-regulatory defects in type-1 diabetes. 

Phrase: "Multiple immuno-regulatory defects in type-1 diabetes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0243067:defects [Functional Concept]
   711 E C1457869:Defect [Functional Concept]
   711 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.570: J. 

Phrase: "J."
Processing 00000000.tx.571: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.572: Invest. 

Phrase: "Invest."
Processing 00000000.tx.573: 109:131140.[Abstract/Free FullText] Schmidt, M.L., J.N. 

Phrase: "109"

Phrase: ":"

Phrase: "131140."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schmidt,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "J.N."
Processing 00000000.tx.574: Lukens, R.C. 

Phrase: "Lukens,"

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.575: Seeger, G.M. 

Phrase: "Seeger,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.576: Brodeur, H. 

Phrase: "Brodeur,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.577: Shimada, R.B. 

Phrase: "Shimada,"

Phrase: "R.B."
Processing 00000000.tx.578: Gerbing, D.O. 

Phrase: "Gerbing,"

Phrase: "D.O."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512020:D.O. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.579: Stram, C. 

Phrase: "Stram,"

Phrase: "C."
Processing 00000000.tx.580: Perez, G.M. 

Phrase: "Perez,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.581: Haase, and K.K. 

Phrase: "Haase,"

Phrase: "and"

Phrase: "K.K."
Processing 00000000.tx.582: Matthay. 

Phrase: "Matthay."
Processing 00000000.tx.583: 2000. 

Phrase: "2000."
Processing 00000000.tx.584: Biologic factors determine prognosis in infants with stage IV neuroblastoma: a prospective Children's Cancer Group study. 

Phrase: "Biologic factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005515:Biologic Factors [Biologically Active Substance]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "determine"

Phrase: "prognosis in infants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033325:Prognosis [Health Care Activity]

Phrase: "with stage IV neuroblastoma"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0278694:Stage IV Neuroblastoma [Neoplastic Process]
  1000   C1135161:stage iv neuroblastoma [Neoplastic Process]
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C3540583:Neuroblastoma [Intellectual Product]
   734   C0441772:Stage IV [Intellectual Product]

Phrase: ":"

Phrase: "a prospective Children's Cancer Group study."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0033522:prospective study [Research Activity]
   897   C1709709:Prospective Study [Research Activity]
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]
   717   C1516476:Children's Cancer Group [Health Care Related Organization]
Processing 00000000.tx.585: J. 

Phrase: "J."
Processing 00000000.tx.586: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.587: Oncol. 

Phrase: "Oncol."
Processing 00000000.tx.588: 18:12601268.[Abstract/Free FullText] Lee, P.T., K. 

Phrase: "18"

Phrase: ":"

Phrase: "12601268."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "P.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.589: Benlagha, L. 

Phrase: "Benlagha,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.590: Teyton, and A. 

Phrase: "Teyton,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.591: Bendelac. 

Phrase: "Bendelac."
Processing 00000000.tx.592: 2002. 

Phrase: "2002."
Processing 00000000.tx.593: Distinct functional lineages of human V()24 natural killer T cells. 

Phrase: "Distinct functional lineages of human V()24 natural killer T cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0282637:Lineages, Cell [Idea or Concept]
   704   C1881379:Lineage [Conceptual Entity]
Processing 00000000.tx.594: J. 

Phrase: "J."
Processing 00000000.tx.595: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.596: Med. 

Phrase: "Med."
Processing 00000000.tx.597: 195:637641.[Abstract/Free FullText] Gumperz, J.E., S. 

Phrase: "195"

Phrase: ":"

Phrase: "637641."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gumperz,"

Phrase: "J.E.,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.598: Miyake, T. 

Phrase: "Miyake,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.599: Yamamura, and M.B. 

Phrase: "Yamamura,"

Phrase: "and"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.600: Brenner. 

Phrase: "Brenner."
Processing 00000000.tx.601: 2002. 

Phrase: "2002."
Processing 00000000.tx.602: Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. 

Phrase: "Functionally distinct subsets of CD1d-restricted natural killer T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   761   C0080202:T-Cell Subsets [Cell]
   761   C2362651:T cell subsets [Finding]
   706   C1515021:Subset [Classification]

Phrase: "revealed by CD1d tetramer staining."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0039686:Tetramere [Eukaryote]
   760   C0443289:Revealed [Qualitative Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1413210:CD1D [Gene or Genome]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.603: J. 

Phrase: "J."
Processing 00000000.tx.604: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.605: Med. 

Phrase: "Med."
Processing 00000000.tx.606: 195:625636.[Abstract/Free FullText] Kim, C.H., E.C. 

Phrase: "195"

Phrase: ":"

Phrase: "625636."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "C.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "E.C."
Processing 00000000.tx.607: Butcher, and B. 

Phrase: "Butcher,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335755:BUTCHER [Professional or Occupational Group]
  1000   C1706208:Butcher [Activity]

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.608: Johnston. 

Phrase: "Johnston."
Processing 00000000.tx.609: 2002. 

Phrase: "2002."
Processing 00000000.tx.610: Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. 

Phrase: "Distinct subsets of human Valpha24-invariant NKT cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   761   C0080202:T-Cell Subsets [Cell]
   761   C2362651:T cell subsets [Finding]
   706   C1515021:Subset [Classification]

Phrase: ":"

Phrase: "cytokine responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "chemokine receptor expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0597360:receptor expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0524914:chemokine receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.611: Trends Immunol. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.612: 23:516519.[CrossRef][Medline] Kawakami, K., Y. 

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "516519."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kawakami,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Y."
Processing 00000000.tx.613: Kinjo, K. 

Phrase: "Kinjo,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.614: Uezu, S. 

Phrase: "Uezu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.615: Yara, K. 

Phrase: "Yara,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.616: Miyagi, Y. 

Phrase: "Miyagi,"

Phrase: "Y."
Processing 00000000.tx.617: Koguchi, T. 

Phrase: "Koguchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.618: Nakayama, M. 

Phrase: "Nakayama,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.619: Taniguchi, and A. 

Phrase: "Taniguchi,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.620: Saito. 

Phrase: "Saito."
Processing 00000000.tx.621: 2001. 

Phrase: "2001."
Processing 00000000.tx.622: Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. 

Phrase: "Monocyte chemoattractant protein-1-dependent increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0442805:Increase [Functional Concept]
   734   C0128897:Monocyte Chemoattractant Protein-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1337092:monocyte chemoattractant protein-1 [Gene or Genome]
   734   C1522558:Monocyte Chemoattractant Protein 1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "of V alpha 14 NKT cells"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   877   C0040210:V T [Finding]
   877   C2350466:Natural Killer T-Cells [Cell]
   860   C0030280:Alpha cell [Cell]
   852   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   852   C2363836:Natural Killer Cells [Laboratory Procedure]
   845   C0039195:killer t cells [Cell]
   829   C0022686:Killer Cells [Cell]
   818   C0039194:T-Cells [Cell]
   818   C2709199:Natural killer [Cell]
   795   C0007634:Cells [Cell]
   795   C0205296:Natural [Functional Concept]
   795   C1336644:KILLER [Gene or Genome]
   795   C1705132:KILLER [Gene or Genome]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "in lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "their roles in Th1 response"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "host defense in cryptococcal infection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0520990:Host defence [Organ or Tissue Function]
   760   C1880266:Defense [Conceptual Entity]
Processing 00000000.tx.623: J. 

Phrase: "J."
Processing 00000000.tx.624: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.625: 167:65256532.[Abstract/Free FullText] Graves, D.T., and A.J. 

Phrase: "167"

Phrase: ":"

Phrase: "65256532."

Phrase: "[Abstract/Free FullText"

Phrase: "] Graves,"

Phrase: "D.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.626: Valente. 

Phrase: "Valente."
Processing 00000000.tx.627: 1991. 

Phrase: "1991."
Processing 00000000.tx.628: Monocyte chemotactic proteins from human tumor cells. 

Phrase: "Monocyte chemotactic proteins from human tumor cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0282566:Monocyte Chemotactic Proteins [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0260034:Tumor proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0026473:Monocyte [Cell]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.629: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.630: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.631: 41:333337.[CrossRef][Medline] Nesbit, M., H. 

Phrase: "41"

Phrase: ":"

Phrase: "333337."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nesbit,"

Phrase: "M."

Phrase: ","

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.632: Schaider, T.H. 

Phrase: "Schaider,"

Phrase: "T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.633: Miller, and M. 

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.634: Herlyn. 

Phrase: "Herlyn."
Processing 00000000.tx.635: 2001. 

Phrase: "2001."
Processing 00000000.tx.636: Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. 

Phrase: "Low-level monocyte chemoattractant protein-1 stimulation of monocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   742   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "leads to tumor formation"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0181586:leads [Medical Device]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522492:Formation [Functional Concept]
   770   C1522538:Lead [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3273930:Tumor [Finding]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in nontumorigenic melanoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C1513095:Melanoma Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.637: J. 

Phrase: "J."
Processing 00000000.tx.638: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.639: 166:64836490.[Abstract/Free FullText] Brossay, L., M. 

Phrase: "166"

Phrase: ":"

Phrase: "64836490."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brossay,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.640: Chioda, N. 

Phrase: "Chioda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.641: Burdin, Y. 

Phrase: "Burdin,"

Phrase: "Y."
Processing 00000000.tx.642: Koezuka, G. 

Phrase: "Koezuka,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.643: Casorati, P. 

Phrase: "Casorati,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.644: Dellabona, and M. 

Phrase: "Dellabona,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.645: Kronenberg. 

Phrase: "Kronenberg."
Processing 00000000.tx.646: 1998. 

Phrase: "1998."
Processing 00000000.tx.647: CD1d-mediated recognition of an -galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. 

Phrase: "CD1d-mediated recognition of an -galactosylceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524637:Recognition [Mental Process]

Phrase: "by natural killer T cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C2350466:Natural Killer T-Cells [Cell]
   923   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   923   C0039195:killer t cells [Cell]
   923   C2363836:Natural Killer Cells [Laboratory Procedure]
   875   C0022686:Killer Cells [Cell]
   861   C0039194:T-Cells [Cell]
   861   C2709199:Natural killer [Cell]
   812   C0007634:Cells [Cell]
   812   C0205296:Natural [Functional Concept]
   812   C1336644:KILLER [Gene or Genome]
   812   C1705132:KILLER [Gene or Genome]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved through mammalian evolution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015219:Evolution [Genetic Function]
   770   C0024660:Mammalian [Mammal]
Processing 00000000.tx.648: J. 

Phrase: "J."
Processing 00000000.tx.649: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.650: Med. 

Phrase: "Med."
Processing 00000000.tx.651: 188:15211528.[Abstract/Free FullText] Wu, D.Y., N.H. 

Phrase: "188"

Phrase: ":"

Phrase: "15211528."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "D."

Phrase: "Y.,"

Phrase: "N.H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.652: Segal, S. 

Phrase: "Segal,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.653: Sidobre, M. 

Phrase: "Sidobre,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.654: Kronenberg, and P.B. 

Phrase: "Kronenberg,"

Phrase: "and"

Phrase: "P.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539794:P-B [Gene or Genome]
Processing 00000000.tx.655: Chapman. 

Phrase: "Chapman."
Processing 00000000.tx.656: 2003. 

Phrase: "2003."
Processing 00000000.tx.657: Cross-presentation of disialoganglioside GD3 to natural killer T cells. 

Phrase: "Cross-presentation of disialoganglioside GD3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1257986:Cross-Presentation [Cell Function]
   760   C0449450:Presentation [Idea or Concept]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "to natural killer T cells."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C2350466:Natural Killer T-Cells [Cell]
   923   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   923   C0039195:killer t cells [Cell]
   923   C2363836:Natural Killer Cells [Laboratory Procedure]
   875   C0022686:Killer Cells [Cell]
   861   C0039194:T-Cells [Cell]
   861   C2709199:Natural killer [Cell]
   812   C0007634:Cells [Cell]
   812   C0205296:Natural [Functional Concept]
   812   C1336644:KILLER [Gene or Genome]
   812   C1705132:KILLER [Gene or Genome]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.658: J. 

Phrase: "J."
Processing 00000000.tx.659: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.660: Med. 

Phrase: "Med."
Processing 00000000.tx.661: 198:173181.[Abstract/Free FullText] Wolfl, M., W.Y. 

Phrase: "198"

Phrase: ":"

Phrase: "173181."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wolfl,"

Phrase: "M."

Phrase: ","

Phrase: "W.Y."
Processing 00000000.tx.662: Batten, C. 

Phrase: "Batten,"

Phrase: "C."
Processing 00000000.tx.663: Posovszky, H. 

Phrase: "Posovszky,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.664: Bernhard, and F. 

Phrase: "Bernhard,"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.665: Berthold. 

Phrase: "Berthold."
Processing 00000000.tx.666: 2002. 

Phrase: "2002."
Processing 00000000.tx.667: Gangliosides inhibit the development from monocytes to dendritic cells. 

Phrase: "Gangliosides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017082:Gangliosides [Lipid,Pharmacologic Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the development from monocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "to dendritic cells."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.668: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.669: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.670: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.671: 130:441448.[CrossRef][Medline] Smyth, M.J., N.Y. 

Phrase: "130"

Phrase: ":"

Phrase: "441448."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Smyth,"

Phrase: "M."

Phrase: "J.,"

Phrase: "N.Y."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.672: Crowe, and D.I. 

Phrase: "Crowe,"

Phrase: "and"

Phrase: "D."

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.673: Godfrey. 

Phrase: "Godfrey."
Processing 00000000.tx.674: 2001. 

Phrase: "2001."
Processing 00000000.tx.675: NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. 

Phrase: "NK cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
  1000   C2363836:Natural Killer Cells [Laboratory Procedure]
   901   C0022686:Killer Cells [Cell]
   901   C2709199:Natural killer [Cell]
   827   C0007634:Cells [Cell]
   827   C0205296:Natural [Functional Concept]
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "NKT cells"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C2350466:Natural Killer T-Cells [Cell]
   923   C0022688:Natural Killer Cells [Cell]
       E   Killer cell
   923   C0039195:killer t cells [Cell]
   923   C2363836:Natural Killer Cells [Laboratory Procedure]
   875   C0022686:Killer Cells [Cell]
   861   C0039194:T-Cells [Cell]
   861   C2709199:Natural killer [Cell]
   812   C0007634:Cells [Cell]
   812   C0205296:Natural [Functional Concept]
   812   C1336644:KILLER [Gene or Genome]
   812   C1705132:KILLER [Gene or Genome]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "collaborate"

Phrase: "in host protection from methylcholanthrene-induced fibrosarcoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1545588:Protection [Finding]
Processing 00000000.tx.676: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.677: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.678: 13:459463.[Abstract/Free FullText] Yanagisawa, K., K. 

Phrase: "13"

Phrase: ":"

Phrase: "459463."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yanagisawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.679: Seino, Y. 

Phrase: "Seino,"

Phrase: "Y."
Processing 00000000.tx.680: Ishikawa, M. 

Phrase: "Ishikawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.681: Nozue, T. 

Phrase: "Nozue,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.682: Todoroki, and K. 

Phrase: "Todoroki,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.683: Fukao. 

Phrase: "Fukao."
Processing 00000000.tx.684: 2002. 

Phrase: "2002."
Processing 00000000.tx.685: Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide. 

Phrase: "Impaired proliferative response of V alpha 24 NKT cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C2748560:Impaired T cell proliferative response [Finding]
   738   C0871261:Response [Organism Attribute]
   738   C1704632:Response [Finding]
   738   C1706817:Response [Intellectual Product]
   738   C2911692:Response [Mental Process]

Phrase: "from cancer patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1516213:Cancer Patient [Patient or Disabled Group]
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "against alpha-galactosylceramide."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0534775:Alpha Galactosylceramide [Lipid,Pharmacologic Substance]
  1000   C1528871:alpha-galactosylceramide [Carbohydrate]
   861   C0016960:Galactosylceramide [Biologically Active Substance,Lipid]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.686: J. 

Phrase: "J."
Processing 00000000.tx.687: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.688: 168:64946499.[Abstract/Free FullText] Giaccone, G., C.J. 

Phrase: "168"

Phrase: ":"

Phrase: "64946499."

Phrase: "[Abstract/Free FullText"

Phrase: "] Giaccone,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "C.J."
Processing 00000000.tx.689: Punt, Y. 

Phrase: "Punt,"

Phrase: "Y."
Processing 00000000.tx.690: Ando, R. 

Phrase: "Ando,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.691: Ruijter, N. 

Phrase: "Ruijter,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.692: Nishi, M. 

Phrase: "Nishi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.693: Peters, B.M. von Blomberg, R.J. 

Phrase: "Peters,"

Phrase: "B.M. von Blomberg,"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.694: Scheper, H.J. van der Vliet, A.J. van den Eertwegh, M. 

Phrase: "Scheper,"

Phrase: "H.J. van der Vliet,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0557775:Van [Manufactured Object]
   804   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "A.J. van den Eertwegh,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.695: Roelvink, J. 

Phrase: "Roelvink,"

Phrase: "J."
Processing 00000000.tx.696: Beijnen, H. 

Phrase: "Beijnen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.697: Zwierzina, and H.M. 

Phrase: "Zwierzina,"

Phrase: "and"

Phrase: "H.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348952:H/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.698: Pinedo. 

Phrase: "Pinedo."
Processing 00000000.tx.699: 2002. 

Phrase: "2002."
Processing 00000000.tx.700: A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. 

Phrase: "A phase I study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0920321:Phase I Study [Research Activity]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "of the natural killer T-cell ligand alpha-galactosylceramide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C0534775:Alpha Galactosylceramide [Lipid,Pharmacologic Substance]
   818   C1528871:alpha-galactosylceramide [Carbohydrate]
   795   C0016960:Galactosylceramide [Biologically Active Substance,Lipid]
   795   C0439095:Alpha [Intellectual Product]
   795   C2003941:Alpha [Intellectual Product]
   795   C2350010:Alpha [Qualitative Concept]
   710   C2350466:Natural Killer T-Cell [Cell]

Phrase: "(KRN7000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0534775:KRN7000 [Lipid,Pharmacologic Substance]

Phrase: ")"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with solid tumors."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0280100:solid tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   861   C0205208:Solid [Qualitative Concept]
   861   C0302909:Solid [Substance]
   861   C1378566:Solid [Biomedical or Dental Material]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]
Processing 00000000.tx.701: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.702: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.703: 8:37023709.[Abstract/Free FullText] Maris, J.M., and K.K. 

Phrase: "8"

Phrase: ":"

Phrase: "37023709."

Phrase: "[Abstract/Free FullText"

Phrase: "] Maris,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "K.K."
Processing 00000000.tx.704: Matthay. 

Phrase: "Matthay."
Processing 00000000.tx.705: 1999. 

Phrase: "1999."
Processing 00000000.tx.706: Molecular biology of neuroblastoma. 

Phrase: "Molecular biology of neuroblastoma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   770   C0005532:Biology [Biomedical Occupation or Discipline]
   770   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.707: J. 

Phrase: "J."
Processing 00000000.tx.708: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.709: Oncol. 

Phrase: "Oncol."
Processing 00000000.tx.710: 17:22642279.[Abstract/Free FullText] Raetz, E.A., M.K. 

Phrase: "17"

Phrase: ":"

Phrase: "22642279."

Phrase: "[Abstract/Free FullText"

Phrase: "] Raetz,"

Phrase: "E.A.,"

Phrase: "M."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.711: Kim, P. 

Phrase: "Kim,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.712: Moos, M. 

Phrase: "Moos,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234884:moos [Individual Behavior]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.713: Carlson, C. 

Phrase: "Carlson,"

Phrase: "C."
Processing 00000000.tx.714: Bruggers, D.K. 

Phrase: "Bruggers,"

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.715: Hooper, L. 

Phrase: "Hooper,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.716: Foot, T. 

Phrase: "Foot,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0016504:Foot [Body Part, Organ, or Organ Component]
  1000   C0347981:foot [Quantitative Concept]
  1000   C1281587:Foot [Body Part, Organ, or Organ Component]
  1000   C2346504:Foot [Quantitative Concept]
  1000   C2348613:foot [Quantitative Concept]
  1000   C2348704:foot [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.717: Liu, R. 

Phrase: "Liu,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.718: Seeger, and W.L. 

Phrase: "Seeger,"

Phrase: "and"

Phrase: "W.L."
Processing 00000000.tx.719: Carroll. 

Phrase: "Carroll."
Processing 00000000.tx.720: 2003. 

Phrase: "2003."
Processing 00000000.tx.721: Identification of genes that are regulated transcriptionally by Myc in childhood tumors. 

Phrase: "Identification of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "transcriptionally by Myc"

Phrase: "in childhood tumors."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1368871:Childhood Tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]
Processing 00000000.tx.722: Cancer. 

Phrase: "Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.723: 98:841853.[CrossRef][Medline] Nesbit, C.E., J.M. 

Phrase: "98"

Phrase: ":"

Phrase: "841853."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nesbit,"

Phrase: "C.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.724: Tersak, and E.V. 

Phrase: "Tersak,"

Phrase: "and"

Phrase: "E.V."
Processing 00000000.tx.725: Prochownik. 

Phrase: "Prochownik."
Processing 00000000.tx.726: 1999. 

Phrase: "1999."
Processing 00000000.tx.727: MYC oncogenes and human neoplastic disease. 

Phrase: "MYC oncogenes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:Oncogenes, myc [Gene or Genome]
   861   C0029016:Oncogenes [Gene or Genome]

Phrase: "and"

Phrase: "human neoplastic disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0027651:Neoplastic Disease [Neoplastic Process]
   901   C1882062:Neoplastic disease [Neoplastic Process]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.728: Oncogene. 

Phrase: "Oncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.729: 18:30043016.[CrossRef][Medline]

Phrase: "18"

Phrase: ":"

Phrase: "30043016."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

